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Neurons of the adult mammalian central nervous system (CNS) and peripheral nervous 
system (PNS) differ in their response to injury. PNS neurons have a robust growth 
response and are capable of regenerating their axons and reinnervating peripheral 
targets following nerve injury. However, despite this robust regenerative response, 
specificity of target reinnervation is often poor, leading to a suboptimal functional 
outcome. In contrast, injured CNS neurons have a poor growth response and completely 
fail to regenerate, but uninjured axons that survive the injury undergo some degree of 
spontaneous reorganisation that is accompanied by limited functional improvement. In 
theory, appropriate reorganisation of central connections could compensate for 
topographical errors in the periphery and enhancing the innate capacity for 
reorganisation after CNS injury could compensate for lost function. Thus, recovery 
from both types of injury may benefit from strategies to enhance CNS plasticity. 
 
This Thesis makes use of an experimental strategy to promote plastic changes, that is, 
the enzyme chondroitinase ABC (ChABC) which degrades chondroitin sulphate 
proteoglycans – a major class of inhibitory extracellular matrix molecules. Viral vector 
technology was used to optimise the delivery of ChABC by gene transfer to host spinal 
cord cells. A lentiviral vector expressing the ChABC gene (LV-ChABC) was delivered 
to the adult rat spinal cord to achieve long-term delivery of active ChABC in vivo. After 
peripheral nerve injury, where two forelimb nerves were cut and repaired with different 
levels of inaccuracy, electrophysiological studies demonstrated that LV-ChABC 
injection led to significant plasticity of central connections, such as reorganisation of 
high and low threshold polysynaptic reflexes. This included preservation of the 
phenomenon of wind-up of flexor motor neurons, which was found to collapse after 
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nerve injury, as well as enhanced wind-up responses elicited by radial nerve stimulation. 
ChABC did not lead to any changes in reflex activity in uninjured animals. These 
results indicate that ChABC facilitates the amplification of compensatory changes in the 
spinal cord following injury to the periphery. 
 
ChABC treatment was also investigated in the context of CNS injury. Following 
contusion injury, a clinically relevant model which mimics the functional and 
pathological characteristics typical of a human spinal cord injury, LV-ChABC injection 
led to significant functional improvements, including enhanced conduction, 
reorganisation of spinal reflexes below the lesion and improved performance on a 
sensorimotor behavioural task.  
 
Finally, viral vector technology was used to develop a novel tool for the study of 
anatomical plasticity. By expressing the construct synaptopHluorin (SpH), lentiviral and 
adenoviral-associated viral vectors were used to label presynaptic terminals in vitro and 
in vivo. As the pHluorin component of the label is pH sensitive, this tool has the 
potential additional advantage of enabling the visualisation of synaptic function in vivo. 
The SpH vector was used to label a major motor pathway, the corticospinal tract, as 
well as sensory neurons, and to visualise their terminals as SpH-labelled puncta. Using 
this tool, it will be possible to study synaptogenesis in a quantifiable manner, with the 
potential to study the activity of these new synaptic terminals.   
 
Thus, this Thesis uses a gene delivery approach to deliver ChABC to the spinal cord 
after central or peripheral neuronal injury, leading to the promotion of plasticity and 
functional repair. The development of a novel tool for visualising synapses is also 
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Traumatic spinal cord injury (SCI) is a significant clinical problem. It is estimated that 
2.5 million people worldwide live with the consequences of SCI, which include 
permanent neurological deficits in motor, sensory and autonomic function. Most 
patients exhibit a degree of spontaneous recovery after injury, but the majority are still 
left with permanent disabilities and no effective treatment for spinal injury currently 
exists. Nevertheless, optimism exists within the research community due to the 
emergence of therapies that have shown great promise preclinically, with the 
demonstration of functional improvements in experimental SCI models using a number 
of treatments. These potential future repair strategies will not be described in detail here, 
but have been extensively reviewed (Schwab, 2002; Fehlings and Baptiste, 2005; 
Bradbury and McMahon, 2006; Thuret et al., 2006; Donnelly and Popovich, 2008).  
 
Following traumatic SCI two types of pathological process occur, consisting of primary 
and secondary events (Fehlings and Baptiste, 2005). Primary injury includes the 
physical forces acting on spinal cord tissue, such as compression, contusion or shear 
forces, and is not amenable to therapy. Secondary, reactive changes are triggered by the 
primary mechanical trauma and include processes such as blood-spinal cord barrier 
breakdown, disturbed ionic homeostasis, cellular dysfunction and inflammatory and 
immune changes (Dumont et al., 2001; Gris et al., 2008). These insidious, destructive 
pathophysiological changes are responsible for much of the tissue degeneration 
following injury and have been the focus of intensive research into neuroprotective 
mechanisms that aim to maximally preserve function of remaining tissue after the 
primary trauma (Hall and Springer, 2004). A number of pharamacological agents are 
currently in clinical trials including riluzole, a neuroprotective agent that prevents 
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glutamate release, and fampridine, a specific blocker of potassium channels on 
demyelinated axons (Hayes et al., 2004; Rabchevsky et al., 2011).  
 
1.1 Promoting regeneration of injured axons 
 
Despite the best efforts to contain the secondary effects of SCI, a significant degree of 
functional impairment will remain due to damage sustained by spinal neurons and 
axons. Interruption of axonal pathways leads to a total or partial disconnection of spinal 
segments below the lesion from supraspinal centres, which leads to a debilitating loss of 
voluntary control (Schwab and Bartholdi, 1996). A considerable research effort has 
focussed on stimulating the elongation of injured axons, with the aim of inducing them 
to regenerate beyond the lesion and reconnect with target neurons by forming 
functional synapses. Experimental approaches aiming to promote regeneration of 
injured axons broadly fall into two categories: enhancing the intrinsic ability of neurons 
to regenerate and neutralisation of inhibitory influences. In contrast with the robust 
regeneration of peripheral nerves, frank regeneration does not normally occur in the 
central nervous system (CNS) and it was long believed that this was an immutable state 
(Cajal, 1928). Pioneering experiments by Aguayo in the early 1980s questioned the 
dogma of the impossibility of CNS regeneration by showing that several hundred 
damaged CNS neurons would grow into a peripheral nerve graft (Richardson et al., 
1980; David and Aguayo, 1981). These results indicated that, when presented with a 
growth-promoting microenvironment, injured CNS axons could regenerate. These 
findings led to the identification of growth-promoting factors found in the periphery 





1.1.1 Enhancing the intrinsic regenerative ability of neurons 
Peripheral sensory neurons residing in the dorsal root ganglia have the unusual property 
of possessing two axons: one projecting through a peripheral nerve and the other 
projecting centrally, to the spinal cord. Some of these axons reach the dorsal column 
nuclei. This configuration lends itself to the study of peripheral versus central 
regeneration. Following injury to the peripheral branch of a sensory neuron, many 
transcriptional changes take place within these cells and a robust regenerative response 
ensues, whereas axon damage to the axon residing in the CNS does not result in any 
regeneration. However, when a conditioning lesion is applied to a peripheral nerve, 
central branches of primary sensory neurons exhibit an enhanced regenerative response 
(Richardson and Issa, 1984; Neumann and Woolf, 1999), suggesting that the failure of 
axotomoised CNS neurons to express growth-promoting genes contributes to their poor 
regenerative capability. Approaches to increase the regenerative ability of CNS neurons 
include the manipulation of signalling molecules such as cAMP that have been found to 
determine the intrinsic growth properties of CNS neurons (Qiu et al., 2002; Hannila and 
Filbin, 2008), decreasing the activity of the PTEN/mTOR pathway (Park et al., 2008; 
Liu et al., 2010), inhibiting the activity of the small GTPase RhoA (Ellezam et al., 
2002) and promoting KLF4-mediated transcription (Moore et al., 2009). Additionally, 
the application of neurotrophins, such as BDNF and NT-3, has been found to 
remarkably increase the regenerative ability of CNS neurons (Bradbury et al., 1999; 
Ramer et al., 2000; Lu and Tuszynski, 2008). However, none of these manipulations 




1.1.2 Enhancing regeneration by targeting myelin 
Another important difference in regeneration between injured peripheral and central 
axons is the presence of inhibitory molecules after SCI, preventing regeneration beyond 
the injury site. This theory was first proposed in the 1980s when it was found that the 
injured CNS is a source of molecules that potently inhibit neurite outgrowth (Berry, 
1982). A series of seminal papers followed, identifying CNS myelin as an important 
negative regulator of neurite outgrowth (Caroni and Schwab, 1988b). CNS myelin 
contains multiple proteins with growth inhibitory activity; the best studied of these is 
Nogo-A, which is taken to be the most potent myelin inhibitor (Cafferty et al., 2010). It 
has been reported that the application of neutralising antibodies against Nogo-A renders 
CNS tissue a more permissive substrate in vitro (Caroni and Schwab, 1988a; Savio and 
Schwab, 1989; Chen et al., 2000; Prinjha et al., 2000; Oertle et al., 2003). The 
application of Nogo-A antibodies in vivo has also been reported to promote 
regeneration, plasticity and functional recovery in animal models of SCI (Schnell and 
Schwab, 1990; Bregman et al., 1995; Maier et al., 2009), as has Nogo receptor blockade 
(GrandPre et al., 2002; Li and Strittmatter, 2003; Li et al., 2004; Li et al., 2005a; 
Freund et al., 2006). However, subsequent experiments using triple knockout mice 
lacking the three dominant axons growth inhibitors in myelin (Nogo, MAG and OMgp) 
proved controversial, with conflicting evidence from different laboratories (Silver, 
2010). A thorough study using multiple lesion paradigms to study both regeneration 
and sprouting failed to show any significant regeneration through or beyond the lesion 
and only a slight increase in sprouting, which was not accompanied by behavioural 
improvement (Lee et al., 2010). At the same time, a different laboratory reported robust 
sprouting and regeneration in triple knockout mice, accompanied by remarkable 
behavioural recovery (Cafferty et al., 2010). This latter study used a single dorsal 
hemisection model of SCI, which is vulnerable to sparing of corticospinal tract  (CST) 
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axons in the lateral funiculus or at the base of the dorsal columns and could lead to the 
false appearance of regeneration (Steward et al., 2003). Nevertheless, a human anti-
Nogo-A antibody (ATI355) has completed a Phase I clinical trial, with no deleterious 
side effects observed (www.clinicaltrials.gov/ct2/show/NCT00406016), although 
efficacy has not yet been tested.   
 
1.1.3 Enhancing regeneration by targeting the glial scar 
A second inhibitory obstacle for regenerating axons is the glial scar, a dense collection 
of reactive astrocytes that seal the wound and protect surrounding tissue from cellular 
damage (Faulkner et al., 2004). The reactive astrocytes of the glial scar produce a range 
of molecules that are inhibitory to axonal growth (Silver and Miller, 2004). A 
prominent inhibitory family of molecules is the chondroitin sulphate proteoglycans 
(CSPGs), many of which are strongly inhibitory to neurite outgrowth in vitro (McKeon 
et al., 1991; Friedlander et al., 1994; McKeon et al., 1995; Smith-Thomas et al., 1995). 
The most common approach to mitigating CSPG-mediated inhibition is the use of a 
bacterial enzyme, chondroitinase ABC (ChABC) to cleave the glycosaminoglycan 
(GAG) chains from the core protein of the molecule (Prabhakar et al., 2005), thereby 
removing their inhibitory potential. This approach has been applied to many CNS 
injury models and has promoted regeneration of injured axons in vitro and in vivo 
(Smith-Thomas et al., 1995; Davies et al., 1999; Crespo et al., 2007). Following 
experimental SCI and ChABC treatment, regeneration of axons from different neuronal 
populations including motor (Bradbury et al., 2002; Iseda et al., 2008; Garcia-Alias et 
al., 2009), and sensory fibres (Bradbury et al., 2002; Yick et al., 2003; Cafferty et al., 
2007; Shields et al., 2008) has been observed. Functional recovery has often 
accompanied these observations. A member of the receptor protein tyrosine 
20 
 
phosphatase (RPTP) family, RPTPσ, has recently been found to be a receptor that 
interacts with CSPGs, signalling neuronal inhibition (Shen et al., 2009). The loss of 
RPTPσ has been reported to accelerate axonal regeneration in the periphery of adult 
mice (McLean et al., 2002; Thompson et al., 2003) and has led to improved axonal 
regeneration after optic nerve injury (Sapieha et al., 2005). Similarly, following SCI 
axonal growth into the lesion after dorsal column crush injury is markedly enhanced by 
loss of RPTPσ (Shen et al., 2009), as is CST regeneration beyond a dorsal hemisection 
(Fry et al., 2010). However, the contribution of regeneration to the functional recovery 
seen in these animals is unknown, and the distances regenerated by axons are typically 
modest. In the early studies using ChABC, functional recovery was often attributed to 
the regeneration of fibres seen using anterograde or retrograde labelling, but it is 
possible that plasticity in other, untraced spinal systems were at least partly responsible 
for the improvements seen. Evidence for plasticity as a mechanism underlying the 
effects of ChABC is discussed below. 
 
1.1.4 Cellular transplantation for SCI 
In humans most spinal injuries result from blunt trauma and are contusive in nature, 
featuring a fluid-filled cyst or cavity surrounded by a rim of spared tissue (Norenberg et 
al., 2004). This large cavity represents an extremely hostile environment and a 
considerable obstacle for regenerating axons to negotiate. Attempts to counter this 
problem include the development of grafting and cellular transplantation therapies, 
which provide physical support across the lesion, as well as trophic support. Substrates 
that have been used to bridge lesion cavities include peripheral nerve, foetal cell or 
Schwann cell grafts, which provide a physical scaffold for elongating axons (Reier et 
al., 1988; Paino and Bunge, 1991; Cheng et al., 1996; Raisman, 1997). An important 
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role of transplanted cells is their considerable ability to enhance neuronal survival, 
regeneration and repair by secreting neuroprotective factors (Jones et al., 2001; Teng et 
al., 2006; Glazova et al., 2009). Specialised cells have also been used to combat the 
dysmyelination of axons that occurs after injury, including oligodendrocyte precursor 
cells and Schwann cells, that ensheath growing axons (Barnabe-Heider and Frisen, 
2008; Rossi and Keirstead, 2009). 
 
Clearly, SCI is a multifactorial problem including an unfavourable growth-inhibitory 
environment (Silver and Miller, 2004; Xie and Zheng, 2008), glial and inflammatory 
reaction (Popovich and McTigue, 2009), neuronal cell death and axonal disruption 
(Schwab and Bartholdi, 1996), insufficient stimulation of axonal growth by guidance 
cues (Giger et al., 2010) and an intrinsic failure of mature CNS neurons to activate 
regenerative transcriptional programs (Sun and He, 2010). The individual approaches 
described above will be limited in their ability to achieve CNS repair, as each 
experimental treatment will tackle only one of the many facets of this complex problem. 
Evidence from studies using combinatorial approaches is promising and reviewed 
thoroughly elsewhere (McCall et al., 2012). 
 
1.2 Beyond regeneration 
 
Promoting regeneration of the CNS after injury by targeting the lesion site has been the 
focus of much work for over a century, but the neurological significance of the 
regeneration observed experimentally remains unclear (Illis, 2012). There are several 
considerations that should be noted: the proportion of regenerating axons is small, the 
distance regrown by axons is modest and the contribution of regeneration to recovery is 
unknown. In one of the most impressive examples of CNS regeneration, PTEN 
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knockout mice exhibited axonal regeneration of up to 3mm beyond a complete spinal 
cord crush (Liu et al., 2010), but the authors report that many axons fail to penetrate the 
lesion site. Clearly, if the goal of regenerative research were for re-growing axons to 
reconnect with their original targets there remains a huge hurdle to achieving this goal, 
especially as in humans many thousands of neurons would have to regenerate tens of 
centimetres to reach their target neurons. There is more reason for optimism regarding 
the small numbers of regenerating axons, as it has been shown many times that even a 
small percentage of spared or regenerated axons can foster functional recovery 
(Bradbury and McMahon, 2006). The issue of connectivity of regenerated axons 
remains elusive. Ultrastructural evidence for synapse formation by regenerating axons 
has been described in several studies (Alto et al., 2009; Lu et al., 2012) and 
immunohistochemical visualisation of the immediate early gene c-fos provides a strong 
indication of connectivity. Firm electrophysiological evidence exists for the functional 
regeneration of sensory neurons following dorsal rhizotomy (Ramer et al., 2000; 
Steinmetz et al., 2005). Following SCI, there is an interruption of connections and the 
goal of most therapeutic strategies is to re-establish the connection between supraspinal 
centres and their target neurons below the lesion, either directly or indirectly. Direct 
reconnection can be provided by axonal regeneration, whereas indirect reconnection 
occurs via an alternative, multi-synaptic pathway and this compensatory anatomical 
rearrangement is known as plasticity. Evidence for regeneration has been provided in 
experimental models involving complete spinal cord transection (e.g. Fouad et al., 
2005), but where the injury is incomplete it is difficult to separate the contributions of 
plastic and regenerative effects. The majority of human SCI is contusive in nature, with 
some degree of neural tissue sparing even in the most severe injuries (Kakulas, 1987; 
Tuszynski et al., 1999) and imaging evidence from a rat contusion model has shown 
that grey and white matter sparing is predictive of behavioural and electrophysiological 
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recovery (Kim et al., 2012). This remaining tissue presents a potentially more tractable 
target than for interventions aimed at promoting functional recovery after SCI 
compared to achieving true regeneration.  
 
1.3 Neuronal Plasticity 
 
The mature CNS was once thought to be hard-wired but changes in neural organisation 
are now known to be possible. The term ‘neuronal plasticity’ describes two main 
phenomena. Synaptic plasticity is the activity-dependent change in the efficacy of 
existing synapses. This form of plasticity is prominent during development when many 
connections are made, but experience determines which are maintained and which are 
pruned; it also underlies learning and memory formation. Anatomical plasticity is the 
structural, adaptive reorganisation of neural pathways and occurs after injury to the 
CNS. 
 
1.3.1 Origins of the concept of neuronal plasticity 
William James first linked the modifiability of behavioural habits and the strengthening 
of specific brain pathways by repeated use (James, 1890). He suggested that, as with 
footpaths, repeated use of neural paths would reinforce them. Tanzi and Lugaro built 
upon these ideas, proposing that localised synaptic facilitation was necessary for 
learning skills and forming mental associations (reviewed in Berlucchi and Buchtel, 
2009). This view is remarkably aligned with the modern view of plasticity, especially in 
view of the fact that until Sherrington in 1897 there was no concept of the synapse 
(Berlucchi and Buchtel, 2009). At this time a clear theory of mental association was put 
forward by Lugaro: a coincidence of activity in two neurons leads to a newly formed 
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association between them (Lugaro, 1898). Although he was probably not the first to use 
the term neuronal plasticity, Cajal’s theory of ‘cerebral gymnastics’ was very influential. 
He proposed that mentation was a product of plasticity, such that continuing stimuli 
would lead to an increase in neuronal connections (DeFelipe, 2006).  
 
Plasticity was then largely ignored for several decades until the publications of 
Konorski (1948) and Hebb (1949), who brought the subject back into fashion with the 
publication of The Organisation of Behaviour (Hebb, 1949). Hebb favoured the concept 
of a reinforcement of existing synapses and changes attributed to this form of plasticity 
are sometimes referred to as ‘Hebbian’. Evidence supporting his view that coincident 
activity leads to strengthened connections was provided by the discovery of long-term 
potentiation (Bliss and Lomo, 1973; Sejnowski, 1999). Cajal favoured the formation of 
new connections as a mechanism explaining plasticity and evidence supporting this 
theory was provided some years later by the discovery that dendrite branching and 
spine density increase when animals are exposed to enriched environments (Volkmar 
and Greenough, 1972). 
 
1.3.2 Regeneration, sprouting and plasticity  
So far interventions that aim to achieve re-growth of injured axons have been 
considered. However, this is just one form of growth response that occurs after injury. 
Before we consider the role of spontaneous and experimentally induced plasticity in 
CNS repair, it is important to define the axonal growth responses that occur after injury. 
It is now recognised that axonal growth after injury is a dynamic continuum, consisting 
of related phenomena (reviewed in Cafferty et al., 2008a). At one end of the spectrum is 
‘true’ regeneration, which is the re-growth of an injured axon from its severed end. 
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Axons growing in this way rarely elongate more than a millimetre in the adult 
mammalian CNS, but can grow considerably more following experimental intervention 
(e.g. Schnell and Schwab, 1990). At the other end of the spectrum is synaptic plasticity, 
which occurs on the scale of microns and includes changes to spine density and 
dendritic branch morphology (Tan and Waxman, 2012). This form of growth involves 
biochemical change and anatomical alterations that are small but may nonetheless have 
significant biological consequences. Between these two extremes of the scale is the 
phenomenon of sprouting, which occurs on the scale of millimetres and can either be 
collateral (i.e. growth from the intact proximal segment of an injured axon) or sprouting 
stimulated in intact axonal fibres that are in proximity to injured fibre tracts, but 
undamaged themselves (Cafferty et al., 2008a). These are not clearly delineated terms 
and distinguishing sprouting and regenerating axons is not straightforward. However, it 
is important to understand the differences between such terms, if we are to correctly 
describe the effects of experimental therapies.  
 
To study axonal growth after injury the classic method involved cutting a tract, 
labelling the axons of that tract and designating labelled fibres below the lesion as 
regenerated. However, if the lesion was incomplete, then spared fibres could be 
mistaken for regenerated fibres (Steward et al., 2003). When designing a study, the type 
of axonal growth expected will influence the choice of experimental injury model. For 
example, although a dorsal over-hemisection is a good model for studying CST 
regeneration, it is not a good model for CST sprouting and unilateral pyramidotomy 
would perhaps be more suitable (Lee and Zheng, 2012). Therefore, knowledge of the 
types of axonal growth stimulated by a treatment is important. Here, we define only 
growth of injured axons from the severed end as regeneration; this is often termed ‘true’ 
or ‘frank’ regeneration and was discussed above in the context of spinal cord repair. 
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Plasticity is a term encompassing the concepts of sprouting (both injured and intact 
fibres) and synaptic plasticity. 
 
Cajal was the first to demonstrate synaptic replacement due to collateral sprouting in 
the dentate gyrus after a unilateral entero-rhinocortical lesion (Illis, 2012), although this 
finding was largely forgotten for a few decades, when Liu and Chambers (1958) 
reported collateral sprouting of intact afferents into regions of spinal cord denervated by 
dorsal root section. The first use of the term anatomical plasticity was by Raisman 
(1969) who demonstrated synaptic replacement due to collateral sprouting in septal 
nuclei at the ultrastructural level (Raisman, 1969). In contrast to axonal regeneration, 
sprouting is commonly observed spontaneously after SCI and several experimental 
treatments have been reported to enhance this response; these will be discussed in later 
sections. 
 
 As mentioned above, plasticity does not necessarily mean structural alterations but can 
include altered CNS physiology due to changes in synaptic input to cells (Illis, 2012). 
An important example is the unmasking of latent synapses when cells are deprived of 
their normal input (Wall, 1977) and begin to respond to new inputs that would not 
cause responses in intact animals.  
 
1.3.3 Spontaneous Plasticity after Spinal Cord Injury 
Most human spinal cord injuries are incomplete and accompanied by a degree of 
spontaneous functional recovery, which can be substantial (Wernig and Muller, 1992; 
Dietz et al., 1998; Fawcett et al., 2007). Experimental SCI in animal models is also 
followed by a period of improvement in locomotion and on behavioural tasks 
(Rossignol et al., 1999; Weidner et al., 2001; Bareyre et al., 2004; Courtine et al., 2005). 
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This improvement in function was originally attributed to recovery from spinal shock 
(Holaday and Faden, 1983; Hiersemenzel et al., 2000), a period following SCI that, in 
humans, is characterised clinically by areflexia or hyporeflexia (1-3 days) and the 
gradual return of reflexes and the development of hyper-reflexia, over weeks and 
months (Ditunno et al., 2004). The initial phase of spinal shock is thought to be due to a 
loss of descending excitatory influence to spinal neurons, as well as loss of descending 
inhibition of spinal inhibitory neurons (Ditunno et al., 2004), but it has become 
increasingly apparent that neural plasticity underlies many of the changes in reflex 
activity and function during this dynamic period. For example, it has been shown that 
two major components underlying improved function in humans were compensation 
and neural plasticity (Curt et al., 2008). Compensation refers to an improvement in 
function without an accompanying change in neurological deficit, e.g. an adapted 
movement strategy, as opposed to plasticity, which involves a change in neural circuitry.  
 
1.3.3.1 Cortical reorganisation after nervous system injury 
Although axonal regeneration rarely, if ever, occurs spontaneously in the adult 
mammalian CNS, spontaneous reorganisation of the adult CNS neuronal connections 
occurs readily after neural injury. Early studies focussed on cortical reorganisation 
following nerve injury in the periphery, where it was shown that denervated areas of 
cortex are initially silenced, but are invaded over time by neighbouring, intact afferents 
(Kaas, 1991). This has been shown to occur in the cortices of adult primates (Merzenich 
et al., 1983b; Merzenich et al., 1983a; Pons et al., 1991) and rats (Donoghue et al., 
1990; Sanes et al., 1990). Cortical neurons appear to compete to occupy space and 
several mechanisms have been suggested to underlie this ‘invasion’ of unoccupied 
cortical space, including the unmasking of horizontal connections. Features of the 
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sensory environment are processed vertically across cortical layers, but horizontal 
projections between neighbouring cortical representational areas allow context-
dependent processing of this information and the balance of excitation and inhibition 
promotes competition (Adesnik and Scanziani, 2010). In addition, experience-
dependent activity between neighbouring cortical neurons, such as LTP, may be 
responsible for the recognition of patterns of representation and represent a spatial 
substrate for competition (Hess and Donoghue, 1994, 1996). The removal of 
intracortical inhibition after nerve injury has also been shown to contribute to 
alterations in connectivity (Jacobs and Donoghue, 1991; Brasil-Neto et al., 1993), 
especially in the light of the finding that intracortical inhibitory neurotransmitter levels 
can be related to sensory experience (Hendry and Jones, 1986). Finally, changes in 
cortical synapse number and morphology have been described during motor map 
reorganisation (Kleim et al., 2004; Kim et al., 2008). 
 
1.3.3.2 Cortical reorganisation after SCI 
Spontaneous reorganisation of motor and sensory cortical areas has also been observed 
following incomplete SCI. Numerous electrophysiological studies have shown 
remodelling of the somatosensory cortex following sensory afferent damage in the 
dorsal columns of the spinal cord (Kaas et al., 2008). For example, following partial 
dorsal column section, intact afferents initially continue to activate their normal target 
territories, but after some weeks these target areas become enlarged (Jain et al., 1997). 
Similarly, functional recovery of hand function has been shown to parallel re-
emergence of the hand cortical map after unilateral CST lesion (Schmidlin et al., 2004). 
Rodent models of SCI have used electrophysiological, anatomical and imaging 
techniques to show this expansion of intact cortex into neighbouring, deprived areas. 
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Electrophysiological approaches include intracortical microstimulation (Fouad et al., 
2001; Martinez et al., 2009) and recording cortical activation in response to peripheral 
stimuli (Ghosh et al., 2010), which has shown that cortical changes occur within 
minutes of injury (Aguilar et al., 2010). Imaging studies have also shown the dynamic 
nature of cortical maps, with techniques such as voltage-sensitive dye (Ghosh et al., 
2009; Ghosh et al., 2010) and functional magnetic resonance imaging (fMRI) (Endo et 
al., 2007; Nishimura and Isa, 2009; Ghosh et al., 2010) being employed. These studies 
showed an expansion of the representation of the unimpaired limb (Endo et al., 2007; 
Ghosh et al., 2009) and the importance of both ipsi- and contralateral cortical changes 
in recovery (Nishimura and Isa, 2009). More recently similar changes have been 
observed in humans using positron emission tomography (Bruehlmeier et al., 1998; 
Curt et al., 2002a), fMRI (Curt et al., 2002b) and transcranial magnetic stimulation 
(Brasil-Neto et al., 1993; Endo et al., 2009). 
 
1.3.3.3 Spinal reorganisation after SCI 
Although less research has focussed on spontaneous plasticity after injury at the spinal 
level, recent observations suggest that reorganisation of spinal neural circuitry is 
considerable (Raineteau and Schwab, 2001). Studies have largely considered three main 
fibre systems: descending tracts from supraspinal centres, the propriospinal system of 
interneurons and the spinal locomotor pattern generator. Following experimental SCI, 
sprouting of injured and uninjured spinal axons occurs spontaneously in response to 
distant synaptic loss. For example, sprouting of lesioned hindlimb CST neurons into 
cervical spinal cord has been shown following a distant (thoracic) SCI and these axons 
become rewired in order for injured hindlimb CST axons to innervate the neurons of a 
spared body part (Fouad et al., 2001; Ghosh et al., 2010). Similarly, disruption of the 
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major, dorsal component of the CST has led to extensive spontaneous sprouting of the 
minor ventral and lateral CST components at the lesion site (Weidner et al., 2001; 
Bareyre et al., 2005) and this sprouting parallels functional recovery (Weidner et al., 
2001). Spontaneous sprouting has long been suggested to contribute to functional 
recovery (Murray and Goldberger, 1974; Aoki et al., 1986) and it still believed that 
sprouting of CST fibres is important in mediating functional recovery after SCI 
(Jankowska and Edgley, 2006). As well as sprouting at and above the lesion site, a 
robust sprouting response of spared axons into the distal, denervated lumber segment of 
cord has been described, including spared descending serotonergic axons (Saruhashi et 
al., 1996) and ascending sensory afferents (Ondarza et al., 2003). Studies involving 
lesions of single tracts reveal that certain tracts can compensate for the loss of others. 
For example, the rubrospinal and bulbospinal tracts mediate functional compensation 
following the loss of the CST (Kennedy, 1990) and rats with localised damage to the 
lateral or ventral funiculi, which contain the reticulospinal and vestibulospinal tracts, 
exhibit similar functional recovery so presumably one tract compensates for the loss of 
the other (Loy et al., 2002).  
 
The role of plasticity of the proriospinal system in mediating functional recovery was 
shown in an elegant study from the Schwab laboratory. Following a thoracic dorsal 
hemisection, injured CST fibres rostral to the lesion sprouted into the ipsilateral grey 
matter and made novel connections with propriospinal neurons, forming a route to 
bypass the injury and maintain a pathway for communication between corticospinal 
neurons and spinal motor neurons (Bareyre et al., 2004). The functionality of the newly 
formed connections was confirmed using both electrophysiology and trans-synaptic 
tracing, and improvements in hindlimb function were observed. Re-lesion of the CST 
rostral to the lesion reversed the functional improvements and electrophysiological 
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responses to cortical stimulation, suggesting that the rewiring of CST connections was 
necessary for mediating the functional improvement (Bareyre et al., 2004). Furthermore, 
the formation of relay circuits via reorganisation of descending and propriospinal 
connections can mediate recovery of treadmill locomotion, even if all descending 
pathways have been interrupted by staggered hemisections (Courtine et al., 2008). This 
ability of the spinal cord to remodel and form relay connections to bridge an injury site 
presents a different and possibly more achievable approach to treating CNS lesions, 
such as those found in stroke, multiple sclerosis and SCI. 
 
The central pattern generator (CPG) is a circuitry within the spinal cord that is capable 
of generation the basic locomotor rhythm (Rossignol et al., 2006). The rhythmic, 
alternating patterns of excitation and inhibition are generated by the oscillatory 
properties of pacemaker cells coupled with excitatory interneurons (Grillner, 2003; 
Brocard et al., 2010). Following thoracic/cervical SCI an intact system of spinal circuits 
and sensory afferents remains to organise locomotion, entirely or partly cut off from 
supraspinal control. It has been shown that kittens (Forssberg et al., 1980) and adult 
cats (Barbeau and Rossignol, 1987; Belanger et al., 1996; de Leon et al., 1998b) can 
recover hindlimb locomotion following a T13 complete transection and several weeks 
of locomtor training. Sensory inputs are not required to produce the basic oscillatory 
rhythm but are critical in modulating and adapting locomotion to suit the environment. 
Afferent input from joints, skin and muscles interact with the CPG and dynamically 
shape the locomotor output (reviewed in Rossignol et al., 2006). The reliance of 
locomotion on sensory feedback is heightened after the loss of descending inputs and 
this was shown by experiments where animals underwent peripheral nerve injury before 
or after complete SCI (Rossignol and Frigon, 2011). If peripheral nerves were disrupted 
before injury, the recovery process was severely disrupted (Frigon and Rossignol, 
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2009). However, if an animal underwent spinal transection and locomotor training 
before the nerve injury, recovery did not suffer (Carrier et al., 1997), showing that 
sensory input alters reflexes in a desirable way during the training process. 
Considerable changes in spinal reflexes after SCI occur both spontaneously and due to 
activity-dependent processes, such as training (Cote and Gossard, 2003). Indeed, 
following incomplete SCI the novel appearance of evoked responses in rats after 
epidural stimulation (Lavrov et al., 2006) and humans after cutaneous nerve stimulation 
(Dietz et al., 2009) has been associated with recovery of locomotion. However, 
incomplete SCI presents a more complex picture, as there are several descending 
modulatory influences with access to spinal circuitry that may be spared. The 
reticulospinal and vestibulospinal tracts are important for the initiation of, and postural 
control during, locomotion. The CST and rubrospinal tracts are involved in the 
execution of more volitional, complicated tasks and goal-directed locomotion (Drew et 
al., 2004). The propriospinal system has also been shown to contribute to the recovery 
of volitional locomotion (Kato et al., 1984; Courtine et al., 2008). Importantly, 
connectivity from supraspinal centres is necessary for regaining voluntary control of 
locomotion, which is a desirable outcome for many spinal injured patients. The 
importance of compensation by intrinsic spinal circuitry has been investigated using a 
dual injury paradigm of an incomplete lesion followed several weeks later by a 
complete transection (Barriere et al., 2008; Barriere et al., 2010). Cats that undergo 
complete transection normally take several weeks and intensive training to regain 
treadmill locomotion, but those that had received an incomplete injury prior to the 
transection were able to walk within hours of the transection (Barriere et al., 2008; 
Barriere et al., 2010). These findings demonstrate the essential nature of an intact 
intrinsic spinal circuitry that is able to form new, adaptive configurations. Similarly, 
Basso et al. (1996) found that rats that underwent a spinal contusion 7 weeks prior to a 
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complete transection achieved better scores on a test of locomotor function than those 
that received transection only (Basso et al., 1996). Many studies of partial spinal lesions 
have attributed any observed functional improvements to effects mediated by 
descending tracts and have largely overlooked the potential importance of changes in 
spinal circuitry (Rossignol and Frigon, 2011). 
 
1.3.4 Promoting plasticity after SCI – rehabilitation 
Spontaneous plasticity after SCI parallels a functional improvement, independent of 
any therapeutic intervention, that leads to partial recovery. There is now considerable 
evidence that rehabilitative training can further promote this plasticity and harness it for 
useful functional changes (Fouad and Tetzlaff, 2012; Musienko et al., 2012). The 
potential of rehabilitative training to promote functional improvement after SCI was 
first shown using cats with complete spinal cord transection. After several months of 
intense treadmill training, cats regained weight-bearing locomotion and were able to 
walk on a treadmill for considerable periods of time (Lovely et al., 1986; Barbeau and 
Rossignol, 1987). The plasticity underlying these improvements was found to be 
activity dependent as improvements were observed only in tasks that the cats had been 
trained to perform. For example, cats that had been trained to stand were not able to 
step on a treadmill (Tillakaratne et al., 2002), showing that the isolated spinal cord had 
‘learned’ a specific task in a ‘Hebbian’ manner. In this way, coordinated neuronal 
activity that is triggered by the repetitive movements during rehabilitative training can 
promote recovery after CNS injuries. It is likely that rehabilitation-induced plasticity is 
superimposed onto spontaneous changes. However, separating the contribution of the 
two types of plasticity in rodent models of SCI is not straightforward because rodents 
tend to self-train in their home cages because they remain mobile, even after a severe 




Locomotor training has been used successfully to improve motor function below the 
level of SCI, both clinically and in laboratory experiments (Edgerton et al., 2006). For 
example, daily treadmill training of rats with thoracic transection has been shown to 
reinforce spinal locomotor circuitry (Ichiyama et al., 2008). The success of locomotor 
training in achieving weight-bearing locomotion in the laboratory has led to the 
translation of activity-based rehabilitation into the clinic, where it is used as therapy for 
humans with partial SCI (Dietz and Harkema, 2004; van Hedel and Dietz, 2010). This 
approach has yielded improvements in ambulatory function in patients with incomplete 
SCI (Wernig and Muller, 1992; Dietz et al., 1994; Barbeau et al., 1999; Behrman and 
Harkema, 2000). Indeed, rehabilitative training alone is currently the most successful 
treatment for SCI, as has been shown by a clinical trial which reported that 92% of 
subjects regained the ability to walk at a functional speed within 3 months (Dobkin et 
al., 2007). However, locomotor training does not result in improvements in locomotion 
in patients with severe SCI (Dietz, 2009). This has been suggested to be due to the 
depressed state of spinal networks, such that there is insignificant activity in neuronal 
networks remaining to be trained (Dietz et al., 1994; Harkema, 2008). Strategies to 
change the physiological state of spinal circuits have been developed to increase 
neuronal activity and thereby facilitate stepping and weight bearing. These include 
electrical spinal cord stimulation and the use of pharmacological agents to promote a 
permissive state (reviewed in Musienko et al., 2012). 
 
Physical rehabilitation may improve functional outcomes in several ways (Fouad and 
Tetzlaff, 2012). Electrophysiological studies have shown that motor training can affect 
the neurophysiological characteristics of motoneurons. For example, one study showed 
that there was a strong correlation between stepping behaviour after training and the 
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amplitude of synaptic inputs to motoneurons, as well as the action potential 
afterhyperpolarisation amplitude (Petruska et al., 2007). Physical rehabilitation has also 
led to rearrangements of cortical maps, such that the area representing the trained limb 
expands (Girgis et al., 2007). In addition, the up-regulation of growth factors following 
physical rehabilitation has been described (Maier et al., 2008), particularly brain 
derived neurotrophic factor, BDNF (Vaynman and Gomez-Pinilla, 2005; Ying et al., 
2005). 
 
Despite the promising results described above, several studies in recent decades have 
shown that rehabilitative training can be a double-edged sword (Tetzlaff et al., 2009). 
Cats that had been trained to weight-bear learned to stand for long periods, but 
performed worse than untrained cats on a treadmill; in contrast cats trained to walk 
could stand less well than untrained cats (De Leon et al., 1998a, b). Similarly, rats with 
cervical spinal lesions that had been trained to perform a reaching task deteriorated in 
their performance on an untrained locomotor task, the horizontal ladder (Girgis et al., 
2007). In addition, animals trained in a task specific manner to perform reaching and 
grasping had improved manual dexterity (when combined with CSPG digestion) but 
animals treated with ChABC and given general rehabilitation in an enriched 
environment performed even worse on the reaching task than untreated control animals 
(Garcia-Alias et al., 2009). Encouragingly, one study has reported that the combination 
of training for both ladder walking and grasping leads to improvements in both trained 
tasks (Dai et al., 2009). Taken together, these results suggest that considerable care 
should be taken when planning rehabilitation so that certain tasks are not gained at the 





1.3.5 Promoting plasticity after SCI – targeting myelin 
 
1.3.5.1 Myelin and plasticity in the naïve brain 
The role of myelin-associated inhibitors in restricting plasticity after SCI is well 
described and will be discussed below. More recently it has been established that these 
molecules play a physiological role in the intact CNS by limiting anatomical, 
experience-dependent and activity-dependent plasticity.  
 
A classic example of CNS plasticity is the shift in ocular dominance of binocular cortex, 
whereby deprivation of one eye leads to an increased representation of the other in the 
visual cortex (Crair et al., 1998). This shift can only be induced during the critical 
period of development (Crair et al., 1998), a period of heightened plasticity, during 
which neuronal properties are highly prone to modification, especially through 
experience (Berardi et al., 2000). The end of this activity-driven period of heightened 
plasticity in the visual system occurs weeks to months after birth in rodents and at about 
5 years of age in humans (Hensch, 2004). Its closure coincides with an increase in 
myelination in the visual cortex, suggesting a role for myelin in the loss of ocular 
dominance shifts as adulthood is reached (McGee et al., 2005). Nogo plays a role in 
restricting ocular dominance plasticity in an NgR1-dependent manner, as shown by 
experiments with Nogo-A and NgR1 knockout mice. Loss of either protein leads to a 
persistence of ocular dominance shifts well into adulthood, clearly indicating a role for 
the Nogo-Ngr1 axis in the closure of the critical period (McGee et al., 2005). Another 
recently described high affinity receptor for inhibitory myelin components, Paired 
Immunoglobulin-like Receptor B (Atwal et al., 2008), also limits ocular dominance 
plasticity (Syken et al., 2006). Thus, experience-dependent processes in the mature, 
intact CNS are regulated by myelin components. 
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1.3.5.2 Inhibition of myelin 
The earliest evidence for the limitation of collateral sprouting by myelin components 
came from experiments employing unilateral CST lesions at the level of the medullary 
pyramid, which completely lesion one tract, while leaving the other projection intact. 
The first study showing sprouting of intact CST fibres after pyramidotomy 
administered an anti-Nogo antibody, IN-1, post-lesion and saw significant sprouting of 
CST fibres in the developing spinal cord (Schwab and Schnell, 1991). Anti-Nogo 
treatment has also led to CST sprouting in the mature rat spinal cord of both intact and 
injured axons, which were visualised by anterograde labelling of the lesioned CST, and 
this was accompanied by recovery of forelimb function (Thallmair et al., 1998; 
Z'Graggen et al., 1998). Pyramidotomy has also been shown to lead to CST sprouting in 
the brainstem, at the level of the pontine nucleus (Blochlinger et al., 2001). CST 
plasticity has also been studied in the context of experimental stroke models where, at 
the level of the brainstem or spinal cord, one CST tract is damaged and the other left 
intact by a distant injury. Sprouting of the intact CST into the denervated side was seen 
at the level of the midbrain and spinal cord and was associated with improved 
functional recovery (Papadopoulos et al., 2002; Lee et al., 2004). In addition to rodent 
studies, anti-Nogo antibody treatment has been shown to improve primate hand 
function following a cervical unilateral hemisection (Freund et al., 2006, 2009) 
accompanied by an increased number of midline crossing sprouts (Freund et al., 2007). 
These studies showed that CST axons sprout across the midline, leading to bilateral 
innervation of spinal cord or brainstem targets. Of course, the CST is not the only tract 
to undergo plastic changes following suppression of Nogo-A using antibodies. For 
example, intact rubrospinal tract fibres have been reported to sprout into the ventral 
horn of the spinal cord after bilateral pyramidotomy (Raineteau et al., 2002). 
Serotonergic fibres have also been shown to sprout into lumbar spinal cord after 
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thoracic SCI and re-establish connections after application of an anti-Nogo antibody 
(Mullner et al., 2008; Maier et al., 2009). In addition to antibodies, other treatment 
types that block the Nogo receptor (NgR1) or its ligands have also been employed to 
similar effect. NgR1 blockade using the antagonist NEP1-40 leads to sprouting of 
various descending tracts after SCI, including serotonergic and CST fibres, and this has 
often accompanied functional improvements (GrandPre et al., 2002; Li and Strittmatter, 
2003; Cao et al., 2008). Targeting the NgR1 co-receptor, LINGO-1, has also led to 
sprouting of both rubrospinal and CST axons (Ji et al., 2006). Moving away from 
pharmacological or immunotherapy, transgenic studies using knockout mice lacking 
myelin components such as myelin-associated glycoprotein (MAG), oligodendrocyte 
myelin glycoprotein (OMgp) and various Nogo isoforms (Nogo-A, -B and -C) have 
also been carried out. Following SCI in MAG/OMgp/Nogo-A knockouts enhanced 
sprouting has been observed, primarily due to the loss of Nogo-A (Cafferty et al., 2010; 
Lee et al., 2010). However, the functional significance of this finding is controversial as 
improved locomotion was found by one laboratory (Cafferty et al., 2010) but not by 
another (Lee et al., 2010). The pharmacological and immunotherapy studies targeting 
Nogo or NgR1 were primarily carried out in rats, whereas the transgenic studies utilised 
mice. However, the magnitude of improvements seen in performance on behavioural 
tests was comparable between studies using Nogo-A or NEP1-40 (e.g. GrandPre et al., 
2002; Lee et al., 2004) and those using Nogo-A knockout mice (Cafferty et al., 2010). 
Deletion of Nogo-A/-B has been shown to lead to a significant increase in sprouting of 
both injured and uninjured axons in mouse models of SCI of differing severity (Kim et 
al., 2003; Simonen et al., 2003; Cafferty and Strittmatter, 2006). In one of these studies, 
the increase in midline-crossing sprouts correlated with functional recovery (Cafferty 
and Strittmatter, 2006). Similarly, in mice lacking NgR1 that had undergone thoracic 
hemisection collateral sprouting of the raphespinal tract was observed and this was 
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responsible for the improved locomotor recovery in knockouts versus heterozygotes 
(Kim et al., 2004).  
These studies provide evidence that myelin-associated factors inhibit collateral 
sprouting, suggesting that they restrict non-regenerative growth. As the sprouting 
phenomenon often coincides with functional recovery, it is likely that compensatory 
anatomical growth is aiding the development of indirect connections between the brain 
and the spinal cord, thereby mediating behavioural improvements.  
 
1.3.6 Promoting plasticity after SCI – targeting CSPGs 
 
1.3.6.1 Structure and interactions of CSPGs in the CNS  
CSPGs are major components of the CNS extracellular matrix (ECM). They are a 
divergent group of molecules that are grouped according to the characteristics of their 
core proteins, which contain different domains (Fig. 1.1). The specific protein moieties 
of the core protein affect the interactions and signalling capabilities of the particular 
CSPG family member. The core protein is covalently linked to linear polysaccharide 
chains, known as chondroitin sulphate glycosaminoglycans (CS-GAGs; Kjellen and 
Lindahl, 1991), which vary in number between 1 to >100 per core protein molecule. 
The disaccharide sugar units that make up CS-GAGs can be sulphated by chondroitin 
sulphotransferases (Sugahara and Mikami, 2007). The resulting heterogeneous and 
precise sulphation patterns determine the interactions of CSPGs with other molecules 
and encode functional information (Gama et al., 2006). The variation in structure of 
CSPGs helps to explain their wide range of molecular interactions, including ECM 
proteins and growth factors. CSPG interactions with other ECM proteins are essential 
for the formation of the perineuronal nets (PNN), which are structures of condensed 
matrix that form around the cell bodies and proximal dendrites of certain classes of 
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neuron (Celio et al., 1998). Other major PNN components include the tenascins 
(Bruckner et al., 2000), hyaluronan (Yasuhara et al., 1994), and link protein (Bekku et 
al., 2003), all of which are known to interact with CSPG components of the PNN 
(Galtrey and Fawcett, 2007a). A summary of the interactions of lecticans, the most 
abundant CSPG family in the CNS, is shown in Fig. 1.1B. During CNS development, 
expression levels and sulphation patterns of CSPGs are tightly regulated (Cortes et al., 
2009). The participation of CSPGs during the development is reviewed elsewhere 
(Oohira et al., 2000; Carulli et al., 2005; Sugahara and Mikami, 2007).  
 
1.3.6.2 CSPGs in the visual system 
As mentioned above, the phenomenon of ocular dominance plasticity involves the shift 
towards increased cortical representation of one non-deprived eye following 
deprivation of the other eye (Berardi et al., 2003). As the CNS matures, this shift is no 
longer possible. Evidence for the involvement of CSPGs in limiting cortical plasticity 
has been revealed by several studies investigating ocular dominance. Organisation of 
CSPGs into PNNs coincides with the end of this period of heightened plasticity 
(Pizzorusso et al., 2002). Dark rearing prolongs the critical period and delays CSPG 
accumulation into PNNs in the visual cortex (Guimaraes et al., 1990; Hockfield et al., 
1990; Lander et al., 1997; Pizzorusso et al., 2002), indicating that PNN formation in the 
visual cortex is activity-dependent. Digestion of PNN CSPGs in the visual cortex using 
ChABC led to an ocular dominance shift following monocular deprivation in adult rats 
(Pizzorusso et al., 2002), showing that the mature ECM inhibits experience-dependent 
plasticity and that CSPG degradation can reactivate cortical plasticity. In a further study, 
rats were subjected to monocular deprivation prior to the end of the critical period, until 
adulthood. This led to an irreversible shift in ocular dominance and a reduction in 





















Fig. 1.1: Schematic representation of the most common CNS CSPGs and their 
environmental interactions. (A) Lecticans are composed of two globular N- and C-
terminal domains (G1 and G3, respectively) flanking a core protein region where GAG 
chains attach via serine residues. Aggrecan has an additional G2 domain adjacent to the 
G1 domain. (B) Phosphacan is a splice variant of the full-length receptor-type protein-
tyrosine phosphatase β (RPTPβ) that lacks the two intracellular tyrosine phosphatase 
domains (D1 and D2). Both of these have an N-terminal carbonic anhydrase domain 
(CA), CS-GAG attachment regions and a fibronectin type III domain (FN). (C) 
Schematic showing molecular components of the G1 and G3 domains of a lectican, 
indicating target areas for interactions with binding partners and interactions with other 
ECM molecules (red arrows). CRD, Carbohydrate recognition domain; CBP, 
complement binding protein; EGF, epidermal growth factor; Ig, immunoglobulin. From 









animals with ChABC led to a complete recovery of ocular dominance, visual acuity and 
spine density (Pizzorusso et al., 2006). Similar results have been described in mice 
lacking the cartilage link protein Crtl1, which had disrupted PNN formation and 
elevated levels of ocular dominance plasticity persisting into adulthood (Carulli et al., 
2010). Together, these studies show that disrupting PNNs by targeting one of their 
major components can lead to persistent plasticity and that an intact PNN is required to 
restrict plasticity in the mature CNS. 
 
1.3.6.3 CSPGs in memory 
Evidence for a role of CSPGs in CNS plasticity has also come from memory-related 
models, including long-term potentiation (LTP) and long-term depression (LTP) in the 
hippocampus (Dityatev and Schachner, 2003), as well as from studying fear memories 
(Quirk et al., 2010).  
 
Fear conditioning, in adult animals, is induced by pairing an ambient stimulus with a 
painful stimulus, which results in the formation of a permanent memory that is resistant 
to erasure. Extinction training can generate an inhibitory memory capable of 
suppressing the conditioning effect, but only temporarily (Quirk et al., 2010). In 
contrast, extinction training can completely erase the fear memory if performed during 
the postnatal period. The amygdala is involved in fear conditioning and contains PNNs, 
which have recently been suggested to play a role in the developmental regulation of 
fear conditioning (Gogolla et al., 2009). The appearance of PNNs in the amygdala 
coincides with the end of the developmental period when extinction can result in 
permanent erasure of fear memories, suggesting a role for PNNs in preserving these 
memories. Furthermore, ChABC digestion of PNN CSPGs in the amygdala of adult 
mice led to the permanent erasure of fear memories using extinction, without affecting 
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the acquisition of the conditioning effect (Gogolla et al., 2009). These results suggest 
that the fear memories of adult animals are actively protected by the presence of PNNs.  
The hippocampus has been extensively studied for its plasticity in response to brief 
periods of altered input, LTP and LTD (Bliss and Collingridge, 1993; Malenka and 
Bear, 2004). The role of PNNs in this form of plasticity has been investigated using 
hippocampal slice cultures. The removal of CS-GAG chains by exposing the slice to 
ChABC was found to reduce both LTP and LTD (Bukalo et al., 2001). Transgenic 
approaches allow the modification of PNNs by removal of single components. PNNs 
are less prominent in brevican deficient mice and the maintenance of hippocampal LTP 
is severely impaired (Brakebusch et al., 2002). Neurocan knockout mice have normal-
looking PNNs and LTP development, but the maintenance of late-phase LTP is 
impaired (Zhou et al., 2001). The divergent effects of neurocan and brevican absence 
on LTP suggest that PNN components have differing roles in the development and 
maintenance of LTP.  
  
1.3.6.4 CSPGs in synaptic stability – possible mechanisms 
Once neural circuits have been formed by experience-dependent processes their 
connections must be stabilised to maintain performance. Due to its known inhibitory 
effects on structural rearrangements and axonal growth, the ECM is believed to play an 
important role in long-term synaptic stabilisation and the maintenance of synaptic 
networks (Dityatev et al., 2010a). This is illustrated by examples from the visual system 
and memory-related models in the preceding sections. However, the molecular 
mechanisms of this inhibition remain elusive. Putative mechanisms include (i) 
signalling pathway regulation, (ii) a physical barrier for the lateral diffusion of 
membrane molecules, and (iii) regulation of neuronal excitability. 
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Growth inhibitory molecules, including CSPGs, signal through epidermal growth factor 
receptor (EGFR), RhoA and ROCK (Koprivica et al., 2005). Activation of this 
signalling pathway leads to growth cone collapse and ChABC may promote structural 
plasticity by blocking the activation of this pathway (Borisoff et al., 2003; Sivasankaran 
et al., 2004). In addition, ChABC treatment leads to an increase in the phosphorylated 
form of extracellular regulated signal kinase 1 (ERK1), an enzyme involved in 
excitatory synaptic plasticity (Carter et al., 2008). Direct interactions of CSPGs with 
specific receptors also inhibit axonal outgrowth and induce growth cone collapse. It has 
recently been shown that CSPGs bind with high affinity to the protein tyrosine 
phosphatase σ (PTPσ) transmembrane receptor (Shen et al., 2009; Fry et al., 2010) and 
prevent their oligomerisation, leading to the inhibition of axonal growth (Coles et al., 
2011). 
 
Transmembrane proteins, including neurotransmitter receptors, can move laterally in 
the membrane but do not move freely as they are limited by intracellular proteins and 
ECM molecules. The fast exchange of AMPA receptors between synaptic and 
extrasynaptic sites allows the modulation of synaptic transmission (Heine et al., 2008) 
but the presence of compartments formed by PNNs limits this lateral diffusion 
(Frischknecht et al., 2009). In this study, enzymatic removal of a key PNN component, 
hyaluronan, led to increased receptor exchange and changes in short-term plasticity 
(Frischknecht et al., 2009).  
 
CSPGs are enriched around axons and have been implicated in the 
compartmentalisation of axonal proteins. For example, brevican is enriched at the axon 
initial segment and perisomatically (John et al., 2006). It also accumulates at the nodes 
of Ranvier of large diameter myelinated axons and is likely to be responsible for 
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organisation of other nodal ECM components (Bekku et al., 2009). Experiments using 
mice lacking the versican splice variant V2 have shown that paranodes form normally 
and nodal ion channels cluster appropriately, but the nodal ECM formation is largely 
impaired (Dours-Zimmermann et al., 2009). Experiments using cultured hippocampal 
interneurons have shown that CSPGs accumulate around axons in an activity-dependent 
way and their removal with ChABC leads to increased neuronal excitability (Dityatev 
et al., 2007). This finding suggests that CSPGs are involved in the regulation of 
neuronal activity. Supporting evidence for this hypothesis is provided by the 
observation that CS-GAGs are involved in the regulation of local diffusion of Ca
2+
 in 
the brain (Hrabetova et al., 2009). Extracellular Ca
2+
 concentration plays a critical role 
in regulating neuronal excitability and synaptic transmission and it is possible that 
CSPG-mediated limitation of its diffusion may regulate these features. 
 
1.3.6.5 ChABC treatment promotes plasticity after SCI  
As discussed in previous sections, axonal sprouting and new circuit formation 
following SCI parallels spontaneous recovery (Weidner et al., 2001; Bareyre et al., 
2004; Courtine et al., 2008; Rosenzweig et al., 2010). As CSPGs play a significant role 
in restricting plasticity in the mature CNS, CSPG modification presents an attractive 
approach to enhance the spontaneous plasticity after injury and potentially improve 
functional recovery. The most common strategy used to target CSPGs is their digestion 
with ChABC, which removes their inhibitory CS-GAG side chains and has been shown 
by many studies to have positive effects on functional recovery after experimental SCI, 
when used alone or in combination (Bradbury and Carter, 2011). It has been 
convincingly demonstrated that ChABC treatment promotes regeneration and 
neuroprotection (Bradbury et al., 2002; Fouad et al., 2005; Crespo et al., 2007; Carter et 
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al., 2008; Tester and Howland, 2008; Carter et al., 2011). Here, the beneficial effects of 
CSPG modification on promoting plasticity after SCI will be discussed. 
 
CSPGs are present in the uninjured spinal cord in the form of PNNs, which encapsulate 
many spinal neurons and restrict their growth and plasticity. After SCI, a glial scar 
forms and CSPG levels rapidly increase, which makes the environment intensely 
inhibitory to axonal growth (Silver and Miller, 2004; Busch and Silver, 2007). Thus, 
CSPGs are exerting inhibitory effects at two levels: the PNNs surrounding surviving 
neurons and glial scar-associated CSPGs, providing two targets for anti-CSPG therapies 
to promote plasticity following SCI. 
 
ChABC injection can render the uninjured CNS more adaptive, as shown by 
experiments in the visual system (Berardi et al., 2004). ChABC has also been shown to 
increase structural plasticity in the form of sprouting in denervated CNS regions, 
following distant injury. For example, following partial retinal injury, undamaged 
retinal axons exhibited significantly increased sprouting into the superior colliculus 
with ChABC and BDNF treatment (Tropea et al., 2003). In the partially denervated 
brainstem, following cervical dorsal column lesion, ChABC treatment led to increased 
sprouting of uninjured forelimb primary afferents into denervated territory (Massey et 
al., 2006). This sprouting was visualised anatomically, using cholera toxin tract tracing, 
and the functional connectivity of these sprouts was shown using electrophysiological 
receptive field mapping. This study is significant because it demonstrates that sprouting 
can be directly linked to a functional improvement. Spared primary afferents have also 
exhibited significantly increased sprouting in the dorsal horn that was denervated by 
multiple cervical rhizotomies of the C5, C6, C8 and T1 dorsal roots (Cafferty et al., 
2008b). This sprouting of spared C7 fibres was accompanied by improved sensory 
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behavioural function and electrophysiological changes, which showed the novel 
formation of connections between second order spinal neurons and spared primary 
afferent fibres in ChABC treated animals. Increased plasticity in the denervated spinal 
cord following peripheral nerve injury has also been observed by increased 
immunostaining for a marker of sprouting axons, phosphorylated MAP1B, after spinal 
microinjection of ChABC (Galtrey et al., 2007). Sprouting was accompanied by 
behavioural improvements in grip strength and skilled reaching after nerve injury 
paradigms that resulted in misguided regeneration in the periphery. This study shows 
that central plasticity can compensate for inaccurate motor and sensory reinnervation in 
the periphery. Plasticity of both intact and injured fibres within the spinal cord 
following SCI was first shown by Barritt et al., (2006). A cervical dorsal column lesion 
was employed and intrathecal ChABC treatment was found to promote sprouting of 
intact serotonergic fibres and peptidergic primary afferents caudal to the lesion (Barritt 
et al., 2006). Unlesioned fibres of the dorsolateral CST have also been shown to sprout 
into spinal grey matter regions containing digested CSPGs following disruption of the 
major, dorsal CST component (Garcia-Alias et al., 2009). This ChABC induced 
sprouting accompanied a partial recovery of motor function. The above studies have all 
been carried out in rodent SCI models but it has also been shown that ChABC treatment 
of a cervical hemisection in a larger mammal, the cat, led to marked serotonergic 
sprouting and improved functional recovery (Tester and Howland, 2008). These studies 
show that compensatory plasticity by spared fibres is restricted by CSPGs and may play 
an important role in promoting useful function after SCI and ChABC treatment. 
 
Sprouting of injured fibres after SCI has also been described. Following a cervical 
dorsal column lesion that almost entirely abolished the dorsal CST, tract tracing showed 
that injured CST fibres sprouted rostral to, within and caudal to the lesion (Barritt et al., 
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2006). Long distance regeneration of CST fibres would be required for reconnection 
with their original targets, which is rarely seen using any experimental treatment and 
only in a small number of fibres. The formation of a relay circuit by sprouting CST 
fibres connecting with the propriospinal system to bypass the lesion has been suggested 
as an attractive alternative to long distance regeneration (Courtine et al., 2008) and 
could be enhanced by ChABC.  
 
1.3.6.6 Plastic changes after combinatorial treatments using ChABC 
SCI is a severe, multifactorial problem with many concurrent problems and mitigation 
of inhibitory CSPGs is just one of the many possible targets for potential therapies. By 
combining experimental treatments that target distinct problems, it has been possible to 
achieve better results than by using therapies in isolation (Lu and Tuszynski, 2008). 
One strategy has been to combine a peripheral nerve graft (PNG) with ChABC to make 
the tissue surrounding the graft more permissive. Houle et al., (2006) used a PNG to 
bridge a C3 hemisection and applied ChABC at the distal site of apposition with the 
cord. This study showed a synergistic effect of using both approaches together, with 
animals performing significantly better on behavioural tests of forelimb use. After 
cutting the PNG some of the behavioural effects lingered, suggesting that local 
reorganisation of spinal circuitry induced by ChABC may have contributed to the 
functional improvement (Houle et al., 2006). Recently, a similar study used a C2 
hemisection model to investigate the effect of PNG combined with ChABC treatment 
on recovery of respiratory function (Alilain et al., 2011). This study showed that 
ChABC alone could cause sprouting of intact serotonergic fibres and a limited 
restoration of diaphragm function investigated using electrophysiological techniques. 
However, when the ChABC and a PNG were used in combination, diaphragmatic 
recovery was remarkable (Alilain et al., 2011). Further, transection of the PNG led to a 
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transient increase in tonic diaphragm activity, indicating considerable remodelling of 
spinal circuitry. As this was not observed in animals that had received the PNG alone, 
the role of CSPGs in restricting functional reorganisation is confirmed. Other 
combinatorial strategies include the combination of ChABC with growth factors or cell 
transplants. One study using the growth factor NT-3 in combination with ChABC 
showed that reinnervation of the deafferented gracile nucleus could be promoted by 
either treatment alone, but using both together led to a superior synergistic effect 
(Massey et al., 2008). Karimi-Abdolrezaee et al. (2010) also used a combination 
therapy approach and showed that ChABC is an important part of the therapy. This 
study combined ChABC, a cocktail of growth factors and a transplant of neural 
progenitor cells to promote the survival of graft cells and encourage functional 
plasticity. The results of this study were that both CST remodelling and a functional 
improvement were achieved only when all three of the therapies were combined. 
Importantly, when ChABC was left out of the combination no increase in 
neuroanatomical sprouting was observed, underlining the key role for CSPG digestion 
in promoting plasticity (Karimi-Abdolrezaee et al., 2010). A recent convincing example 
of increased plasticity consisted of a lateral hemisection and a combination treatment 
consisting of ChABC, NT-3 and the NR2D subunit of the NMDA receptor (Garcia-
Alias et al., 2011). In this study electrophysiological techniques were used to 
demonstrate the formation of a relay pathway around the hemisection, allowing novel 
polysynaptic connectivity of lateral white matter fibres with ipsilateral lumbar 
motoneurons. This plasticity was accompanied by sprouting of reticulospinal fibres, 
which was only present in ChABC treated animals, and accompanied a behavioural 
improvement (Garcia-Alias et al., 2011). Only those animals that received the full 
combination exhibited these plastic phenomena, suggesting that the growth-promotion 




1.3.7 Combination of plasticity-enhancing therapies and rehabilitation 
Ultimately, an SCI therapy is likely to combine a regenerative or plasticity-promoting 
pharmacological treatment with training to direct meaningful connectivity. This 
principle is reminiscent of the situation during development of the nervous system, 
where many connections are made, but only those that are used are maintained and 
stabilised, whereas unused connections are pruned (Murakami et al., 1992). In principle 
a plasticity-promoting treatment could facilitate the formation of numerous non-specific 
connections, which will then be refined and translated into functional recovery by 
rehabilitative training. As all SCI patients receive some form of rehabilitation as part of 
their care, any pharmacological treatment would have to work in conjunction with 
training (Dobkin and Havton, 2004). Thus, pre-clinical studies assessing this 
combinatorial approach are vital. Recently a number of studies have addressed this 
issue and have combined training regimes with growth factors, ChABC (Garcia-Alias 
and Fawcett, 2012) or anti-Nogo treatment (Starkey and Schwab, 2012). 
 
Boyce and colleagues (2007) performed complete spinal transections in adult cats and 
assessed their ability to regain quadrupedal stepping on a treadmill. Animals received 
either a transplant of NT-3 and BDNF expressing fibroblasts into the lesion site, daily 
treadmill training, or both combined. The authors reported that untrained animals that 
received neurotrophins only performed as well as animals that had undergone daily 
treadmill training. Animals that received a combination of training and neurotrophins 
did not exhibit further improvements, except on one outcome measure (Boyce et al., 
2007). As axonal growth through the transplant was observed, it is likely that the 
neurotrophins were affecting spinal circuits below the level of the injury (de Leon, 
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2007). As release of neurotrophins is one mechanism by which training exerts its 
effects, this may explain the lack of additive effect of the two treatments. 
 
A second study examined the effects of daily treadmill training combined with anti-
Nogo antibody treatment after an incomplete thoracic SCI in adult rats (Maier et al., 
2009). Animals that received the antibody alone showed a good recovery of 
coordinated locomotion as shown by detailed kinematic analysis. Rats that had received 
treadmill training only also recovered coordinated locomotion, although kinematic 
parameters indicated a more abnormal gait than antibody treated rats. Surprisingly, rats 
that received both interventions performed worse than both other groups, with very 
dysfunctional stepping. The authors suggest that the differing mechanisms of 
improvement induced by the two treatments may interfere with each other, or that the 
timing of the commencement of training was inappropriate (Maier et al., 2009). The 
latter explanation is supported by the finding that, when using the same injury and anti-
Nogo treatment, delaying the onset of training to four weeks after injury resulted in a 
very good functional outcome (Marsh et al., 2011). 
 
A third investigation from the Fawcett laboratory investigated the effects of ChABC 
treatment and task specific training, either alone or in combination, on rats’ ability to 
reach for sugar pellets after a dorsal column injury (Garcia-Alias et al., 2009). Neither 
ChABC treatment nor reaching training alone led to any recovery of skilled forelimb 
function. However, administering both treatments simultaneously led to a significant 
effect, with rats recovering the ability to retrieve around two-thirds as many pellets as 
they had pre-lesion. As improved hand function is a high priority for patients with 
spinal cord injuries (Anderson, 2004), this study indicates an exciting opportunity 
towards developing combination treatments for patients. A cautionary element of the 
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study by Garcia-Alias et al. (2009) is the detrimental effect on forelimb reaching the 
authors observed when animals underwent general rehabilitation. Clearly, the 
competing and synergistic effects of pharmacological and rehabilitative therapies are 
not straightforward and further work will be required to elucidate the mechanisms 
underlying injury- and treatment-induced changes. 
 
1.4     Aims of the Thesis 
The work in this Thesis aims to firstly, use viral vector technology to deliver the 
enzyme chondroitinase ABC to the rodent spinal cord following peripheral or central 
nervous system injuries; secondly, to investigate the functional and anatomical changes 
associated with injury and treatment, with an emphasis on electrophysiology; and 
thirdly, to develop a novel tool for investigating plasticity in the nervous system by 
using viral vectors to label the synaptic terminals of neuronal populations both in vitro 
and in vivo. 
 
The experimental findings are presented in the following Chapters: 
 
 Chapter 2: Chondroitinase ABC promotes plasticity of spinal reflexes following 
peripheral nerve injury 
Chapter 2 uses electrophysiological techniques to investigate the effect of two different 
levels of inaccurate peripheral reinnervation on low and high threshold spinal reflexes. 
Following lentiviral delivery of ChABC to digest CSPGs, several indicators of 
reorganisation of central connections were observed. These included increases in the 
amplitude of low threshold polysynaptic reflexes, protection of a high threshold reflex, 
wind-up, from injury induced collapse and the novel appearance of wind-up responses 
in an extensor nerve, the radial. These results suggest that the application of a plasticity-
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promoting treatment to the spinal cord allows reorganisation of central connections in 
response to inaccurate wiring in the periphery. 
 
Chapter 3: Gene delivery of chondroitinase ABC promotes functional repair after 
spinal cord injury 
Employing a thoracic contusion injury, Chapter 3 examines the functional outcomes 
after SCI and treatment with lentiviral ChABC. Functionally, in vivo 
electrophysiological testing reveals increased conduction across the lesion and 
plasticity of spinal reflexes below the lesion, and animals also performed better on a 
behavioural test of sensorimotor function. Anatomical examination showed a 
significant amelioration of lesion pathology and changes in the appearance of the glial 
scar of treated animals. Together, these results indicate that CSPG digestion can 
promote repair and functional improvement after traumatic SCI. 
 
Chapter 4: Developing viral vectors for the study of anatomical plasticity in the 
nervous system 
Chapter 4 describes the development lentiviral vectors expressing synaptic proteins and 
their use in vitro. Application of different viral vectors in vivo revealed that an 
adenoviral vector of AAV2/5 serotype produced better transduction than lentiviral 
vectors. Thus, AAV2/5 was used to express a synaptic protein with pH-sensitive GFP 
tag, synaptopHluorin, in two neuronal populations in vivo, the CST and sensory 
neurons. The terminals of labelled axons were brightly labelled, allowing quantification 
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2.1.1 Peripheral nerve injury 
Peripheral nerve injury frequently has long-term debilitating consequences due to the 
loss of motor and sensory function conveyed by that nerve, as well as secondary 
consequences such as neuropathic pain (Jaquet et al., 2001). Despite refinement of 
surgical techniques for peripheral nerve repair, functional recovery is often only partial 
(Lundborg, 2003). This is in part due to poor specificity of target reinnervation by 
regenerating axons, which is known to be inaccurate when axons regenerate over long 
distances (Koerber et al., 1989; Valero-Cabre et al., 2004; Guntinas-Lichius et al., 
2005b; Navarro et al., 2007).  
 
In theory, it is possible that topographical errors in regeneration can be compensated for 
with appropriate reorganisation of central processing. However, such plasticity appears 
to be limited. It has been reported that children recover better than adults after surgical 
repair of a peripheral nerve (Rosen et al., 2000; Lundborg and Rosen, 2001; Jerosch-
Herold, 2003). Studies comparing outcomes after nerve repair in adult or infant 
monkeys found that regeneration success was not different, even though functional 
outcomes were better in the younger group (Almquist et al., 1983). This suggests that 
the immature CNS has a greater capacity for central reorganisation. 
 
2.1.2 Central plasticity after peripheral nerve injury 
In adult mammals there is some evidence for central plasticity. For example, after cut 
and repair of the sciatic nerve regenerating sensory neurons lose normal topography 
(Fawcett and Keynes, 1990). When these sensory axons first regenerate to skin, dorsal 
horn neurons receiving sciatic input exhibit, as expected, very large and diffuse 
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receptive fields. However, with time, these receptive fields become focussed and 
approximately normal in size (Lewin et al., 1994). This reorganisation is blocked by 
spinal NMDA antagonists, suggesting an activity-dependent, Hebbian mechanism of 
functional reorganisation of sensory connections. However, such reorganisation is 
limited in extent. For instance, somatotopic reorganisation remains disrupted. Further, a 
number of studies have demonstrated that some spinal circuitry, for instance 
monosynaptic connections made by muscle spindle afferents with homonymous 
motoneurons cannot be respecified (Mendell and Scott, 1975; Lisney, 1983). Thus, 
despite the capacity for central changes following peripheral nerve injury, functional 
outcome remains poor.  
 
2.1.3 Enhancing plasticity with ChABC 
Strategies to enhance central plasticity may improve the outcome, for example 
modulating components of the CNS extracellular matrix. CSPGs have emerged as 
important regulators of plasticity (Kwok et al., 2008; Bartus et al., 2011). Their 
appearance in the spinal cord during development, in the form of PNNs, marks the end 
of the critical period of plasticity (Kalb and Hockfield, 1988, 1990; Takahashi-Iwanaga 
et al., 1998; Galtrey and Fawcett, 2007a) and mice lacking a PNN component, tenascin-
R, show improved functional recovery after facial nerve injury and repair (Bruckner et 
al., 2000; Guntinas-Lichius et al., 2005a). Similarly, animals lacking Crtl1 link protein 
with attenuated PNNs have persistent anatomical plasticity in medullary sensory nuclei 
(Carulli et al., 2010). Furthermore, CSPGs have recently been shown to be involved in 
receptor exchange between synaptic and extrasynaptic sites (Frischknecht et al., 2009), 
the maintenance of contextualised fear memories (Gogolla et al., 2009) and the 
induction of hippocampal long-term potentiation and depression (Bukalo et al., 2001). 
These findings suggest that CSPGs are involved in stabilising synaptic connections 
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(Dityatev et al., 2010b). A commonly employed strategy for manipulating CSPGs is 
enzymatic removal of their inhibitory glycosaminoglycan side chains using the bacterial 
enzyme ChABC. This strategy has been shown to improve functional recovery after 
CNS injury, particularly in the spinal cord (Bradbury et al., 2002; Caggiano et al., 2005; 
Tester and Howland, 2008; Garcia-Alias et al., 2009) and there is a growing consensus 
that plasticity is at least partially responsible for this improvement (Barritt et al., 2006; 
Tester and Howland, 2008; Garcia-Alias et al., 2009; Alilain et al., 2011; Bradbury and 
Carter, 2011). In addition to promoting plasticity when delivered to the vicinity of an 
injury, ChABC has also been shown to reactivate plasticity in the intact CNS, when its 
delivery to the visual cortex allowed a shift in ocular dominance following visual 
deprivation during the critical period (Pizzorusso et al., 2002; Pizzorusso et al., 2006). 
CSPG digestion has also been shown to have a remarkable plasticity-promoting effect 
when ChABC is applied to the denervated brainstem (Massey et al., 2006) or spinal 
cord (Galtrey et al., 2007; Cafferty et al., 2008b).  
 
Galtrey et al. (2007) used peripheral nerve injuries of varying severities to study the 
effect of central delivery of ChABC, together with daily training, on functional 
recovery. These injuries provided degrees of misguidance for the regenerating axons. 
Behavioural testing following treatment revealed significantly improved grip strength 
in animals that were severely impaired due to a misguided nerve injury paradigm; 
furthermore, animals that had undergone correct repair showed improvements in skilled 
forelimb function. However, the nature of changes in connectivity that might underlie 






2.1.4 Aims of the Chapter 
In the present Chapter electrophysiological techniques were used to investigate the 
effect of ChABC on spinal reflexes after peripheral nerve injuries of varying severities. 
The crossed nerve injury employed by Galtrey et al. (2007) involved crossing two 
forelimb flexor nerves. In contrast, here the more severe of the injury paradigms 
involved crossing a flexor nerve with an extensor, resulting in a greater degree of 
misguidance. Results show that the monosynaptic reflex between heteronymous 
muscles did not change after nerve injury, but polysynaptic connections of both 
myelinated and unmyelinated afferents were altered following application of a plasticity 
promoting treatment to the spinal cord. We propose that in this way inaccurate wiring 
in the periphery is compensated for by reorganisation of spinal circuitry due to 



















2.2.1 Surgical procedures 
Animals and experimental groups. 46 male Wistar rats were used in this study. There 
were 5 experimental groups: naïve (n=9), correct repair (n=7), crossed repair (n=8), 
correct repair treated with ChABC (n= 10) and crossed repair treated with ChABC 
(n=6). Of the groups with correctly repaired nerves, a subset of untreated (n=3) and 
ChABC-treated (n=6) rats were used exclusively for pain studies. The remaining rats 
were used for electrophysiology and assessment on a skilled behavioural test. The 
contralateral forelimb nerves of 8 ChABC-treated rats were used as treated, uninjured 
controls. An additional group of 6 naïve animals was used to investigate the time course 
of CSPG digestion following LV-ChABC injection (n=2 at 2 weeks; n=2 at 4 weeks; 
n=2 at 8 weeks). 
Lentiviral vector. ChABC was delivered via an integrating, self-inactivating lentiviral 
vector, which is described in detail in a recent publication (Zhao et al., 2011). The 
vector was pseudotyped with VSV-G and produced using a second-generation system, 
as described previously (Naldini et al., 1996b; Hendriks et al., 2007). Expression of the 
ChABC gene was driven by the cytomegalovirus promoter. The ChABC gene inserted 
into the lentiviral vector was a modified version designed to optimise enzyme secretion 
from mammalian cells (Muir et al., 2010). Viral titre, obtained by a p24 ELISA assay, 
was 99μg/ml, corresponding to 6x105TU/μl. 
ChABC delivery and peripheral nerve injuries. All surgical procedures were performed 
in accordance with U.K. Home Office regulations (European Communities Council 
Directive of 24 November 1986 (86/609/EEC)). For recovery surgery, sterile 
precautions were used. Rats were anaesthetised with 60mg/kg ketamine and 0.25mg/kg 
medetomidine, diluted in saline and administered i.p. Body temperature was monitored 
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rectally and used to regulate a homeothermic blanket. A lentiviral vector expressing 
ChABC (LV-ChABC) was used in these experiments, delivered by intraspinal injection. 
Lentiviral vector mediated gene delivery to the CNS is highly efficient and not 
cytotoxic (Kordower et al., 2000; Abordo-Adesida et al., 2005; Abdellatif et al., 2006). 
Minimal, asymptomatic inflammation caused by lentiviral vectors is especially weak 
when using VSV-G coated vectors, as in the present study (Mazarakis et al., 2001). 
Rats were prepared for surgery by shaving and disinfecting the dorsal surface of the 
back over the scapulae. After skin incision the layers of muscles were dissected through 
to expose the lower cervical vertebrae. A partial laminectomy of the C5 vertebra was 
performed and gel foam soaked in 0.2% lignocaine was placed on the dura covering the 
dorsum of the spinal cord for two minutes, then a small incision was made in the dura 
using small spring scissors (Fine Science Tools) and lignocaine was reapplied for a 
further two minutes. A single injection of 1ul of LV-ChABC into the right C5 ventral 
horn was then performed using a glass capillary pulled to a diameter of about 20μm, 
connected to a 10μl syringe and driven by a microdrive pump (Harvard Apparatus) at 
0.25μl/min. The injection coordinates were 1mm from the midline, first lowering the 
glass capillary 2mm, then raising it 500μm for the first two minutes of the infusion and 
raising it a further 500μm for the remaining two minutes of the infusion. The capillary 
was left in place for two minutes after the injection. Overlying muscle and skin were 
sutured in layers. 1mg/kg atipamezole hydrochloride subcutaneously was used to 
reverse the anaesthetic. Animals recovered in an incubator and received 0.05mg/kg 
buprenorphine postoperatively. A group of rats received LV-ChABC only and were 
sacrificed at 2 (n=2), 4 (n=2) and 8 (n=2) weeks to investigate the extent of CSPG 
digestion. All other rats were left for 3 weeks before undergoing nerve injury to allow 




For the peripheral nerve injuries, animals were anaesthetised as described above and 
incisions to the ventral skin and pectoralis major muscle of the right forelimb were 
made, exposing the brachial plexus near the axilla. The median and radial nerves were 
identified and underwent one of two types of lesion and repair (Fig. 2.1B): (i) both 
nerves were cut and repaired correctly by re-anastomosis (median to median and radial 
to radial); (ii) both nerves were cut and a crossover repair was performed (proximal 
median stump to distal radial stump and vice versa). Nerve transection was performed 
using spring scissors and repair entailed one or two stitches with 10-0 sutures (Ethicon, 
Ethilon
TM
) to the epineurium. Surgery was concluded as described above and rats were 
left for up to 12 weeks in order for axonal regeneration to occur before animals 
underwent electrophysiological assessment. Animals recovered uneventfully and did 
not exhibit autotomy. 
 
2.2.2 In vivo electrophysiological recordings 
Preparation. Rats were terminally anaesthetised with an intraperitoneal injection of 
1.25g/kg urethane (Sigma-Aldrich). Percutaneous electrodes in the left and right 
forelimbs recorded the electrocardiogram and body temperature was maintained around 
37°C using a homeothermic blanket. A tracheotomy was performed and a tracheal 
cannula inserted. The brachial plexus of the right forelimb was exposed and the median, 
ulnar and radial nerves were dissected free from surrounding connective tissue. Skin 
flaps from the incision formed a pool, which was filled with paraffin oil. Whole nerve 
recordings, with the ulnar nerve mounted on silver wire hook electrodes, were used in 
these experiments. To confirm nerves had regenerated to the intended targets, the 
median and radial nerves were electrically stimulated in turn (100μs, 0.5Hz, 0-100μA), 
while mounted on silver wire hook electrodes proximal to the nerve repair site and the 
threshold for visible muscle contraction, as well as the type of contraction (flexor or 
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extensor), were noted. In all cases, correctly repaired median nerves produced flexor 
contraction and correctly repaired radial nerves produced extensor contraction. Median 
nerves that had been sutured into distal radial nerve stumps now produced extensor 
contraction and crossed radial nerves now produced flexor contraction. Nerves were 
then cut just proximal to the anastomosis site before reflex experiments were carried 
out (Fig. 2.1A). 
Fast reflexes. The magnitude of monosynaptic and polysynaptic reflexes was 
determined in ulnar nerves upon stimulation of myelinated afferents in other 
brachial nerves. Electrical stimuli of increasing amplitude from 50 to 500µA, in 
50μA steps, (100µs square wave pulse at 0.5Hz) were delivered from a constant 
current stimulator to the median or radial nerves. Ulnar nerve response to each 
stimulus was recorded. Recordings were captured with Scope software 
(ADInstruments). An average of 64 sweeps at 400µA was calculated online for 
each nerve and used to find the difference in amplitudes of reflexes evoked by 
median and radial nerve stimulation. This was achieved using software to 
calculate the absolute integral of any response between 1.5 and 3ms 
(monosynaptic) or 3 and 7ms (polysynaptic), regardless of whether a response is 
observed qualitatively (Fig. 2.2A). The 1.5-3ms window was chosen based on a 
calculation as follows: the afferent and efferent limbs of the reflex have a 
maximum conduction velocity of approximately 50m/second (Munson et al., 
1997) and the conduction distance in both cases is 50mm. The quickest time 
for 2 synapses is 1msec (more for multi-synaptic responses). Therefore: 
2msec conduction time + 1msec for 2 synapses = 3msec (fastest possible 
disynaptic response) 




The 3-7ms interval was defined by the above calculation and the observation that 
polysynaptic responses rarely, if ever, appeared later than 7ms at low threshold 
stimulation. 
Wind up. Peripheral nerve recordings can be used to study the phenomenon of wind up 
of motoneurons (Schouenborg and Sjolund, 1983; Woolf and Wall, 1986), a reflex 
reflecting spinal processing of nociceptive information. A train of 25 supramaximal 
stimuli was delivered to the median or radial nerves in turn at a stimulus intensity of 
4mA (1ms square wave pulse at 0.5Hz). Recordings of ulnar nerve activity for 1 second 
after each impulse were captured using LabChart software (ADInstruments). Ulnar 
nerve activity was also recorded for 20 seconds prior to and 50 seconds after the 
stimulation period. Three trials were carried out for each nerve, with an interval of 5 
minutes between trials to allow the ulnar nerve to return to its resting level of activity. 
A multi-unit recording of all spikes approximately 25% greater than the mean noise 
level was made, typically producing ~5 spikes per second under resting conditions. The 
number of spikes reaching this threshold was recorded for each second before, during 
and after the period of stimulation and plotted as a graph. To quantify wind-up from 
spike frequency plots, area under the curve analysis was performed. This value was 
then normalised to baseline nerve activity levels and input (the number of spikes 
discharged during the second following the first stimulus). The normalisation serves to 
control for differences in recording conditions and nerve excitability and is calculated 
as follows: 
Wind-up = (total spikes) – ((input x 25) – (basal x 25)) 
Total spikes = sum of spikes recorded during the stimulating period. Basal = average 
number of spikes per second in the 20 seconds prior to the stimulating period. Two-way 



















Figure 2.1: Diagram illustrating electrophysiology and nerve injury 
paradigms. A: reflexes were measured by recording from the ulnar nerve, cut 
distally (blue, right). Recording electrodes were placed approximately 5mm apart. 
The median (middle, green) and radial (left, orange) nerves were stimulated in 
turn. Stimulating electrodes were placed distally, near the cut end of each nerve, 
approximately 2mm apart. B: two levels of severity of nerve injury were 
performed to produce graded levels of inaccurate reinnervation. For correct 
repair: the median (green) and the radial (orange) nerves were cut and 
immediately repaired and axons regenerated towards their original targets. For 
crossed repair the median and radial nerves were cut and the proximal stump of 
the median nerve (green), a flexor, was sutured to the distal stump of the radial 
nerve (orange), an extensor, so that regenerating median nerve axons (green 
lines) would reinnervate extensor radial nerve targets; the proximal stump of the 
radial nerve (orange) was sutured to the distal stump of the median nerve (green) 
so that regenerating radial nerve axons (orange lines) would reinnervate flexor 









2.2.3 Behavioural assessment 
Skilled motor function. The staircase test, which provides a measure of skilled forepaw 
sensorimotor function, was used to assess reaching performance (Montoya et al., 1991). 
The use of this test after graded peripheral nerve injury has been described in detail 
elsewhere (Galtrey and Fawcett, 2007b). The apparatus (Campden Instruments Ltd.) 
consists of a central platform with seven steps either side. Each step holds one pellet 
(45mg, Research Diets Inc.) that the rat can reach for from the platform. The corridor 
containing the platform and steps is sufficiently narrow to prevent the rat reaching 
pellets on the right with the left paw and vice versa. Rats were trained daily for 3 weeks 
prior to nerve injury and those failing to reach the minimum criterion for inclusion in 
the study (2 pellets/side/day) were excluded from this behavioural test. Of the rats 
trained on this test (n=5 per group), 3 had to be excluded (1 each from repair untreated, 
crossed untreated and crossed treated). After injury, during thrice-weekly testing 
sessions the number of pellets successfully retrieved (7 pellets for each side per trial) 
was recorded. Each session consisted of two 5-minute trials at least 10 minutes apart. 
Mean scores per rat per testing week were calculated and baseline scores reflect the 
total number of pellets retrieved during the final week of training. Rats were on a 
restricted diet of 15g of food pellets per day during training and testing to encourage 
participation, and were weighed weekly to ensure that they maintained their body 
weight. 
Sensory testing. Mechanical and thermal thresholds were ascertained to assess the 
effects of LV-ChABC and peripheral nerve injury on pain sensitivity. Pain behaviour 
after formalin injection was also assessed. Mechanical withdrawal thresholds were 
assessed using a dynamic plantar anaesthesiometer (Ugo Basile). Animals were placed 
in clear plexiglass cubicles on top of a metal grid and allowed to acclimate for 15 
minutes.  A computer-controlled stimulus was applied to the forepaw that applied a 
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linearly increasing force ramp. A cut-off of 50g was imposed to prevent any tissue 
damage. The force necessary to elicit paw withdrawal was recorded. Thermal 
hyperalgesia was assessed by applying a radiant heat source to the plantar surface of the 
forepaw and measuring the time taken for the rat to withdraw its paw (Hargreaves et al., 
1988). The time taken to withdraw was measured three times for each paw and the 
mean latency was analysed. For both mechanical and thermal testing, the withdrawal 
threshold of each forepaw was calculated as the average of 3 consecutive tests with at 
least 5 minutes between each test. Measurements were taken on 3 separate days before 
injury and weekly thereafter. Formalin testing was performed at the end of the study 
(approximately 12 weeks after injury) as previously described (Dubuisson and Dennis, 
1977). Briefly, 50µl 5% formalin in sterile saline was injected under the skin of the 
plantar surface of the right forepaw. The rat was then placed in a plexiglass observation 
chamber and the time spent licking/biting was measured over 45 minutes, in 5 minute 
bins. 
 
2.2.4 Tissue processing and immunohistochemistry 
C-4-S: For visualisation of digestion by virally expressed chondroitinase, rats were 
deeply anaesthetised using sodium pentobarbitone (80mg/kg, i.p.) and transcardially 
perfused with 200ml heparinised saline followed by 400ml paraformaldehyde (4% in 
0.1M phosphate buffer). Spinal cords were dissected and post-fixed in 4% 
paraformaldehyde overnight at 4°C, then transferred into 20% sucrose for 48 hours at 
4
o
C. The tissue was blocked in OCT embedding compound for cryostat sectioning. 
20µm thick sagittal sections were thaw-mounted onto Superfrost Plus slides and stored 
at -20
o
C. To visualise GAG digestion sections were immunostained for chondroitin-4-
sulphate (C-4-S), which is the digested stub of the CS-GAG chain. The frozen sections 
were incubated in the following (with three PBS washes between each step): normal 
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goat serum (10%, 30 minutes), mouse anti-C4S (1:5000, overnight; ICN Biochemicals), 
horse anti-mouse biotinylated secondary antibody (1:400, 90 minutes; Jackson 
ImmunoResearch), ABC reagent (1:250, 20 minutes; Vector Labs), biotinyl tyramide 
(1:75, 10 minutes; PerkinElmer Life Sciences) and ExtrAvidin TRITC (1:200, 2 hours; 
Sigma). Slides were coverslipped with Vectashield mounting medium (Vector Labs). 
Wisteria floribunda agglutinin (WFA): this lectin binds to the terminal N-
acetylgalactosamine residues of chondroitin sulphate chains (Young and Williams, 
1985) and is reactive to PNNs in the CNS (Brauer et al., 1993). Slides were washed 
three times in PBS and incubated with TRITC conjugated WFA lectin (Patricell Ltd.) 





















2.3.1 Characterisation of spinal reflexes in intact animals 
Stretch reflex 
A paradigm for studying a well-known spinal reflex, the monosynaptic stretch reflex 
between Ia afferents and motoneurons, was developed. A stereotypical fast wave in the 
ulnar nerve was observed upon median nerve stimulation. This wave had a latency of 
1.83±0.025ms and appeared when a stimulation intensity of 100μA or higher was 
applied (Fig. 2.2A). As expected, it could not be elicited by stimulation of the extensor, 
radial nerve (Fig. 2.2B; p<0.05). Reflex magnitude was calculated by calculating the 
absolute integral and these data are shown in Table 2.1. As the latency of this fast 
response is consistent with a heteronymous connection of Ia spindle afferents in the 
median nerve exciting α-motoneurons that innervate synergist muscles in the ulnar 
nerve territory (Nelson and Mendell, 1978), this wave will hereafter be referred to as 
the monosynaptic reflex. Several responses of a longer latency (approx. 3.5-7ms) were 
also observed, this time after either median or radial nerve stimulation (Fig. 2.2A). The 
amplitude of these later responses evoked by stimulation of median and radial 
stimulation did not differ (Fig. 2.2C; p>0.05). The latency of these waves is consistent 
with spinal polysynaptic relays. Thus two types of spinal reflex that can be elicited 
between nerves of the brachial plexus were characterised and subsequently used to 
study plasticity following peripheral nerve injury. 
 
Wind-up 
In addition to the low threshold responses described above, ulnar nerve response to 
either median or radial nerve stimulation at supramaximal C-fibre intensities was 



















Figure 2.2: Characterisation of low threshold spinal reflexes. A: shown are 
representative examples of whole ulnar nerve recordings after stimulation of the 
median nerve (top trace) or radial nerve (bottom trace). The traces shown are 
averages of 64 sweeps, while stimuli of 400µA amplitude and 100µs pulse width 
were delivered at 0.5Hz. A fast reflex of 1.5-3ms latency is observed after 
median nerve stimulation. Longer latency, polysynaptic reflexes are present in 
both traces at 3-8ms. B: monosynaptic reflex amplitude was quantified by 
calculating the absolute integral of the trace between 1.5 and 3ms, using 64 
sweep-averages at 400µA. Median nerve stimulation results in a 15 fold greater 
response than radial nerve stimulation (p<0.05, n=5; Student’s t-test). C: 
absolute integral values between 3 and 7ms show no significant difference 
between polysynaptic reflex amplitude elicited in the ulnar nerve by stimulation 
of the median or radial nerves (p>0.05, n=9; Student’s t-test). Data are shown as 









increase in the number of spikes evoked in the ulnar nerve (Fig. 2.3A). This 
phenomenon is known as wind-up. The number of spikes evoked in the ulnar nerve by 
the first stimulus at C-fibre intensity (4mA, 1ms) is generally modest but the bursts of 
activity intensify between the second and tenth stimuli (Fig. 2.3B) before reaching a 
gradually decaying plateau until the end of the stimulating period, when responses drop 
off rapidly. Although the precise number of spikes varied somewhat between 
individuals, the pattern of progressively increasing response to low frequency, repeated 
stimuli was extremely consistent. After the end of the 25 stimuli a period of heightened 
activity in the ulnar nerve in the absence of any stimulus is observed (Fig. 2.3C); this 
after-discharge would gradually subside back to resting levels of activity over 2-3 
minutes. Radial nerve stimulation did not elicit wind up to the same extent. Rather, the 
number of spikes was mildly elevated throughout the stimulating period and dropped to 
basal levels immediately thereafter (Fig. 2.3D). Fig. 2.3E illustrates the difference 
between the number of spikes evoked by median and radial stimulation. Spikes per 





seconds (Fig. 2.3E; 36-52s p<0.001, 32-62s p<0.01, 30-68s 
p<0.05).  
Different methods of quantifying wind up responses have been described. In 
accordance with others (Castro et al., 2011) an area under the curve analysis was used, 
taking into account the ‘input’ (size of response to the first stimulus), which produces a 
measure of excess spikes. In addition, normalisation according to the baseline noise 
levels was performed to account for variations in whole nerve recording conditions. 
Figures attained from such calculations are referred to as wind-up and these are shown 
in Table 2.1. This analysis revealed a consistent difference in the number of spikes 
evoked between the median and the radial nerves (Fig. 2.3F; p<0.05). During the final 
















Figure 2.3: Characterisation of high threshold reflexes. A: shown is an 
example of a whole ulnar nerve recording before, during and after stimulation of 
the median nerve at C-fibre intensity (4mA amplitude, 1ms square wave pulse) 
and low frequency (0.5Hz). 25 stimuli were delivered during each trial, indicated 
by asterisks. Evoked spikes increase during the stimulating period. B: enlarged 
view of ulnar nerve activity during the first five stimuli of a wind-up trial and for 
one second preceding the first stimulus. The number of spikes evoked by each 
successive stimulus increases progressively. C: wind-up trials are followed by a 
period of continuing elevated activity in the absence of stimuli for some seconds. 
Shown are the final two stimuli of a wind-up trial and a period of after-discharge. 
D: response of the radial nerve to a wind-up trial. Wind-up is not observed to the 
same extent as after median nerve stimulation. E: spike frequency plot 
quantifying the features of wind-up exemplified in A-D. The ulnar nerve has low 
levels of basal activity. Upon initiation of a wind-up trial (20 seconds), 
stimulating the median nerve, a rapid rising slope of increasing evoked activity 
occurs reaching a plateau after 10 stimuli (40 seconds). This level of activity 
slightly decays over the remainder of the trial and dramatically when stimulation 
ceases (70 seconds). Activity is elevated above basal levels for the remainder of 
the recording period (70-120 seconds). Radial nerve stimulation induces an 
increase in activity during the wind-up trial to a significantly lesser extent than 
during median nerve stimulation (36-52s p<0.001, 32-62s p<0.01, 30-68s p<0.05, 
n=9; two way RM-ANOVA) and ulnar nerve activity returns to basal 
immediately after cessation of stimulation. F: area under the curve quantification 
confirms significantly greater wind-up elicited by median vs. radial nerve 




usually around the 10
th
 stimulus. By the end of the stimulating period the number of 
spikes elicited by the 25
th
 stimulus was reduced by 33.0±12.2% from the peak levels of 
activity.  
These results indicate that wind-up can be readily elicited in a flexor nerve by high 
intensity stimulation of a synergistic flexor nerve, but not by identical stimulation of an 
extensor nerve in the same plexus. This robust difference in capacity to produce wind-
up in the ulnar nerve provides a convenient paradigm to study plasticity of spinal 
reflexes in the context of peripheral nerve injury. 
 
2.3.2 Effect of peripheral nerve injury on spinal reflexes 
Animals underwent electrophysiological testing approximately 12 weeks after receiving 
peripheral nerve injury, with either correct or crossover repair. The effect of injury was 
investigated using the paradigms for studying spinal reflexes described above. 
 
Fast reflexes 
Correct repair had no impact on the size of the monosynaptic reflex with the size of the 
short latency response almost identical to uninjured animals (Fig. 2.4A, black bars). 
Incorrectly repaired median nerves had fast latency waves of much greater variability 
but with a mean area similar to control animals. As we did not observe any fast latency 
response upon radial nerve stimulation in any nerve injury paradigm this was not 
measured. 
The longer latency, low threshold polysynaptic reflexes in correctly repaired nerves 
were, again, unchanged for both median and radial nerve stimulation, compared to 
controls (Fig. 2.4B, C, black bars; p>0.05). Rats with incorrectly repaired nerves 
displayed a trend towards decreased polysynaptic reflex amplitude in the radial but not 
























Uninjured 19.0±4.0 1.3±0.05 63.7±10.8 50.3±8.4 1105±334 207±79 
Correct 18.9±5.7 n/a 65.9±13 40.0±9.9 247±102 51±20 
Crossed 17.1±10.0 n/a 44.3±9.3 14.5±3.6 264±67 363±239 
ChABC-
treated 
Uninjured 19.3±6.9 n/a 71.8±17 51.6±13.1 911±241 241±85 
Correct 21.9±9.0 n/a 123.0±32.0 70.9±19.1 1007±133 526±246 
Crossed 29.1±1.0 n/a 110.0±20.2 46.5±11.9 701±197 825±231 
 
 
Table 2.1: Values for reflex magnitude in electrophysiology experiments. Reflex 
amplitude in shown for low threshold mono- and polysynaptic reflexes. For wind-up 
the number of spikes, corrected for input and basal activity, is shown. Data are shown 











p=0.089 for radial). These results indicate that peripheral nerve injury has a minimal 
effect on the amplitude of median nerve monosynaptic and low threshold polysynaptic 
spinal reflexes, but which included a trend towards a decrease in crossed radial nerve 
low threshold polysynaptic reflex amplitude. 
 
Wind-Up  
Ulnar nerve wind-up in response to flexor stimulation was considerably reduced after 
both types of peripheral nerve injury (Fig. 2.6G, black bars; p<0.01). These results 
indicate that wind-up collapses after peripheral nerve injury and that the severity of the 
injury does not affect the size of the reduction: an approximately 80% reduction in 
flexor wind-up is observed after both correct and crossed repair of the median nerve. 
Flexor motoneuron responses to extensor stimulation, which even in intact nerves are 
small, were not significantly altered after peripheral nerve injury (Fig. 2.6H, black bars; 
p>0.05).  In all cases radial nerve wind-up does not significantly change, especially in 
the case of the correctly repaired nerve, but there is an interesting trend for misdirected 
nerves (where regenerated fibres now inappropriately innervate ‘flexor’ tissues) to 
exhibit a greater degree of wind-up. The mean wind-up in this group is sevenfold 
greater than the correct repair group, although the results were highly variable. 
  
These results show a divergent effect of peripheral nerve injury on high and low 
threshold spinal reflexes. Whereas low threshold reflexes remain largely unchanged, 
high intensity stimulation uncovers a difference in wind up between injured and 






2.3.3 Effect of ChABC treatment 
 
Effect of LV-ChABC on spinal reflexes after injury – fast reflexes 
The size of responses elicited from the uninjured ulnar nerve after median nerve 
stimulation showed animals that received LV-ChABC had a monosynaptic compound 
action potential of the same size as untreated animals (Fig. 2.4A). Following nerve 
injury those animals with correctly repaired median nerves similarly evoked a 
monosynaptic wave of statistically unchanged amplitude after treatment (Fig. 2.4A) and 
animals with crossed median nerves showed a non-significant trend towards and 
increased amplitude with ChABC treatment (Fig. 2.4A).  
 
The low threshold, polysynaptic reflexes for both the median and radial nerves were 
again unchanged when the intact nerves of animals treated with LV-ChABC were 
stimulated (Fig. 2.4B, C). However, in the presence of a peripheral nerve injury the size 
of responses recorded between 3-8ms were significantly increased for the median nerve 
after both correct repair and crossed repair (Fig. 2.4B; significant effect of treatment 
p<0.01). Radial nerve stimulation provoked an increased response in LV-ChABC 
treated animals with correctly repaired nerves and a response of pre-injury magnitude 
upon stimulation of crossed nerves (Fig 2.4C; effect of treatment p=0.052).  
 
Overall, these results indicate that ChABC treatment does not affect the amplitude of 
the median nerve monosynaptic reflex, whether or not the animals have undergone 
peripheral nerve injury. However, low threshold polysynaptic reflexes from both nerves 
















Figure 2.4: ChABC treatment enhances polysynaptic but not monosynaptic 
low threshold reflex amplitude after peripheral nerve injury. A: the 
amplitude of median nerve reflexes at monosynaptic latency (1.5-3ms) does not 
change in the presence of ChABC, regardless of whether or not the nerve has 
been injured (effect of treatment p=0>0.05; treated: n=6 uninjured, n=3 correct 
repair, n=3 crossed repair; two way ANOVA). B, C: low threshold polysynaptic 
reflexes produced upon both median (B) and radial (C) stimulation increase in 
amplitude in the presence of ChABC, but only after nerve injury (effect of 
treatment: p<0.01 for median, p=0.052 for radial; untreated: n=9 uninjured, n=7 
correct repair, n=5 crossed repair; treated: n=8 uninjured, n=4 correct repair, n=6 












Effect of LV-ChABC on spinal reflexes after injury – wind-up 
Both types of peripheral nerve injury studied caused a reduction in wind-up elicited by 
median nerve stimulation (Fig. 2.5A-C). Rats that received LV-ChABC in addition to 
peripheral nerve injury had a marked increase in response to C-fibre stimulation (Fig. 
2.5E, F). Qualitatively, recordings from ChABC treated animals (Fig. 2.5D-F) appear to 
show many more spikes compared to spikes elicited from untreated nerve-injured rats 
(Fig. 2.5B, C). Changes after nerve injury with or without ChABC treatment are 
illustrated in spike frequency plots (Fig. 2.6). Here the collapse in median nerve wind-
up after nerve injury (Fig. 2.6A, C, E) and its restoration (Fig. 2.6D, F) can be clearly 
observed. After nerve injury there is no change in the radial nerve activity of untreated 
rats after correct repair (Fig. 2.6C) but there is a slight increase after crossed repair, 
which occurred to variable degrees between individual animals (Fig. 2.6E). In contrast, 
radial nerve stimulation begins to elicit sizable wind-up responses in the nerve injury 
groups of animals treated with LV-ChABC, where none was present without treatment 
(Fig. 2.6D, F). Quantification of these results confirms the observed changes in spike 
frequency. Following administration of LV-ChABC median nerve wind-up was 
restored to pre-injury levels for rats that underwent correct repair; those that received 
crossed repair also showed a significant increase in wind-up, albeit to a lesser extent 
than the milder injury (Fig. 2.6G; significant effect of treatment p<0.05 in both cases). 
Intact animals treated with LV-ChABC have similar levels of wind-up to naïve rats. 
Radial nerve wind-up does not change following LV-ChABC administration to intact 
animals (Fig. 2.5D, 2.6H), but starts to appear after both types of nerve injury (Fig. 
2.6D, F; significant effect of treatment p<0.05). The wind-down phenomenon that can 
be observed in control animals is still present in animals that received ChABC but no 
injury, albeit to a slightly lesser extent. The number of spikes after the 25
th
 stimulus was 
67.0±12.2% of that after the 10
th
















Figure 2.5: Representative traces of wind-up trials illustrate differences 
between injury and treatment groups. Shown are the first 10 stimuli, indicated 
by asterisks. A: uninjured animals exhibit classic wind-up. B, C: wind-up is 
greatly reduced after peripheral nerve injury. D-F: ChABC treatment restores 
wind-up in uninjured and correctly repaired groups and increases wind-up in 
animals with crossed repair. The size of the evoked spikes also appeared to be 



















Figure 2.6: ChABC treatment induces plasticity of wind-up after peripheral 
nerve injury. A-F: spike frequency plots showing the number of spikes recorded 
per second before (0-20 seconds), during (20-70 seconds) and after (70-120 
seconds) a wind-up trial, consisting of 25 stimuli at supramaximal C-fibre 
threshold (amplitude: 4mA, pulse width: 1ms). Wind-up evoked by median nerve 
stimulation (red) is robust in control animals (A) but reduced dramatically after 
peripheral nerve injuries of varying severity (C, E). In the presence of ChABC 
control animals exhibit unchanged levels of wind-up (B), while injured animals 
show significantly increased levels wind-up (D, F). Radial nerve wind-up (black) 
is modest under control conditions (A), remains so after correct repair (C) and 
increases somewhat after crossed repair (E). In the presence of ChABC radial 
nerve wind-up responses become larger (D, F). G: area under the curve 
quantification shows that ChABC does not change median nerve stimulation 
evoked wind-up magnitude in the absence of nerve injury but induces significant 
increases in amplitude when animals have been subjected to peripheral nerve 
injury. H: radial nerve stimulation evoked wind-up remains modest in uninjured 
animals in the presence of ChABC, but significantly increases in magnitude after 
both types of nerve injury. Both median and radial nerves had a significant 
overall effect of treatment, p<0.001, two-way ANOVA, but there were no 
significant differences between individual groups; untreated: n=9 uninjured, n=7 
correct repair, n=5 crossed repair; treated: n=8 control, n=4 correct repair, n=6 





uninjured animals (Fig. 2.6A, B). In contrast, after injury ChABC treated animals 
maintain the plateau in the number of spikes that is reached at the peak of wind up. 
After the 25
th
 stimulus the number of spikes was 110±11.1% of the number of spikes 
after the 10
th
 stimulus for correct repair and 97.3±8.2% for crossed repair (Fig. 2.6D, F). 
This loss of wind-down suggests an increase in spinal excitability after peripheral nerve 
injury and ChABC treatment. 
 
Taken together, the changes we observe in wind-up following ChABC treatment, 
namely restoration of median nerve wind-up and the appearance of novel wind-up in 
the radial nerve, as well as the loss of wind-down, are strong indicators of 
compensatory plastic changes occurring in the spinal cord as a result of CSPG digestion, 
but only apparent in nerve-injured animals. 
 
Effect of LV-ChABC treatment on reaching behaviour 
Since inaccurate reinnervation of sensorimotor targets after nerve injury and repair 
leads to poor recovery of fine motor control skilled paw movements were tested using 
the staircase test (Montoya et al., 1991). Rats with correctly repaired nerves recovered 
the ability to reach for sugar pellets over time, almost returning to baseline performance 
over the testing period of 14 weeks post-injury, reaching a plateau at 10 weeks (Fig. 
2.7A; 30.75±0.25 pellets at baseline and 3.0±1.3 pellets at week 1 to 24.8±6.9 pellets 
by week 10). LV-ChABC treatment did not enhance the rate or degree of recovery, 
indeed the animals in this group exhibited a tendency towards performing less well than 
untreated animals on this task (Fig. 2.7A; untreated vs. ChABC, p>0.05). Animals in 
the group that received incorrect repair did not regain the ability to reach for and grasp 
more than one or two sugar pellets with their injured paw (Fig. 2.7B; 31.5±1.5 pellets at 




Figure 2.7: ChABC treatment did not improve reaching behaviour on the staircase 
test after peripheral nerve injury. A: animals with correctly repaired nerves regain 
the ability to reach for sugar pellets by 10 weeks post-injury. ChABC treated animals 
do not recover any better than untreated animals (p>0.05; n=4 untreated, n=5 treated; 
two way RM-ANOVA). B: animals with crossover nerve repair do not regain the ability 
to retrieve sugar pellets from the staircase, either with or without ChABC treatment 





LV-ChABC treatment did not improve the reaching ability of the rats in this injury 
group, although there was a trend towards improved scores in the last two weeks of 
testing (Fig. 2.7B; 9±1.3 vs. 6±1.0 pellets at 15 weeks, untreated vs. ChABC).  
 
2.3.4 Confirmation of CSPG digestion  
To confirm the presence of digested CSPGs in the spinal cord, the expression of 
chondroitin-4-sulphate (C-4-S) was measured. C-4-S is the protein stub region that is 
exposed after GAG chain cleavage from CSPGs by ChABC. We employed a gene 
delivery method to administer ChABC to the spinal cord via lentiviral vector. First, LV-
ChABC was injected into the cervical spinal cord of naïve rats to investigate the extent 
of digestion of CSPGs. After a single injection of LV-ChABC sustained, widespread 
digestion of CSPGs was observed. This was visualised by the intense C-4-S 
immunostaining that is apparent 2 weeks after injection (Fig. 2.8A) and is maintained at 
the same level of intensity at 4 weeks (Fig. 2.8B) and up to 4 months after injection 
(Fig. 2.8C, D). Thus, this delivery method effectively degrades CSPGs in the spinal 
cord for the duration of the study period. To investigate the structure of the 
perineuronal net spinal cords from nerve injured, untreated and treated animals were 
examined for WFA reactivity at the end-point of the experiment (approximately 12 
weeks after injury). WFA was observed surrounding the cell bodies of most spinal 
neurons in untreated, nerve-injured animals (Fig. 2.8F), but was not present around the 
neuronal cell bodies in the spinal cord of LV-ChABC treated rats (Fig. 2.8G). This 



















Figure 2.8: Lentiviral delivery of ChABC induces long-lasting CSPG 
digestion and perineuronal net disruption. A-D, LV-ChABC enzyme injection 
(1µl) into the intact spinal cord produces intense, widespread immounoreactivity 
to chondroitin-4-sulphate (C-4-S) epitopes from 2 weeks post-injection (A). 
Intensity and spread of digestion is maintained at 4 weeks (B), 8 weeks (C) and 4 
months (D) after LV-ChABC injection. WFA reactivity indicates perineuronal 
nets surrounding some spinal neurons (F), which is no longer visible 12 weeks 
after injury (G). In (A-D) the tyramide amplification technique has produced 
some nonspecific staining on the edge of the spinal cord. Scale bars = 1mm (A-













2.3.5 Effect of LV-ChABC treatment on pain behaviour 
It is conceivable that a period of accentuated plasticity could lead to changes in 
connectivity and the formation of aberrant connections, potentially resulting in the 
development of spontaneous pain. Although it is known that repeated intrathecal  
injections of ChABC enzyme do not lead to pain (Barritt et al., 2006), the effect of 
sustained and widespread CSPG digestion has not been extensively studied. Therefore, 
withdrawal thresholds to mechanical and thermal stimulation were tested for animals 
that had undergone correct repair with or without LV-ChABC treatment. In addition, 
pain behaviour after formalin injection to the affected forepaw was assessed. Baseline 
testing revealed no significant difference in mechanical (15.1±0.9g vs. 16.7±0.8g, 
untreated vs. ChABC; p>0.05) or thermal (7.4±0.5s vs. 6.2±0.5s, untreated vs. ChABC; 
p>0.05) thresholds after LV-ChABC treatment. Over 10 weeks of post-injury testing, 
no sensitivity to non-noxious mechanical stimuli (Fig. 2.9A; p>0.05) or noxious 
thermal stimuli (Fig. 2.9B; p>0.05) developed. Similarly, pain behaviour after formalin 
injection into the forepaw exhibited the classic biphasic response of an intense early 
response during the first five minutes and a moderate later response from 15 to 45 
minutes (Dubuisson and Dennis, 1977; Wheeler-Aceto et al., 1990). This did not differ 
between treated and untreated rats (Fig 2.9C; p>0.05). These results show that there is 
no increase in pain sensation with long-term CSPG digestion by ChABC in rats with 
nerve injury. The data also show there is no obvious sedative effect or motor 







Figure 2.9: Long term ChABC treatment does not induce increased pain 
sensitivity following nerve injury and correct repair. ChABC treatment does 
not induce increased sensitivity to non-noxious mechanical (A; p>0.05, n=3 
untreated, n=6 treated; two way RM-ANOVA) or noxious thermal stimuli (B; 
p=0.67, n=3 untreated, n=6 treated; two way RM-ANOVA). C: formalin-induced 
sensitivity is not enhanced in those animals that have received ChABC as well as 
nerve injury (p>0.05, n=3 untreated, n=6 treated; two way RM-ANOVA).  D: no 
significant difference between groups was observed during the early and late 
phases of the response (p>0.05, n=3 untreated, n=6 treated; two way ANOVA). 





The hypothesis that CSPGs restrict the capacity for reorganisation of spinal connections 
following injury is supported by several of the findings from this investigation. Firstly, 
the amplitude of a low threshold, polysynaptic reflex could be increased after peripheral 
nerve injury, but only following treatment with ChABC, which degrades CSPGs. 
Secondly, wind-up of the ulnar nerve in response to median nerve stimulation, which 
collapses after nerve injury, could be protected by ChABC treatment after correct repair, 
or significantly increased after misrouting of the median nerve. Thirdly, wind-up of the 
radial nerve, which is minimal in the uninjured state, becomes significantly stronger in 
rats that have undergone both nerve injury and ChABC treatment. These results provide 
strong evidence that, by removing the inhibitory effects of CSPGs within the spinal 
cord, reorganisation of spinal circuitry after peripheral nerve injury is possible.  
  
2.4.1 Alteration of central connectivity  
Monosynaptic stretch reflex 
Here, the well-studied monosynaptic stretch reflex was used to investigate spinal 
connectivity after nerve injury. We took advantage of the different responses of the 
ulnar nerve, a flexor, to flexor (median) or extensor (radial) nerve stimulation and 
explored the effect of injury on this reflex. Three months after injury, correctly repaired 
nerves showed a monosynaptic reflex of unchanged amplitude upon electrical 
stimulation. Recordings from motoneurons that have been axotomised reveal 
diminished synaptic input (Eccles et al., 1958; Kuno and Llinas, 1970) due to the loss 
of connectivity between Ia afferents and motoneurons (Mendell et al., 1974, 1976). 
However, if a cut muscle nerve successfully reinnervates muscle tissue, reflexes 
recover their normal properties (Carpenter et al., 1963; Farel, 1978), including the 
95 
 
functional connectivity between Ia afferents and motoneurons (Mendell and Scott, 
1975) and our results are in agreement with these findings. It is likely that central 
monosynaptic connections with motoneurons are retained by Ia afferents despite 
potentially failing to reinnervate spindle receptors. It is also important to note that we 
were investigating heteronymous connections by stimulating damaged afferents and 
recording from intact motoneurons in the ulnar nerve, thus the finding of unchanged 
reflex amplitude is not surprising.  
 
Incorrectly repaired nerves also had unchanged monosynaptic reflex amplitude, despite 
inaccurate peripheral regeneration (as confirmed by the observation of muscle twitch 
following electrical stimulation of crossed nerves proximal to the repair site). This was 
expected as it has been shown that regenerated Ia afferents do not need to innervate 
spindle receptors – regeneration into skin is adequate for functional connectivity with 
motoneurons to be maintained (Mendell et al., 1995). In this case, flexor axons that 
have been redirected to innervate extensor targets continue to connect equally strongly 
with flexor motoneurons, indicating an inappropriate monosynaptic connection between 
antagonistic muscles. Spinal ChABC treatment alone did not change the amplitude of 
the monosynaptic reflex and no change was observed after either type of injury, 
indicating that this reflex is a hard-wired, stereotypical response that is not susceptible 
to the plasticity-promoting properties of ChABC.  
 
Fast polysynaptic reflexes 
In contrast to the monosynaptic reflex studied above, low threshold stimulation of both 
flexors and extensors elicited polysynaptic responses in the ulnar nerve and the size of 
these reflexes were not significantly affected by injury. Following injuries of either 
severity, ChABC induced an increase in amplitude of these reflexes to approximately 
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double the size of those found in untreated animals, after both median and radial nerve 
stimulation. In the case of the median nerve, these reflexes were also substantially 
greater than those evoked in the ulnar nerves of naive animals. Interestingly, ChABC 
treatment did not change the size of polysynaptic reflexes of animals without nerve 
injuries. It therefore appears that nerve injury alone is not sufficient to cause a change 
in this spinal reflex but that, in an environment of depleted CSPGs, changes in 
connectivity become apparent. In addition, this finding shows that existing connections 
are not non-specifically altered by ChABC in the absence of nerve injury. 
 
Wind-up 
Wind-up is a well-known phenomenon that is a form of short-term plasticity that can be 
demonstrated by stimulating a peripheral nerve repetitively, at C fibre strength. First 
described by recording from dorsal horn neurons (Mendell and Wall, 1965), the use of 
whole nerve motoneuron recordings has also been described (Schouenborg and Sjolund, 
1983; Woolf and Wall, 1986). Stimulating and recording in the periphery is 
advantageous as the outcome measure is a physiological measure of an integrated, 
modulated spinal reflex (Herrero et al., 2000). This is important because plastic changes 
may be mediated at different levels and by various neuronal cell types. In agreement 
with others, recordings showed that repetitive stimuli at supramaximal C fibre strength 
produced a progressively increasing discharge that peaked after around 10 stimuli 
(Schouenborg and Sjolund, 1983; Gozariu et al., 1997; Solano and Herrero, 1999), 
before reaching a gradually diminishing plateau until the end of the 25 stimuli. After 
the end of the stimulating period, spike discharge remained elevated for some time but 
returned to baseline levels of activity within minutes. These features were consistent 
between animals, despite the inherently variable nature of the absolute number of 
spikes elicited by a single wind-up trial (Castro et al., 2011). Median nerve stimulation 
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robustly induced wind-up recorded in the ulnar nerve, whereas radial nerve stimulation 
using identical parameters produced a much more modest response. This illustrates the 
difference in response of a flexor nerve to synergist compared with antagonist nerve 
stimulation. The difference between the responses of the two nerves provided a 
paradigm within which to investigate plasticity.  
 
Both types of nerve repair resulted in significantly depressed levels of wind-up at a 
chronic time point. Collapse of wind-up occurred irrespective of the severity of 
misdirection of axons, suggesting that this phenomenon is due to central rather than 
peripheral consequences of nerve injury and regeneration. This is supported by the 
previous morphological observations that synaptic vesicles are lost from peptide-
containing primary afferent terminals of axotomised neurons (Zhang et al., 1995). It is 
believed that a synergy between glutamate and peptidergic signalling is a feature of 
wind-up (Randic et al., 1990; Thompson et al., 1993), hence this depletion could 
explain the failure of wind-up upon electrical stimulation. In contrast to the results of 
this Chapter, others have found that wind-up of normal magnitude can be elicited by 
electrical stimulation in animals that have undergone ligation or transection of the 
sciatic nerve (Laird and Bennett, 1993; Xu et al., 1995; Chapman et al., 1998; Jergova 
et al., 2012). However, these other studies were all studying hindlimb nerves, whereas 
the present observations apply to forelimb nerves. In addition, two of the above studies 
were on animals that exhibited increased pain sensation (Laird and Bennett, 1993; 
Chapman et al., 1998), for which no evidence was found here. In addition, this was the 
first description of wind-up in the context of the repaired nerve, as opposed to ligation 




Median nerve stimulation in animals that had undergone correct repair and ChABC 
treatment produced wind up that was similar to that of naïve rats. Indeed, spike 
frequency plots showed that the pattern of wind up appeared even more excitable than 
that of a naive animal. The number of stimuli delivered before activation and the 
amount of after-discharge were both elevated, while the plateau reached stayed 
horizontal rather than decaying. These observations indicate a restoration of 
connectivity within the spinal cord and suggest a state of heightened central excitability. 
The incorrectly repaired median nerve also showed significantly increased wind-up 
after treatment with ChABC and a loss of wind-down. However this was not as robust 
as for the correctly repaired median nerve. Interestingly, radial nerve stimulation after 
ChABC treatment caused the appearance of novel wind-up in the ulnar nerve, in those 
rats that had undergone nerve injury. This indicates the formation of new or more 
effective polysynaptic connections between injury-affected radial nerve afferents and 
ulnar nerve efferents. Cafferty et al. (2008b) showed that ChABC delivered to the intact 
spinal cord in a spared root rhizotomy paradigm resulted in receptive fields that were 
larger than those of intact controls, whereas a restoration of normal function would 
have resulted in a restitution of normal sized receptive fields. Median nerve wind-up 
results similarly appear to show “recovery” of magnitude of response. However, in the 
light of the appearance of novel activity in the radial nerve and in the low threshold 
polysynaptic reflexes described above, it is more likely that a new, alternative function 
has emerged. This is supported by the emergence of new characteristics of median 
nerve wind-up, such as the loss of wind-down. 
 
No change in wind-up was found when the uninjured nerves of ChABC-treated animals 
were tested. In fact, wind-up after either median or radial nerve stimulation in these 
animals was statistically undistinguishable from intact controls. This is consistent with 
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the changes observed in low threshold polysynaptic reflexes described above. These 
results suggest that, when the inhibitory influences of CSPGs are mitigated, the 
capacity for anatomical reorganisation in response to nerve injury becomes realised, as 
has been proposed previously (Cafferty et al., 2008b). As both injury paradigms in both 
nerves result in increased polysynaptic reflex activity, it could be argued that this is a 
change in recording conditions between groups or non-specific hyperexcitability due to, 
for example, lower anaesthetic level. If this were the case, one would expect the size of 
all reflexes to be increased but this is not the case; as discussed above monosynaptic 
reflex size does not change between treated and untreated animals and is therefore 
acting as an internal control, indicative of consistent recording conditions between 
animals.  
 
Wind-up is a response to noxious inputs but it occurs in normal animals and its 
presence does not necessarily signal a pain state. In this Chapter, wind-up was studied 
as a measure of short-term plasticity. It is present in normal animals and collapses after 
nerve injury. The protection against this collapse by ChABC treatment suggests the 
restoration of some capacity for plasticity. However, it is not clear whether this is 
adaptive or maladaptive for the animal. Behavioural testing for thermal hyperalgesia, 
mechanical allodynia and inflammatory pain did not detect any maladaptive changes.  
 
For both high and low threshold reflexes, no evidence emerged to suggest that ChABC 
treatment promoted respecification of connections so they became appropriate to the 
tissues innervated after regeneration. That is, flexor nerves that were misdirected to 
innervate extensor territories did not behave exactly as would be expected of an 
extensor and vice versa, rather the plastic changes observed were more general in 
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nature. Possible mechanisms for the observed ChABC mediated changes are discussed 
below. 
 
2.4.2 Forelimb function 
To investigate whether spinal ChABC could lead to an improvement in skilled forelimb 
movements, such as reaching and grasping, we tested rats weekly on the staircase test 
(Montoya et al., 1991). Rats with correctly repaired nerves recovered reaching ability 
over time but ChABC treatment did not enhance this process, indeed treated animals 
tended to perform worse on this task. This finding is inconsistent with a previous study 
where intraspinal ChABC and a similar nerve injury paradigm were employed and 
animals with correct repair showed an improvement in functional recovery of grasping 
(Galtrey et al., 2007). There is an important difference between the nerve injuries used 
in the present study and that by Galtrey et al. (2007), in their case the authors 
manipulated the median and ulnar nerves, while here the median and radial nerves were 
injured. This is significant because both the median and ulnar nerves are flexors while 
the radial nerve is an extensor. The deficit caused by the injuries in the present study 
will therefore affect both flexor and extensor forelimb functions, and the increased 
severity of the injury may explain the discrepancy between the behavioural results. In 
addition, behavioural data for the correctly repaired nerve injury group includes results 
for animals that, having failed to retrieve pellets for a number of trials following injury, 
gave up attempting retrieval, even though physically they may have been able to 
complete the task. However, in agreement with Galtrey et al. (2007), rats with 
misdirected axon regeneration fail to recover any reaching ability in the present study, 
with or without ChABC treatment. 
 
As suggested by the electrophysiological findings, countering the restrictive influence 
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of perineuronal nets may lead to an increase in general connectivity (low threshold, 
polysynaptic) and effectiveness of connections (wind-up), perhaps indicating the 
potential for functional improvement. Others have shown a weak effect of ChABC 
alone on behavioural improvement but a strong synergistic effect of ChABC and 
rehabilitative training (Garcia-Alias et al., 2009). This observation led the authors to 
suggest that ChABC mediates the formation of multiple connections and rehabilitative 
training selects appropriate connections and eliminates inappropriate ones. Therefore, it 
may be important to combine ChABC-activated plasticity with rehabilitation, as did the 
study by Galtrey et al. (2007), in order to promote recovery of a skilled forelimb 
function such as paw reaching, which is not a behaviour commonly exhibited by 
animals in their home cages (Garcia-Alias et al., 2009).  
 
The question of whether ChABC can improve behavioural outcome is not conclusively 
addressed by the results of the present study. A less demanding behavioural test, such 
as the grip strength or horizontal ladder test, which detects more subtle improvements, 
may be a more promising avenue for future investigation. In addition, experimental 
groups used for this experiment were small, ideally larger groups would be utilised for 
such a complex task with varying levels of engagement. 
 
2.4.3 Mechanisms of ChABC mediated plastic changes 
ChABC has been reported to mediate its effects on functional reorganisation through (i) 
anatomical changes in connectivity as a result of sprouting, (ii) enhancing axonal 
conduction, (iii) neuroprotective effects, and (iv) alteration of synaptic efficacy. Any of 
these mechanisms could contribute to the changes seen here. The phenomenon of 
sprouting of intraspinal axons after ChABC treatment is commonly described (Barritt et 
al., 2006; Massey et al., 2006; Garcia-Alias et al., 2009; Soleman et al., 2012). It has 
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been reported that MAP1B immunoreactivity, indicating newly grown processes, is 
increased in the ChABC-treated spinal cord after periperhal nerve injury (Galtrey et al., 
2007). This sprouting is likely to be due to a tipping of the balance towards axonal 
growth, which, as it has recently been shown, can be regulated by activity of the protein 
tyrosine phosphatase σ receptor (Coles et al., 2011), for which CSPGs are ligands (Shen 
et al., 2009). As we observed evidence of not only recovered but enhanced synaptic 
transmission it is plausible that the formation of novel connections by afferents on 
postsynaptic targets has occurred. It has recently been shown that CSPGs, when applied 
to the spinal cord, can depress axonal conduction and that ChABC can prevent this 
decline (Hunanyan et al., 2010). These findings suggest that CSPGs are inhibitory to 
conduction. Since conduction failure in some central branches of primary sensory axons 
has been described (Titmus and Faber, 1990), CSPG digestion might allow more 
widespread invasion of presynaptic axonal arbours, thereby increasing post-synaptic 
responses. Additionally, perineuronal nets, of which CSPGs are a major component, 
have been implicated in the stabilisation of synapses (Hockfield et al., 1990) and 
disruption of perineuronal net components can effect short and long-term synaptic 
changes (Bukalo et al., 2001; Frischknecht et al., 2009; Dityatev et al., 2010b; Morellini 
et al., 2010). Here we report enhanced spinal reflex activity, which could reflect the 
strengthening of existing spinal connections, consistent with the involvement of CSPGs 
in regulating synaptic efficacy. It has also been suggested that latent, silent synapses 
exist (Wall, 1995) and that the unmasking of these weaker connections, induced by the 
retraction of competing connecting terminals from injured afferents, may be responsible 
for the observed increase in reflex activity (Cafferty et al., 2008b), especially in the 
light of the enhanced axonal conduction described above. Another proposed mechanism 
for the increased reflex activity observed is that ChABC has a neuroprotective function. 
Damaged sensory neurons show widespread changes in structure and function and 
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ameliorating such effects could allow for more effective electrophysiological signalling. 
ChABC has been shown to prevent the atrophy of layer V cortical neurons following 
axotomy at the levels of the spinal dorsal columns (Carter et al., 2008). After peripheral 
nerve injury neurotransmitter levels decrease and second order neurons undergo 
changes, so neuroprotection, perhaps mediated by the release of trophic factors from the 
extracellular matrix after exposure to ChABC, may be responsible for the observed 
increase in neural activity. In the absence of injury neurotransmitters/neuromodulators 
are maintained at normal levels, so this may explain the observed injury-specific 
changes effected by ChABC. It is intriguing that we found evidence for reorganisation 
only with respect to polysynaptic and not monosynaptic reflexes. This is likely to 
reflect the greater susceptibility of these reflexes to modulation due to an increased 
number of loci for such effects. 
 
2.4.4 Conclusion  
This study has shown clear evidence for ChABC mediated plasticity of spinal reflexes 
after peripheral nerve injury. While most studies focus on CSPGs in the context of the 
glial scar, we have demonstrated their importance in the intact spinal cord. 
Reorganisation of intact CNS circuitry following nerve injury in the periphery presents 
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3.1 Introduction  
 
3.1.1 Contusion Injury 
Spinal cord injury (SCI) can lead to devastating permanent deficits in motor, sensory 
and autonomic function. It is a major clinical problem, as it has been estimated that at 
least 2.5 million people worldwide live with a SCI and that over 132,000 people sustain 
a SCI every year (http://www.campaignforcure.org). By examining the histology of 
human traumatic SCI, the types of injury can be classified into four groups: solid cord 
injury, contusion, massive compression and laceration (Bunge et al., 1993). The most 
frequent human SCI is contusion injury, which is a blunt trauma leading to bruising of 
the spinal cord. The injury features intact meninges, a fluid-filled cavity or cyst and 
damage to grey and white matter (Norenberg et al., 2004). It is appropriate to use rats to 
study contusive SCI as they have been found to bear functional and morphological 
similarities to human SCI (Metz et al., 2000; Scheff et al., 2003). Rodent models of 
contusion injury have advanced since the weight drop method originally described by 
Allen (1911) and now feature the use of sophisticated pneumatic-controlled devices that 
allow precise regulation of the severity of the injury, resulting in predictable functional 
deficits (Scheff et al., 2003). In addition, detailed information regarding biomechanics 
may be monitored, such as the velocity or the degree of displacement (Onifer et al., 
2007). Moderate rat contusion injury, such as is used in the present study, has recently 
been extensively characterised by James et al. (2011), who showed that axonal 
conduction in long distance sensory projections is severely impaired after spinal 
contusion. They also show a limited, stereotypical degree of spontaneous functional 
recovery as demonstrated by behavioural and electrophysiological techniques. Thus, 
this clinically relevant, well-characterised injury is an ideal model to study functional 
recovery following SCI and experimental treatments aimed at promoting repair. 
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3.1.2 Chondroitin sulphate proteoglycans in the injured spinal cord   
Following SCI, a reactive process takes place involving the accumulation of glial cells 
which surround the wound to form a glial scar (Reier et al., 1983; Fawcett and Asher, 
1999). In an injury where the meninges are not breached, such as that used in the 
present study, the glial scar is mainly composed of reactive astrocytes (Silver and 
Miller, 2004) that re-establish the blood-brain barrier and seal the wound (Faulkner et 
al., 2004; Sofroniew, 2009). Despite its advantages, the glial scar also represents a 
barrier to regenerating axons, which is both physical and chemical in nature. A major 
inhibitory component of the scar is the chondroitin sulphate proteoglycan (CSPG) 
family of molecules, which are inhibitory to neurite outgrowth in vitro (McKeon et al., 
1991; Brittis et al., 1992; Dou and Levine, 1994; Friedlander et al., 1994; McKeon et al., 
1995). CSPGs are upregulated after spinal cord injury in rodent models, with the 
highest level of expression at 8-14 days and levels remaining heightened into chronic 
stages (Jones et al., 2003b; Tang et al., 2003; Iaci et al., 2007). Although injured spinal 
cord neurons attempt regeneration after transection (Kerschensteiner et al., 2005), the 
inhibitory CSPG-rich milieu of the lesion site precludes significant regeneration. In 
addition, CSPGs are known to block conduction following spinal cord injury 
(Hunanyan et al., 2010), thus hindering the function of any spared axons. 
 
3.1.3 Chondroitinase ABC after spinal cord injury 
Clear evidence for the inhibitory role of CSPGs after spinal cord injury was provided 
by the finding that functional recovery after SCI can be enhanced by treatment with 
ChABC (Bradbury et al., 2002). Subsequently, many studies have shown the potential 
of ChABC to enhance regeneration of sensory axons (Yick et al., 2003; Cafferty et al., 
2007; Shields et al., 2008) and motor axons (Iseda et al., 2008; Garcia-Alias et al., 
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2009; Wang et al., 2011). In addition to increasing the regenerative ability of injured 
axons, it is increasingly evident that ChABC can induce anatomical reorganisation 
through collateral sprouting of intact or injured fibres. Sprouting has been observed 
following ChABC treatment of SCI in the rat (Barritt et al., 2006) and the cat (Tester 
and Howland, 2008; Tom et al., 2009). A functional improvement has often 
accompanied ChABC-induced sprouting (Massey et al., 2006; Cafferty et al., 2008b; 
Tester and Howland, 2008; Garcia-Alias et al., 2009).  
 
Most studies have used partial transection models of spinal cord injury to study the 
effectiveness of ChABC treatment (Bradbury and Carter, 2011). However, it is not 
clear whether similar efficacy can be achieved in a more clinically relevant model of 
spinal injury. One study by Caggiano et al. (2005) used intrathecally delivered ChABC 
and showed some functional recovery, but only after a severe injury. In that study a clip 
compression model was used, which mimics the pathology of a contusion injury 
(Caggiano et al., 2005). In another study, this time in the context of cervical contusion 
injury, and when combined with a peripheral nerve graft, ChABC treatment could elicit 
functional improvement (Houle et al., 2006). Other studies have shown no beneficial 
effects after contusion injury (Tom et al., 2009; Jakeman et al., 2010). The effectiveness 
of ChABC at promoting recovery after injury may be linked to the duration of enzyme 
activity and the severity of the injury. Although administration of a single dose of 
ChABC has been shown to be beneficial after lesions of particular tracts, this does not 
appear to be the case in the context of contusion injury, perhaps due to the more severe 
nature of this type of injury. Most studies showing functional improvements have used 
a repeated administration regimen (Bradbury et al., 2002; Caggiano et al., 2005; Fouad 




3.1.4 A genetic approach to targeting CSPGs 
After a single injection of ChABC enzyme, immunoreactivity for digested CSPGs 
persists for a considerable time (Bruckner et al., 1998), but enzyme activity appears to 
decrease rapidly 1-2 days post-injection (Lin et al., 2008). In order to lengthen the 
duration of enzymatic activity, genetic approaches to CSPG modification have emerged. 
These have included transgenic mice expressing ChABC under the GFAP promoter 
(Cafferty et al., 2007) and the administration of viral vectors expressing ChABC 
(Curinga et al., 2007; Jin et al., 2011). These studies have met with limited success, as 
bacterial proteins are not designed for secretion from mammalian cells and are 
susceptible to interference from the eukaryotic N-glycosylation system, preventing 
secretion of active enzyme. Modification of the ChABC enzyme through directed 
mutagenesis has allowed mammalian cells to express and secrete active enzyme (Muir 
et al., 2010). In vivo expression of this modified enzyme via lentiviral vector (LV) has 
been shown to promote sprouting of injured corticospinal axons in the rat spinal cord 
(Zhao et al., 2011). Thus, ChABC delivery via LV is an attractive strategy as it allows 
targeting of the enzyme to the desired area, expression of ChABC by the cells in the 
vicinity of the injury and longer lasting CSPG digestion than can be achieved by 
enzyme injection alone.  
 
 3.1.5 Aims of the Chapter 
This chapter describes the use of genetically modified ChABC packaged into an LV 
(LV-ChABC) to treat adult rats with spinal cord injury. The model used is the clinically 
applicable contusion injury, applied at thoracic level. Behavioural and 
electrophysiological techniques were employed to investigate functional changes after 
injury and following treatment with ChABC. Results show that LV-ChABC treated 
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animals display both increased conduction across the lesion and plastic changes to 
spinal reflexes below the lesion, and that LV-ChABC treated animals perform better on 
a test of sensorimotor function. In addition, anatomical assessment showed remarkable 
improvements in injury pathology, notably by reducing cavity size and altering the 
appearance of the glial scar. We propose that long-lasting, widespread CSPG digestion 


















3.2.1 Surgical procedures 
Animals. 98 adult female Sprague Dawley rats (200-220g) were used in these studies. 
Behavioural testing was carried out on animals that underwent contusion injury only 
(n=15) and animals that underwent contusion plus either LV-ChABC (LV-3, n=15) or a 
control vector (LV-GFP, n=16). Subsets of these animals also underwent 
electrophysiology (contusion only, n=10; LV-GFP, n=10; LV-3, n=10) and pain testing 
(contusion only, n=7; LV-GFP, n=8; LV-3, n=7). An additional group were used only 
for electrophysiology (LV-1, n=4; LV-2, n=4; ChABC enzyme; n=5). CSPG digestion 
assessment and pain studies were carried out on a further group of naive animals (LV-1, 
n=6; LV-2, n=6; LV-3, n=13; ChABC, n=6; saline, n=8). All surgical procedures were 
performed in accordance with UK Home Office regulations (European Communities 
Council Directive of 24
th
 November 1986 (86/609/EEC)). 
 
Lentiviral vectors. The ChABC gene used is a modified version designed to optimise 
secretion from mammalian cells (Muir et al., 2010). The vectors used to deliver the 
modified ChABC gene were integrating, self-inactivating LVs, which have been 
described in detail elsewhere (Zhao et al., 2011). LV-1 and LV-2 expressed ChABC 
under control of the cytomegalovirus promoter and the LV-3 used the phosphoglycerate 
kinase promoter. All three vectors were pseudotyped with VSV-G and packaged using 
a second generation system, as described previously (Naldini et al., 1996a; Hendriks et 
al., 2007). Viral titres, obtained by a p24 antigen ELISA assay, were 99µg/ml (LV-1) 
and 479µg/ml (LV-3), corresponding to 6x10
5
 TU/µl and 1x10
6
 TU/µl, respectively. 







Intraspinal injections. For recovery surgery, sterile precautions were used. Rats were 
anaesthetised with 60mg/kg ketamine and 0.25mg/kg medetomidine, diluted in sterile 
saline and administered i.p.  Body temperature was monitored rectally and used to 
regulate a homeothermic blanket. A single dose of 5mg/kg carprofen was given 
subcutaneously at the time of induction. Rats were prepared for surgery by shaving and 
disinfecting the dorsal surface of the back over the scapulae. After skin incision the 
layers of muscle were dissected to expose the lower cervical vertebrae. A partial 
laminectomy of the C5 vertebra was performed and gel foam soaked in 2% lignocaine 
was placed on the dura for two minutes, then a small incision was made in the dura 
using small spring scissors (Fine Science Tools) and lignocaine applied for a further 
two minutes. A single intraspinal injection was delivered into the left side of the cord, 
consisting of 1µl of LV-ChABC (LV-1, LV-2, or LV-3), saline or protease free ChABC 
enzyme (Seikagaku Corporation; 10U/ml). Injections were performed using a glass 
capillary pulled to a tip diameter of 20µm, connected to a 10µl syringe and driven by 
a microdrive pump (Harvard Apparatus) at 0.25µl/min. The capillary was left in place 
for 2 minutes after the injection. Overlying muscle and skin were sutured in layers. 
1mg/kg atipamezole hydrochloride was administered subcutaneously to reverse the 
anaesthetic and animals recovered in an incubator. At 2 and 8 weeks post-injection n=3 
animals from each group, except saline, were sacrificed in order to assess CSPG 
digestion.  
 
Spinal cord injury and treatment.  Animals were anaesthetised and prepared for surgery 
as described above. Laminectomies were performed at vertebral level T10 and the 
vertebral column was stabilised using Adson forceps. An Infinite Horizon impactor 
(Precision Systems Instrumentation) was used to deliver a moderate severity (150kdyn) 
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contusion injury, through the intact dura mater, to the exposed spinal cord. Immediately 
after injury animals received intraspinal injections of ChABC, LV-ChABC or LV-GFP 
(0.5µl 1mm rostral and caudal to the injury site as above) and a control group received 
no injection. Overlying muscle and skin were sutured in layers and animals received 
atipamezole (1mg/kg), saline (3-5ml) and enrofloxacin (5mg/kg) subcutaneously. Rats 
were left to recover in cages on heated blankets overnight. Saline and enrofloxacin 
continued to be administered for 3 and 7 days postoperatively, respectively. Manual 
bladder expression was performed twice daily until reflexive emptying returned, 
typically 6-9 days after injury. Animals underwent behavioural testing for 10 weeks 
before electrophysiological assessment was carried out.  
 
3.2.2 In vivo electrophysiology 
Conduction studies. Rats were terminally anaesthetised with an intraperitoneal injection 
of 1.25g/kg urethane (Sigma-Aldrich). The spinal cord was exposed from vertebral 
level T7 to L5, the dura mater was removed and exposed nervous tissue was covered 
with mineral oil. Silver ball stimulating electrodes were placed approximately 5mm 
rostral and caudal to the injury, over the midline. Tiny teased filaments from the left 
and right L3 to S1 dorsal roots were individually mounted on silver wire hook 
electrodes for the recording of impulses running antidromically after dorsal column 
stimulation. Single units, reflecting the activity of single nerve fibres, were recorded 
and quantified from each of these filaments while stimulating above or below the lesion 
site (Fig. 3.3A). First, the number of units present in each filament was counted while 
stimulating caudal to the lesion (typically 5-10 units per filament). Stimulation was then 
applied rostral to the lesion while again counting units in the same filament. In this way 
the number of nerve fibres capable of conducting through the lesion could be calculated. 
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The dorsal columns were stimulated using 0.2ms duration square wave pulses at a 
frequency of 1Hz and at incrementally increasing intensity (0-800µA). Measurements 
of interelectrode distance were made at the end of each experiment to allow calculation 
of conduction velocity, which was measured for each unit and then averaged for each 
animal.  
 
Wind-up. As described in detail in the previous chapter, peripheral nerve recordings can 
be used to study the phenomenon of wind-up of flexor motorneurons. In these 
experiments spinal reflexes below the level of the injury, between hindlimb nerves, 
were examined. Rats were terminally anaesthetised as above and the left sciatic nerve 
and its branches exposed. The motor nerve to biceps femoris and the sural nerve were 
dissected free from surrounding connective tissue and cut distally. The common 
peroneal nerve was dissected free but left intact. Skin flaps from the incision formed a 
pool which was filled with mineral oil. Whole nerve recordings were individually made 
from the motor nerve to biceps femoris and the common peroneal nerves, which were 
mounted on silver wire hook electrodes in turn. Electrical stimulation was applied to the 
sural nerve, also mounted on hook electrodes.  A train of 25 supramaximal stimuli was 
delivered to the sural nerve at a stimulus intensity of 4mA (1ms square wave pulse at a 
frequency of 0.5Hz). Recordings of biceps femoris or common peroneal nerve activity 
for 1 second after each impulse were captured using LabChart software (AD 
Instruments). Nerve activity during the 20 seconds preceding and the 50 seconds 
following each wind up trial was also recorded. Three trials were carried out for each 
nerve, with an interval of 5 minutes between trials to allow the nerves to return to 
baseline levels of resting activity. For the biceps femoris nerve, multi-unit recording of 
all spikes 25% greater than the mean noise level was made, typically producing 5 
spikes per second under resting conditions. The number of spikes that reached this 
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threshold was recorded for each second before, during and after the period of 
stimulation and plotted as a graph. For each animal, recording parameters were not 
changed between biceps femoris and common peroneal nerve recordings and it was 
noted that the common peroneal had higher resting levels of activity, typically 100 
spikes per second. For this nerve the number of spikes elicited by stimulation in 
addition to those present at baseline levels of activity were captured. To quantify wind-
up from spike frequency plots, area under the curve analysis was performed. This value 
was then normalised to baseline nerve activity levels and input (the number of spikes 
discharged during the second following the first stimulus). The normalisation serves to 
control for differences in recording conditions and nerve excitability and is calculated 
as follows: 
Wind-up = (total spikes) – ((input x 25) – (basal x 25)) 
Total spikes = sum of spikes recorded during the stimulating period. Basal = average 
number of spikes per second in the 20 seconds prior to the stimulating period. 
 
 
3.2.3 Behavioural assessment 
Basso, Beattie and Bresnahan locomotor score. Open field hindlimb locomotor 
function was assessed using the Basso, Beattie and Bresnahan (BBB) locomotor rating 
scale (Basso et al., 1995). This involved placing the rat in a circular 1 metre diameter 
open field and assessing the movement of both hindlimbs during locomotion over a 
period of 4 minutes. Criteria include joint movements, paw placement, weight support, 
consistency of stepping, coordination, toe clearance and trunk stability. Each hindlimb 
is scored on a 22 point scale with a maximum score of 21; these are averaged to give 
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each animal’s overall score. Testing was performed on days 2, 5 and 7 after injury and 
weekly thereafter for 10 weeks. 
 
Horizontal ladder. Animals were trained daily for 1 week to run across a 1 metre long 
horizontal ladder with unevenly spaced rungs. On the final day of training a Sony DCR-
SX30E Handycam was used to record each rat running three times across the ladder. 
Videos were analysed in slow motion and the total number of hindlimb foot slips were 
quantified to give each animal a baseline score. A score of 1 was assigned to a slip that 
resulted in the entire paw going below the level of the rung. Animals were tested 
weekly, beginning 7 days after injury, for a total of 10 weeks.  
 
Sensory testing. As in the previous chapter, mechanical and thermal thresholds, as well 
as response to formalin injection, were assessed to investigate whether LV-ChABC has 
an effect on nociceptive processing. We tested forepaw pain sensitivity after cervical 
injection of LV-3 in uninjured animals. Mechanical withdrawal thresholds were 
assessed using a dynamic plantar anaesthesiometer (Ugo Basile). Animals were placed 
in clear plexiglass cubicles on top of a metal grid and allowed to acclimate for 15 
minutes. A computer-controlled stimulus was applied to the forepaw that applied a 
linearly increasing force ramp. A cut-off of 50g was imposed to prevent any tissue 
damage. The force necessary to elicit paw withdrawal was recorded. Thermal 
hyperalgesia was assessed by applying a radiant heat source to the plantar surface of the 
forepaw and measuring the time taken for the rat to withdraw its paw (Hargreaves et al., 
1988). The time taken to withdraw was measured three times for each paw and the 
mean latency was analysed. For both mechanical and thermal testing, the withdrawal 
threshold of each forepaw was calculated as the average of 3 consecutive tests with at 
least 5 minutes between each test. Measurements were taken before spinal injection on 
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three separate days for baselines, 3 days post-injection and weekly thereafter. Formalin 
testing was performed at the end of the study (12 weeks after injury) as previously 
described (Dubuisson and Dennis, 1977). Briefly, 50µl of 5% formalin was injected 
under the skin of the plantar surface of the right forepaw. The rat was then placed in a 
plexiglass observation chamber and the time spent licking or biting was measured over 
45 minutes, in 5 minute bins. 
 
3.2.4 Tissue processing and histology 
Tissue preparation. Animals were deeply anaesthetised using sodium pentobarbitone 
(80mg/kg, i.p.) and transcardially perfused with 200ml heparinised saline followed by 
400ml paraformaldehyde (4% in 0.1M phosphate buffer (PB)). Spinal cords were 
dissected and post-fixed in 4% paraformaldehyde for 2 hours at 4
o
C, then transferred to 
20% sucrose in 0.1M PB for 48 hours at 4
o
C for cryoprotection. The tissue was blocked 
in OCT embedding compound and frozen for cryostat sectioning. 20µm-thick sagittal 
or transverse sections were cut and serially mounted onto glass slides.  
 
Immunohistochemistry. Transverse sections were double stained for glial fibrillary 
acidic protein (GFAP; a marker for mature astrocytes) and NeuN (a marker for 
neuronal cell bodies). After incubation in 10% normal donkey serum (30 minutes), 
sections were incubated in PBS with 0.2% Triton and 0.1% sodium azide containing 
monoclonal mouse anti-NeuN (1:500; Millipore) and rabbit anti-GFAP (1:2000; Dako) 
overnight at room temperature. After three PBS washes, sections were incubated with 
donkey anti-rabbit Alexa 488 (1:1000; Invitrogen) and donkey anti-mouse Alexa 546 
(1:1000; Invitrogen) for 2 hours at room temperature. The method for visualisation of 
CS-GAG digestion by virally expressed ChABC is described in detail in the previous 
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Chapter (2.2.4). Briefly, frozen sagittal sections were incubated in the following (with 
three PBS washes between each step): normal donkey serum (10%, 30 minutes), mouse 
anti-C4S (1:5000, overnight; ICN Biochemicals), horse anti-mouse biotinylated 
secondary antibody (1:400, 90 minutes; Jackson ImmunoResearch), ABC reagent 
(1:250, 20 minutes; Vector Labs), biotinyl tyramide (1:75, 10 minutes; PerkinElmer 
Life Sciences) and ExtraAvidin TRITC (1:200, 2 hours; Sigma). Slides were 
coverslipped with Vectashield mounting medium (Vector Laboratories). Images were 
taken on a Zeiss LSM 710 upright confocal microscope.   
 
Tissue sparing analysis. Eriochrome cyanine R histochemistry was used to differentiate 
grey and white matter, as described previously (James et al., 2011). Sections were 
dehydrated in an ethanol series (5 minutes each), cleared in Histochoice (5 minutes), 
rehydrated in a reverse ethanol series followed by distilled water (5 minutes each) and 
then left in a solution containing 0.16% eriochrome cyanine R, 0.5% sulphuric acid and 
0.4% iron chloride for 10 minutes to stain myelinated fibres. Sections were then washed 
twice in distilled water, differentiated in 0.5% ammonium hydroxide (30 seconds) and 
washed twice in distilled water. Finally, sections were dehydrated and cleared, as above, 
and mounted using DPX. A Zeiss AxioCam microscope camera was used to take 
pictures of sections at 600µm intervals throughout the lesion site. Images were analysed 
using AxioVision software. The perimeters of the spinal cord and of the cavity were 
traced and the total area for each calculated. Cavity area as a percentage of total cord 
area was quantified every 600µm, up to a distance of 3.6mm rostral and caudal to the 
lesion epicentre, which was defined as the section from each animal with the largest 







3.3.1 Comparison of ChABC-expressing vectors 
In initial studies, naïve animals received single intraspinal injections of one of three 
different LVs expressing ChABC into the cervical spinal cord and these were compared 
to single injections of ChABC enzyme. LV expression of ChABC was driven by either 
CMV (LV-1 and LV-2) or by PGK (LV-3) promoters. The extent of CSPG digestion 
after application of each LV or ChABC enzyme was assessed by measuring 
chondroitin-4-sulphate (C-4-S) expression in the spinal cord at 2 or 8 weeks after 
injection. C-4-S is the protein stub region that is exposed after ChABC-mediated GAG 
chain cleavage from CSPGs. ChABC enzyme produces a localised area of intense C-4-
S immunoreactivity by 2 weeks post-injection (Fig. 3.1A) and this becomes less intense 
by 8 weeks (Fig. 3.1B). The three LVs produced very different patterns of digestion 
from each other. After a single injection of LV-1 or LV-3 sustained, widespread 
digestion of CSPGs was observed as visualised by intense C-4-S immunostaining that 
is present at 2 weeks (Fig. 3.1C, G). Over the course of 8 weeks, CSPG digestion 
caused by LV-1 becomes more widespread but less intense (Fig. 3.1D). LV-3 induced 
C-4-S expression remains widespread and becomes more intense (Fig. 3.1H). 
Application of both LV-1 and LV-3 led to widespread CSPG digestion, with C-4-S 
observed over several spinal segments. These findings contrasted with the digestion 
pattern observed after injection of LV-2, which was restricted to the tissue surrounding 
the injection site (Fig. 3.1E, F) and was not so intensely expressed. These results show 
that administration of LVs expressing ChABC can lead to efficient transduction of cells 
and expression of active enzyme, leading to effective degradation of spinal CSPGs. In 



























Figure 3.1: Lentiviral vector ChABC delivery leads to long-lasting and 
widespread CSPG digestion. Sagittal spinal cord sections were immunostained 
for digested CSPGs, shown by C-4-S staining (green). Naïve animals received a 
single injection of ChABC enzyme (A, B), LV-1 (C, D), LV-2 (E, F) or LV-3 (G, 
H) and spinal cords were stained for C-4-S at 2 (left) and 8 (right) weeks after 
injection. After ChABC enzyme injection a localised region of CSPG digestion 
is visible at 2 weeks (A) that becomes less intense by 8 weeks (B). LV-1 
injection leads to intense C-4-S staining by 2 weeks (C), which becomes more 
widespread but less intense after 8 weeks (D). LV-2 injection leads to a small 
area of CSPG digestion by 2 weeks (E) and spreads a very short distance rostral 
and caudal from the injection site by 8 weeks (F). CSPG digestion is already 
very widespread 2 weeks after LV-3 injection (G) and remains so, with even 
more intense C-4-S staining by 8 weeks after injection. Scale bar = 1mm.  
 
 






3.3.2 Effect of long-lasting CSPG digestion on pain behaviour 
As mentioned in the previous chapter, it is possible that a prolonged period of 
accentuated plasticity could lead to the formation of inappropriate connections and the 
development of spontaneous pain. Of the three ChABC-expressing LVs, LV-2 and LV-
3 led to the most CSPG digestion. In the previous chapter we found that the LV-2 
vector did not lead to any heightened sensitivity after spinal injection into the uninjured 
spinal cord. Here we tested whether spinal injection of another LV that leads to 
extensive CSPG digestion, LV-3, similarly does not cause pain. We tested withdrawal 
thresholds to mechanical and thermal stimulation for uninjured animals that had 
received saline or LV-3 injection. Pain behaviour after formalin injection into the 
forepaw was also assessed. No significant differences were observed between LV-
ChABC and saline animals in withdrawal responses to non-noxious mechanical stimuli 
or noxious thermal stimuli in the 12 weeks following injury (Fig. 3.2A, B; p>0.05 for 
both tests). The thresholds did decrease over time for both groups and in both tests, 
presumably due to rats learning to anticipate the probe over time. Formalin testing was 
carried out at the end of the experiment and exhibited the classic biphasic response of 
an intense early response during the first 5 minutes, followed by a lull in pain behaviour 
and the re-emergence of a later response between 15 and 45 minutes. This revealed no 
hypersensitivity in the animals that were treated with LV-ChABC versus the group that 
received saline, in either the late or early phase of the formalin response (Fig. 3.2C, D; 
p>0.05). These results show that there is no increase in pain sensation in naïve rats with 
























Figure 3.2: Persistent and widespread CSPG digestion in the naïve spinal 
cord does not lead to pain hypersensitivity. LV-ChABC treatment does not 
induce increased sensitivity to non-noxious mechanical (A) or noxious thermal 
(B) stimuli (p>0.05 for both tests, n=7 LV-ChABC, n=8 saline; two-way RM 
ANOVA). C, formalin induced sensitivity is not enhanced in animals that have 
received LV-ChABC (p>0.05, n=7 LV-ChABC, n=8 saline; two-way RM 
ANOVA). D: no significant differences in pain behaviour were observed during 
the early and the late phases of the formalin response. (p>0.05, n=7 LV-ChABC, 









3.3.3 Comparison of efficacy of ChABC-expressing vectors on spinal conduction  
As CSPGs are reported to block axonal conduction after spinal injury (Hunanyan et al., 
2010), we investigated whether administration of LV-ChABC could improve 
conduction after a moderate (150kdyn) contusion injury, 10 weeks after injury. The 
population of neurons studied in these experiments were sensory axons that have long-
distance ascending axonal projections running in the dorsal columns. This tract was 
activated by stimulating below the lesion site and recording from single antidromically 
activated fibres running in teased dorsal root filaments, as shown in Fig 3.3A. The 
number of fibres in a particular filament was quantified and then stimulation of the 
same tract above the lesion was performed, allowing quantification of the number of 
fibres capable of conducting through the lesion. Spinal cord contusion led to a 
substantial reduction in the percentage of fibres able to conduct through the injury site, 
with only 10% of units elicited below the injury also present when stimulating above 
the lesion. Animals that were treated with LV-3 showed a significantly increased 
percentage of fibres able to conduct across the lesion (Fig. 3.3B; 24.7±4.3% following 
LV-3 compared with 10.2±0.8% following contusion only; p<0.01) and there was also 
a non-significant trend towards improved conduction after treatment with LV-1 (Fig. 
3.3B; 16.7±4.5% following LV-1; p>0.05). In contrast, there was no improvement in 
conduction after administration of a control LV expressing GFP, ChABC enzyme or 
LV-2 (Fig. 3.3B; 12.5±2.1%, 9.6±0.9% and 7.6±1.5%, respectively; p>0.05). These 
results show that axonal conduction, which is severely impaired by spinal contusion 
injury, can be partially restored by mitigation of the inhibitory influence of CSPGs. The 
degree of restoration of function appears to correspond to the extent of digestion, since 
treatment with ChABC enzyme and LV-2, which both achieve only modest and 















Figure 3.3: Changes in axonal conduction following contusion injury and 
LV-ChABC treatment. A: Diagram illustrating electrophysiology preparation. 
Stimuli are applied caudal to the lesion while antidromic impulses are recorded 
from tiny filaments teased from the L3 to S1 dorsal roots. Once the number of 
units and their latency in a given fibre has been established, a stimulus is then 
applied rostral to the lesion in order to establish the number of units that conduct 
through the lesion. B: 10 weeks following contusion injury alone the number of 
sampled fibres able to conduct through the lesion is low (~10%, n=5). 
Administration of LV-GFP, ChABC enzyme or LV-2 does not lead to any 
increase in conduction (p>0.05, n=4 LV-2, n=5 ChABC and LV-GFP; two-way 
ANOVA). Treatment with LV-1 leads to a non-significant increase in the 
number of conducting fibres (p>0.05, n=4, one-way ANOVA) and treatment 
with LV-3 led to a significant increase in the percentage of fibres able to conduct 














































Figure 3.4: Changes in axonal conduction and conduction delay following 
contusion injury with or without LV-GFP or LV-ChABC treatment.  
A: Conduction velocity was significantly slowed following contusion only (*=p<0.01 
vs. below, n=5; two-way ANOVA) and did not improve following administration of 
LV-GFP or LV-ChABC (p>0.05, n=5 each group; two-way ANOVA). Data are shown 
as mean ± SEM. B: All experimental groups show a degree of conduction delay across 
the lesion, but this is not statistically different between groups (p=0.522, n=5 each 












treatment significantly improved conduction and LV-1 slightly improved conduction. 
This suggests that sustained and widespread CSPG digestion is required for a functional 
improvement to be realised. 
 
Conduction velocity was measured for the two control groups (contusion only and LV-
GFP) and the most efficacious ChABC-expressing viral vector (LV-3, hereafter 
referred to as LV-ChABC). Following contusion only, fibres that retained the ability to 
conduct across the lesion had significantly slowed conduction velocity compared to 
those activated by stimulating below the lesion (Fig. 3.4A; 19.5m/s above compared 
with 27.3m/s below; p<0.01). This suggests that these fibres are not functioning 
normally, despite retaining the ability to conduct action potentials. Neither the LV-GFP 
group nor the LV-ChABC group showed any improvement in conduction velocity (Fig. 
3.4A; conduction velocity above the lesion 21.3m/s and 18.2m/s for LV-GFP and LV-
ChABC, respectively; p>0.05).  
Conduction delay across the lesion was calculated by measuring the difference in 
expected latency based on conduction velocity below the lesion and actual latency. 
There was no significant difference in conduction delay across the lesion between rats 
that received contusion only and those that were treated with LV-GFP and LV-ChABC 
(Fig. 3.4B; conduction delay across the lesion 0.82±0.1ms, 0.99±0.4ms and 1.21±0.1ms 
for contusion only, LV-GFP and LV-ChABC, respectively; p>0.05).  
 
3.3.4 Effect of LV-ChABC on spinal reflexes below the injury  
The effect of LV-ChABC treatment on the magnitude of response of two hindlimb 
nerves upon sural nerve stimulation at supramaximal C-fibre intensities was 
investigated. In these experiments LV-ChABC was compared with the control vector, 
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LV-GFP. Constant, repeated stimulation of the sural nerve elicited the wind-up 
phenomenon, in which the number of spikes evoked increases with successive stimuli. 
As described for brachial nerves in the previous Chapter, 25 high intensity impulses 
delivered to the sural nerve led to increasing bursts of activity in two hindlimb flexor 
nerves, with activity reaching a plateau after approximately 10 impulses. This pattern of 
increasing discharge of flexor motoneurons is known as wind-up. Both nerves studied, 
the motor nerve to biceps femoris and the common peroneal, displayed stereotypical 
wind-up responses but the magnitude of the reflex differed between the two nerves. The 
number of spikes recorded at baseline was typically 5-10 for the biceps femoris but 
much higher in the common peroneal, with approximately 100 spikes per second 
recorded. The maximum number of spikes elicited also varied: approximately 300 for 
the biceps femoris and 1300 for the common peroneal. The pattern of nerve activity 
was nevertheless very similar for both nerves (Fig. 3.5A, B). Upon area under the curve 
quantification, there was no difference in the magnitude of wind-up elicited in the 
motor nerve to biceps femoris between the two treatment groups (Fig. 3.5C; effect of 
treatment: p>0.05) or in the common peroneal nerve (Fig. 3.5D; effect of treatment: 
p>0.05).  
 
The response of the nerves to sural nerve stimulation at A-fibre thresholds was also 
investigated. These low intensity stimuli (50-300μA, 100μs), delivered at the same 
frequency as a wind-up trial, do not provoke wind-up in naïve animals. The advantage 
of studying these lower threshold responses is that they allow us to see effects that may 
be obscured or saturated during higher intensity stimulation. In these experiments we 
did indeed see a clear difference between the treatment groups, as demonstrated in 
spike frequency plots for both the biceps femoris (Fig. 3.6A, C, E) and common 





















Figure 3.5: C-fibre wind-up after contusion injury and LV-ChABC or LV-
GFP treatment. Spike frequency plots showing the number of spikes recorded 
from the biceps femoris (left panel) or common peroneal (right panel) per second 
before (0-20 seconds), during (20-70 seconds) and after (70-120 seconds) a 
wind-up trial. A, B: 25 stimuli of supramaximal C-fibre threshold were applied 
to the sural nerve (amplitude: 4mA, pulse width: 1ms). A: Baseline levels of 
activity in the biceps femoris are low but during the stimulating period a 
dramatic increase in activity is observed, reaching a peak after around 10 stimuli. 
The pattern and magnitude of wind-up is very similar between the treatment 
groups. B: Baseline activity in the common peroneal is higher than in the biceps 
femoris, but still stable at rest. During a C-fibre strength wind-up trial activity 
increases dramatically. The pattern of a rapid increase in activity, followed by a 
gradually decaying plateau is remarkably similar in the LV-GFP and LV-ChABC 
groups, with the LV-GFP group reaching a slightly higher plateau. C, D: The 
magnitude of wind-up elicited by C-fibre strength stimulation is not significantly 
different between the LV-GFP and LV-ChABC treatment groups in the biceps 
femoris (C) or common peroneal (D) nerves upon area under the curve 
quantification, which takes baseline activity and input value into account (p>0.05, 


















Figure 3.6: A-fibre wind-up after contusion injury and LV-ChABC or LV-
GFP treatment. A-F: trials consisting of 25 stimuli of A-fibre strength were also 
applied to both nerves. The pulse width used was 100µs and the amplitudes were 
50µA (A, B), 100µA (C, D) and 300µA (E, F). LV-GFP treated animals did not 
display wind-up responses in either nerve to any amplitude of A-fibre strength 
stimulus. In contrast, wind-up pattern responses were observed in both nerves of 
LV-ChABC animals at all amplitudes. The differences between LV-GFP and 
LV-ChABC are significant at all stimulus amplitudes, apart from 300µA in the 
common peroneal (effect of treatment: 50µA: p<0.0001 for both nerves; 100µA: 
p<0.0001 for both nerves; 300µA: p<0.001 for biceps femoris, p=0.11 for 
common peroneal, n=5, two-way RM ANOVA with Bonferroni post-hoc). G, H: 
Area under the curve quantification of spike discharge during a train of stimuli at 
A-fibre strength shows that LV-GFP treated animals display very small wind-up 
responses, but a trend towards larger responses are observed after LV-ChABC 
treatment, in both the biceps femoris (G) and common peroneal (H) nerves 
(p=0.09 for biceps femoris; p=0.08 for common peroneal; n=5, two-way 







stimulus amplitude studied, apart from the common peroneal at 300uA (50uA: 
p<0.0001 for both nerves; 100uA: p<0.0001 for both nerves; 300uA: p<0.001 for 
biceps femoris, p=0.11 for common peroneal). LV-GFP treated animals never 
demonstrated wind-up like responses after A-fibre intensity stimulation, but some LV-
ChABC treated animals (3 out of 5) displayed wind-up like responses in both nerves. 
Area under the curve quantification of wind-up at A-fibre strength did not reach 
significance (Fig. 3.6G, H; effect of treatment: p=0.09 for biceps femoris, p=0.08 for 
common peroneal). This is most likely due to two of the LV-ChABC treated animals 
that did not display wind-up upon low intensity stimulation.  
 
3.3.5 Pain behaviour after contusion injury and LV-ChABC treatment 
Wind-up is a normal response to noxious inputs. However, its appearance in contused 
animals upon A-fibre stimulation could potentially indicate an abnormal pain response. 
Therefore, the hindpaws of injured rats were tested for hypersensitivity to non-noxious 
mechanical and noxious thermal stimuli. No significant differences in withdrawal 
threshold to mechanical stimuli (Fig. 3.7A; p>0.05) or in latency to withdraw from a 
thermal stimulus were detected between the three treatment groups (Fig. 3.7B; p>0.05). 
These findings indicate that all animals have the motor ability to withdraw the hindpaw 
from a sensory stimulus, and also that long lasting, widespread CSPG digestion 
delivered after contusion injury does not cause pain in the hind paws. 
 
3.3.6 Effect of LV-ChABC on behavioural function 
Animals were tested for performance in hindlimb locomotor function on two different 
tests. BBB scoring assesses gross locomotor function and the horizontal ladder is a 
skilled task that requires integration of sensory and motor skills. Before injury, all 
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animals achieved a baseline BBB score of 21, which indicates normal hindlimb 
locomotion and consistent forelimb-hindlimb coordination. Two days after injury 
animals in the contusion only group were significantly impaired, with mean a BBB 
score of 5.38±0.9. This score represents extensive movements of at least two hindlimb 
joints, but the full range of movement is not achieved and there is no weight support or 
stepping. Both LV treated groups were similarly impaired at this early time-point (Fig. 
3.8A; 5.27±0.8 and 6.68±0.8 for LV-GFP and LV-ChABC, respectively; p>0.05). Over 
the 10 week testing period animals in all three groups achieved improved BBB scores, 
with the degree of improvement reaching a plateau by 3 weeks after injury. There was 
no significant difference in the scores achieved between the treatment groups over time 
(Fig. 3.8A; p>0.05), with animals reaching a plateau around a score of 13. This result 
signifies that, following a moderate contusion injury, animals in all treatment groups 
are similarly impaired after injury and partially recover at the same rate and to the same 
extent on this test of motor function.  
 
At baseline testing rats performed very well on the horizontal ladder test, making errors 
only very rarely. After contusion injury animals were not tested on this task until they 
could take weight-supported steps, which meant the first post-injury assessment was at 
1 week post-injury. At this time point animals in both control groups were severely 
impaired, making many footslips, and although there was some spontaneous recovery, 
this reached a plateau around 4 weeks post-injury and rats remained significantly 
impaired throughout the 10-week testing period (Fig. 3.8B). However, the group that 
received LV-ChABC treatment made significantly fewer errors during the task, as early 
as 1 week after injury (footslips at 1 week: 33.1±3.5 for LV-ChABC compared with 
48.8±3.5 and 47.1±3.9 for LV-GFP and contusion only, respectively; p<0.01). This 






















Figure 3.7: LV-ChABC does not cause pain in the presence of a contusion 
injury. Animals did not develop hindpaw hypersensitivity as assessed by sensory 
testing of mechanical (A) or thermal (B) thresholds to withdraw over the course 
of 10 weeks following injury and treatment. There was no significant difference 


























Figure 3.8: Effect of LV-ChABC on behavioural function. A: BBB locomotor 
rating scores show a severe loss of function in all groups during the acute post-
injury time period. Subsequently, both LV-ChABC treated and control groups 
display improvement, reaching a plateau ~3 weeks after injury, with a BBB score 
of ~13 (signifying frequent/consistent stepping but inconsistent 
forelimb/hindlimb coordination). B: As with the BBB test, animals that received 
no treatment or LV-GFP treatment are severely impaired on the horizontal ladder 
in the acute injury period but improve over time, reaching a plateau ~5 weeks 
after injury. LV-ChABC treated animals are not as severely impaired acutely 
after contusion injury, making ~15 fewer footslips at one week than untreated or 
LV-GFP treated animals. They similarly improve over time, reaching a plateau at 
~4 weeks post-injury (*=p<0.01 vs. LV-GFP; n=15 contusion only and LV-
ChABC, n=16 LV-GFP, two-way RM ANOVA with Bonferroni post-hoc). C: 
Force readouts from the contusion device show that the actual force delivered by 
the impact probe was not significantly different between groups (p>0.05, n=14 








the chronic post-injury period (Fig. 3.8B; footslips at 10 weeks: 14.6±1.6, 28.3±2.8 and 
29.7±3.0 for LV-ChABC, LV-GFP and contusion only, respectively; p<0.01). Since all 
animals were equally impaired at 2 days post-injury in terms of BBB score, it is 
unlikely that LV-ChABC treated animals received milder injuries than controls. In 
addition, force readouts from the contusion device, which reflect the actual force 
delivered by the impact probe, were recorded at the time of injury for all animals. Force 
readout values for individual animals indicated that injuries were consistent and 
reproducible between groups (Fig. 3.8C; p>0.05). These results indicate that ChABC 
treatment can lead to a long-lasting functional improvement in the horizontal ladder, a 
task requiring sensorimotor integration. 
 
3.3.7  LV-ChABC treatment affects lesion pathology 
Contusion injury leads to destruction of spinal grey matter resulting in a cystic cavity in 
the lesion epicentre, surrounded by a rim of spared white matter. A typical section from 
the lesion epicentre of an animal that received contusion only is shown in Fig. 3.9A, 
stained for myelin with the lipophilic eriochrome cyanine stain. The spinal cord has a 
large central cavity with a rim of spared white matter. Following treatment with LV-
ChABC, cavitation at the lesion epicentre at a chronic stage (10 weeks) was 
dramatically decreased compared to LV-GFP and contusion only animals (Fig. 3.9A-C). 
Quantification of the size of the cavity and its rostrocaudal extent was obtained by 
measuring cavity size at 600µm intervals rostral and caudal to the lesion epicentre up to 
a distance of 3.6mm in either direction, confirming the striking reduction in cavity size 
(Fig. 3.9D). In order to investigate the nature of glial scar, the injured spinal cords were 
immunostained for GFAP. After contusion only, a thick border of reactive astrocytes 
forms around the lesion, and here we observe intense GFAP expression (Fig. 3.9E). In 
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contrast, the gliotic border of the injury was very different in LV-ChABC treated 
animals. GFAP expression is more diffuse, with elongated astrocytic processes 
extending into the lesion cavity (Fig. 3.9F). Although there is a rim of spared CNS 
tissue after a contusion injury, the remaining tissue is typically white matter, with 
destruction of grey matter and death of most neurons at the lesion epicentre. To 
investigate whether LV-ChABC could lead to better survival of neurons within the 
lesion, immunostaining for NeuN was performed. Indeed, a greater number of neurons 
appeared to survive the injury, as demonstrated by expression of a neuronal cell body 
marker, NeuN (Fig. 3.9E, F). These results demonstrate amelioration of much of the 




























Figure 3.9: LV-ChABC treatment ameliorates lesion pathology after 
contusion injury. A-C: transverse spinal cord sections from the lesion epicentre 
were stained with the eriochrome cyanine stain for myelin. At 10 weeks post-
injury the epicentre of spinal cords that received contusion only (A) or LV-GFP 
(B) had large central cavities surrounded by a spared rim of white matter, while 
following LV-ChABC treatment, cavitation was much reduced (C). D: Cavity 
size was measured at 600µm intervals for 3.6mm rostral and caudal to the lesion 
epicentre. LV-ChABC treatment led to a significant decrease in cavity size 
compared to contusion only and LV-GFP (**=p<0.001 vs. contusion only and 
LV-GFP, ##=p<0.001 vs. contusion only; n=4; two-way RM ANOVA with 
Bonferroni post-hoc). E, F: transverse spinal cord sections from the lesion 
epicentre were stained for GFAP (red) and NeuN (green). After contusion only a 
border of intense GFAP expression surrounds the lesion cavity and no NeuN 
positive cells are visible at the lesion epicentre (E). After LV-ChABC treatment 
GFAP expression is more diffuse, the lesion border less sharply defined and 
NeuN positive cells are visible near the dorsal surface of the spinal cord (F). 










This study has shown the efficacy of LV-ChABC in a clinically relevant experimental 
model of traumatic spinal cord injury. By using a gene therapy approach, we were able 
to deliver ChABC chronically to the spinal cord. This resulted in a long-lasting 
degradation of CSPGs and in remarkable improvements in lesion pathology, including a 
significantly reduced degree of cavitation and an altered glial scar. Functional recovery 
was demonstrated by improved performance on a behavioural task and improved spinal 
conduction. In addition, reflexes studied below the level of the injury demonstrated the 
plastic potential of the LV-ChABC treated CNS. 
 
3.4.1   Gene delivery of ChABC  
We have used an LV to deliver ChABC to the rat spinal cord. We were able to achieve 
widespread and long-lasting expression of ChABC, with digested CSPGs observed 
several spinal segments away from the site of injection and persisting over many weeks. 
Other studies of ChABC after contusion injury have used multiple administrations or 
continuous infusion of enzyme to see an effect (Caggiano et al., 2005; Karimi-
Abdolrezaee et al., 2010). Improvements in performance on the horizontal ladder task 
were apparent as soon as 1-2 weeks after injury, consistent with the extensive digestion 
of CSPG by 2 weeks post LV-ChABC injection, as visualised by C-4-S expression. The 
importance of the degree of CSPG digestion on functional outcome is illustrated by 
measurements of spinal conduction. Treatment with either LV-2 or bacterial ChABC 
enzyme, both of which produce a localised area of CSPG digestion (Fig. 3.1B), did not 
lead to any improvement in axonal conduction. LV-3 treated animals, in contrast, which 
displayed a very widespread and sustained area of digestion, showed a large and 
significant increase in the number of dorsal column fibres conducting through the 
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conduction site. LV-1 treatment, which led to an intermediate amount of digestion, 
displayed an increased but non-significant improvement in conduction. Therefore, the 
amount of CSPG digestion appears to correspond with the degree of improvement in 
conduction. We have used an efficient method to deliver ChABC to the spinal cord 
over a chronic time period, thereby overcoming the problems of delivering an enzyme, 
which is liable to be degraded after a relatively short period of activity. The use of viral 
vectors as gene therapy agents is promising, especially considering improvements in the 
safety profile of LVs, such as the use of self-inactivating vectors. However, significant 
challenges remain to be addressed. Integration into the host genome can potentially 
result in oncogene activation or inactivation of tumour suppressor genes, and responses 
of the immune system may be detrimental (Matrai et al., 2010). This Chapter reports 
high level, sustained transgene expression, but long-term CSPG digestion may lead to 
unforeseen and undesirable consequences. A possible solution may be the regulation of 
viral transgene expression and the use of inducible or tissue-specific promoters and 
excisable transgenes are currently under development and will improve the translational 
potential of viral vectors (Goverdhana et al., 2005; Bouard et al., 2009). First, more 
detailed knowledge of the appropriate level and time period of ChABC expression is 
required. Nevertheless, LV-mediated ChABC delivery remains an attractive candidate 
for future application in SCI. 
 
3.4.2   Effects of LV-ChABC on lesion pathology  
A moderate severity contusion injury leads to a local loss of neuronal cell bodies, 
destruction of grey matter, progressive cavity formation and reactive gliosis. In these 
studies we observed a reduction in all of these pathological features after LV-ChABC 
treatment. At acute and sub-acute time points (1 day to 2 weeks following injury) cavity 
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area at the lesion epicentre is reported to be approximately 10% of total cord area, 
which progressively increases over time to 30% by 12 weeks after injury (James et al., 
2011). Similarly, in the present study cavity size in contused animals with no treatment 
was large by 10 weeks post-injury. In contrast, contused animals treated with LV-
ChABC had a significantly smaller cavity area at the lesion epicentre and the 
appearance of the cord resembled a lesion arrested at an earlier stage, such as 1-2 weeks 
post-injury. Clearly, a smaller cavity represents a greater amount of potentially viable 
neural tissue. Indeed, we showed a significant increase in conduction in the dorsal 
column pathway following LV-ChABC treatment (discussed below), possibly 
indicating a neuroprotective effect of the treatment. Animals that had received LV-GFP 
injections also had a significantly larger cavity at the epicentre of the injury, but the 
rostrocaudal spread of the cavity is less than that of contusion only animals. This 
finding illustrates the importance of including suitable control treated animals. 
Administering an intraspinal injection of both ChABC and GFP-expressing vectors 
involves an extra ten minutes of anaesthesia, opening of the dura, insertion of a needle 
into the parenchyma of the cord and exposure of nervous system tissue to a viral vector. 
Any of these factors could contribute to the observed reduction in cavity size, compared 
to uninjected animals. For example, opening the dura could relieve a build up of 
pressure due to oedema and haemorrhage after contusion, leading to ameliorated 
ischaemia and improved lesion pathology. It is important to note that the LV-GFP 
animals did not display improved behavioural and electrophysiological outcomes.  
 
Another pathological difference between LV-ChABC and control groups was the 
appearance of the glial scar. Following contusion injury CSPGs are dramatically 
upregulated at the level of the lesion and reactive gliosis progressively becomes more 
focussed around the cavity perimeter to form a dense glial scar (James et al., 2011). In a 
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similar manner to cavity size discussed above, gliosis at a chronic time point in LV-
ChABC treated animals resembled an earlier, sub-acute time point. Reactive astrocytes 
were present in the cord, but were expressed more diffusely around the cavity and had a 
more elongated morphology. This phenomenon is reminiscent of the astrocytic 
response in the hypothalamic arcuate nucleus, where the resident neuropeptide Y 
containing neurons regenerate much more readily than elsewhere in the CNS. 
Following transection of NPY neurons the glial scar is less fibrotic in nature, shows 
astrocytic perikarya which are less closely apposed and connected by fewer gap 
junctions; axons are also able to project into the scar more readily (Alonso and Privat, 
1993). This study suggests that altering the nature of the glial scar may affect outcome, 
in agreement with the present study. 
 
3.4.3 Changes in axonal conduction following LV-ChABC treatment 
The percentage of sampled fibres found to be conducting through a contusion injury 10 
weeks after injury and no treatment was found to be approximately 10% of pre-injury 
levels. This finding is in agreement with others who have reported a 90% decrease in 
dorsal column compound action potential amplitudes across a thoracic contusion injury 
(Hains et al., 2004) and consistent with conduction failure after moderate contusion 
injury (James et al., 2011). A number of contributing factors are likely to be responsible 
for this decreased conduction. Oligodendrocytes undergo apoptosis as a result of SCI 
and contribute to chronic demyelination, which may result in spinal cord dysfunction 
(Blight, 1993; Liu et al., 1997; Beattie et al., 2000), including conduction block 
(McDonald and Sears, 1969; Shuman et al., 1997). The inflammatory response starts 
early after injury and involves the release of numerous factors, including nitric oxide 
(NO), which can cause conduction block (Redford et al., 1997). It is very likely that 
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CSPGs play a part in conduction failure as they are dramatically upregulated after 
injury and this increased expression persists for long periods after the initial trauma 
(Jones et al., 2003a; Tang et al., 2003; Iaci et al., 2007). Indeed, it has recently been 
shown that CSPGs block conduction, either when upregulated after injury or when 
applied directly to the spinal cord (Hunanyan et al., 2010). In this Chapter we describe a 
2.5 fold increase in conduction across a contusion injury when CSPG expression is 
chronically suppressed by administration of LV-ChABC, supporting the hypothesis of a 
role for CSPGs in conduction failure. The mechanism underlying this conduction block 
is currently unknown but a prominent CSPG, NG2, was found by Hunanyan et al. 
(2010) to block conduction more potently than other CSPGs. Since NG2 accumulates at 
Nodes of Ranvier (Butt et al., 1999; Martin et al., 2001), it is possible that it mediates 
nodal dysfunction after SCI. 
 
The conduction velocity of fibres projecting through the lesion was found to be 
significantly slower than those below, indicating that these fibres are not functioning 
normally and this is likely to be due to demyelination of surviving axons (Arvanian et 
al., 2009). LV-ChABC treated animals did not exhibit any increase in conduction 
velocity, so the improved conduction is probably not due to enhanced remyelination. 
Rather, it could be due to lifting of the conduction block by another mechanism, such as 
reversal of nodal dysfunction. ChABC has been reported to promote regeneration of 
axons after injury (Bradbury et al., 2002; Houle et al., 2006) and a population of newly 
regenerated, thinly myelinated axons could have led to our observed results with LV-
ChABC treatment (i.e. an increase in the number of fibres conducting above the lesion, 
but with a slower than normal conduction velocity). Since LV-ChABC treated animals 
exhibit improved sensorimotor function on the ladder test at very early stages after 
injury (1-2 weeks), it is more likely that the increase in conduction is due to sparing of 
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axons rather than regeneration. This hypothesis is supported by the white matter sparing 
seen upon eriochrome cyanine staining. A candidate population of viable, non-
conducting spared fibres were recently identified (James et al., 2011) and it may be this 
population of axons whose conduction is improved by ChABC. To definitively answer 
the question of regeneration versus spared neurons it will be necessary to look at 
conduction above and below the injury at early stages after injury, when behavioural 
effects are already apparent but regeneration could not already have occurred. In 
addition, axonal tracing of dorsal column axons could be performed and would provide 
evidence of any regenerating axons. It is important to note that in this study axonal 
conduction was measured in the dorsal column system, but the anatomical changes 
suggest that multiple ascending and descending pathways may be similarly protected by 
ChABC.  
 
It is known from studies in the field of demyelinating disorders that a major cause of 
permanent neurological deficit in models of multiple sclerosis is axonal degeneration 
(Trapp et al., 1998; Ganter et al., 1999) and the major risk factors for axonal death are 
the presence of inflammation and remyelination (Raine and Cross, 1989; Ferguson et al., 
1997; Trapp et al., 1998), both of which are prominent features in the environment of a 
spinal cord injury (Donnelly and Popovich, 2008; James et al., 2011). This increased 
vulnerability to degeneration can be ameliorated by strategies that protect neurons 
(Bechtold et al., 2005; Bechtold et al., 2006; Black et al., 2006). Several treatments 
have aimed to target the secondary phase of damage after SCI, particularly by 
attempting to minimise damage due to the inflammatory response (Young, 1991; 
Oudega et al., 1999; Popovich et al., 1999). More recently, it has been shown that 
ChABC also has neuroprotective effects in long-range projection neurons (Carter et al., 
2008; Carter et al., 2011) and this is supported by our observation of an increase in 
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NeuN-positive cells at the lesion epicentre, suggesting sparing of neurons in LV-
ChABC treated animals. 
 
Thus, the observed improvement in axonal conduction in the present study may be due 
to mitigation of the CSPG-induced conduction block and/or a neuroprotective effect of 
ChABC, leading to sparing of axons. Our data suggest that regeneration of injured 
axons may not be the leading cause of improved conduction, but this possibility cannot 
be ruled out until further study. 
 
3.4.4 Plasticity of reflexes below the level of the lesion 
Repeated stimulation of a peripheral nerve at C-fibre strength leads to a progressive 
increase in activity of dorsal horn neurons (Mendell and Wall, 1965) and in flexor 
motoneurons (Schouenborg and Sjolund, 1983), as described in the previous chapter. 
Here we have examined this phenomenon, known as wind-up, by stimulating and 
recording from branches of the sciatic nerve in the hindlimbs of rats with thoracic 
contusion. As we were stimulating and recording from branches of the sciatic nerve, 
spinal circuitry involved in these reflexes (largely L4-L5 spinal segments) should be 
structurally intact. Indeed, organised locomotor EMG patterns can be recorded from 
both cats (Duysens and Pearson, 1980; Andersson and Grillner, 1983; Pearson, 1995) 
and humans (Dietz et al., 1995; Harkema et al., 1997; Dietz et al., 2002) following SCI. 
However, inflammatory processes after thoracic SCI can cause changes at the lumbar 
level (Detloff et al., 2008; Garcia-Alias et al., 2010) and the loss of supraspinal input 
can cause spinal neuronal dysfunction (Dietz, 2010). The effect of a moderate severity 
contusion injury on wind-up of flexor motoneurons in peripheral nerves upon 
supramaximal stimulation was investigated. There was no difference in C-fibre wind-up 
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magnitude between LV-GFP and LV-ChABC treated groups. This is consistent with 
findings in the previous Chapter that, when applied to intact spinal circuits associated 
with intact peripheral nerves, ChABC does not elicit an exaggerated wind-up response. 
These findings are in disagreement with a recent publication reporting that sciatic nerve 
wind-up responses increase after spinal injury (Castro et al., 2011). An important 
difference between the two studies is that Castro et al. (2011) found that injured 
animals exhibited hypersensitivity of the hindpaws in association with elevated wind up 
responses, whereas we did not, suggesting that hyperexcitability of spinal reflexes and 
below-level pain are connected.  
 
In addition to studying classic C-fibre mediated wind-up, we measured hindlimb nerve 
responses to repetitive stimuli at A-fibre intensity. In naive animals, wind-up responses 
can only be elicited by the stimulation of primary afferent C-fibres and not by Aβ fibre 
stimulation alone (Schouenborg and Sjolund, 1983; Schouenborg, 1984; Weng et al., 
1998). As expected, A-fibre stimulation did not evoke wind-up of flexor motoneurons 
of LV-GFP treated rats. Conversely, some LV-ChABC treated animals did begin to 
display wind-up responses and these data, although area under the curve quantification 
did not reach the level of statistical significance, showed a clear trend towards an effect 
of treatment and future work will be necessary to validate these results. The wind-up 
responses were observed even at the lowest stimulation paradigm, meaning that it is 
unlikely that we are recruiting C-fibres with lowered activation threshold and rather that 
this is genuine A-fibre mediated wind-up. This phenomenon has been previously 
described in the context of hyperalgesic states induced by peripheral nerve injury or 
inflammation (Thompson et al., 1995) and as spontaneous below-level pain is a feature 
of clinical and experimental SCI (Finnerup and Baastrup, 2012), the possibility that A-
fibre wind-up could underlie this pain is raised, especially as wind-up of motoneurons 
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reflects spinal processing of nociceptive information. However, no evidence for 
heightened pain sensation was found in injured animals treated with LV-ChABC, upon 
behavioural testing. Together with the observation that C-fibre mediated wind-up is not 
different between the two treatment groups, these findings indicate that the emergence 
of this response may not indicate a pain state, but rather suggest that spinal neurons are 
more amenable to plastic change. As shown is Chapter 2, ChABC can potentiate the 
reorganisation of intact spinal circuits in the presence of a distant injury and wind-up is 
a form of short-term plasticity, so it may be that ChABC is increasing the plastic 
potential of spinal neurons.  Indeed, it is possible to capitalise on the ability of spared 
neuronal circuits to reorganise through use-dependent mechanisms and train the 
isolated spinal cord (Dietz, 2010; Musienko et al., 2012). A recent study combining 
ChABC and rehabilitative training showed a strong synergistic effect of the two 
treatments (Garcia-Alias et al., 2009). The authors suggest that the application of a 
plasticity-promoting treatment leads to the formation of random de novo connections 
and that motor training selects the functional connections, eliminating inappropriate 
connections (Garcia-Alias and Fawcett, 2012). The combination of the plasticity 
promoting effects of ChABC and the refining influence of rehabilitative training may 
prove to be a powerful combination for future therapies. 
 
3.4.5 Effect of LV-ChABC on hindlimb function  
To investigate whether spinal ChABC treatment could lead to an improvement in 
hindlimb function we assessed the rats’ behaviour on the BBB (Basso et al., 1995) and 
horizontal ladder (Metz and Whishaw, 2002) tests. The ladder test revealed 
improvements as early as 1 week after injury, and these were maintained throughout the 
testing period. The injury severity did not differ between groups, as shown by force 
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readouts, and animals had similar levels of impairment, as assessed by BBB locomotor 
scores. Therefore, these findings point to an early neuroprotective mechanism behind 
the improved performance. It is known that axonal injury of projection neurons leads to 
a negative effect on distant cell bodies, which die or enter a chronic state of atrophy 
(Egan et al., 1977; Barron et al., 1988; McBride et al., 1989; Wannier-Morino et al., 
2008). ChABC mediated repair is usually attributed to its axonal regeneration and 
plasticity-promoting effects, but there have been recent reports that it may also have 
neuroprotective effects. Carter et al. (2008) showed that degradation of spinal CSPGs 
lead to a reversal of the atrophy of distant axotomised corticospinal cell bodies, 
indicating a retrogradely mediated protective effect. This finding is in agreement with 
other studies showing that suppression of collagenous or glial scarring at the site of an 
SCI by other mechanisms also leads to an amelioration of rubrospinal (Davies et al., 
2006) and corticospinal (Klapka et al., 2005) neuronal cell atrophy. Changes in 
signalling pathways (e.g. PKC, ERK) involved in mediating neuronal survival have also 
been observed, adding further evidence to suggest a neuroprotective mechanism of 
ChABC mediated repair (Carter et al., 2008). Due to this very early effect of ChABC, it 
would be interesting to apply the treatment with a delay in order to investigate whether 
ChABC would be able to rescue ladder performance from a deficit as great as untreated 
animals. This would help to separate the early, neuroprotective effects from later 
regeneration or plasticity-mediated mechanisms of repair. 
 
No differences between groups in performance on the BBB test were detected, with all 
animals plateauing at a BBB score of ~13. This appeared to be due to the failure of the 
animals to become consistently coordinated after injury, which means making no 
mistakes in open field locomotion at all, and no animals reached this hurdle (James et 
al., 2011). The nature of the BBB scoring system is that it is non-linear and exhibits 
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some considerable hurdles in moving from one point to the next at higher points in the 
scale. The test, while having the advantage of being widely used, may not be sensitive 
in some circumstances and may not recognise small improvements in function. Others 
have reported improvements in BBB scores following spinal contusion injury and 
various experimental interventions. However, these studies mostly used injury 
paradigms that were more severe so the separation between groups occurred at lower 
scores, where coordination is not yet considered (Jakeman et al., 1998; Karimi-
Abdolrezaee et al., 2006; Brown et al., 2011; Cerri et al., 2012).  The ladder test 
incorporates both sensory and motor ability and the improved conduction in sensory 
fibres observed during our electrophysiological experiments point to improvement in 
the sensory modality being a factor in the recovery of ladder function. Rat behaviour on 
the ladder test has been shown to correlate over time with electrophysiological 
improvements in conduction, but their performance on the BBB score has a lower 
correlation with improved conduction (James et al., 2011). As the BBB is a gross 
locomotor test and the ladder has a sensory component, this suggests that the sensory 
recovery in this model is important. However, more accurate elucidation of the roles of 
the different neural pathways could be achieved in the future by using additional 
behavioural tests that separate motor, sensory and proprioceptive functions. The failure 
of the animals to become consistently coordinated on the BBB test, for example, may 
be due to a combination of muscle weakness, poor proprioception and limited sensory 
feedback. A pure sensory or proprioceptive test may provide a better correlate for the 





This study has shown clear evidence for the beneficial effect of ChABC treatment in a 
clinically relevant experimental model of spinal cord injury. We propose that long-
lasting and widespread CSPG digestion, achieved by the gene delivery approach 
employed, is responsible for the preservation of neural tissue and significant 

























Developing viral vectors for the study of anatomical plasticity in 


















4.1  Introduction 
 
Anatomical changes after central or peripheral nervous system injury have long been 
studied in order to provide insight into the structural basis for observed functional 
changes. A variety of methods have been used over the last century to this end. Cajal 
used silver staining methods to observe the response of the nervous system to various 
experimental lesions. It was Cajal, for instance, who first showed that damaged dorsal 
roots could regenerate axons towards but not into the spinal cord. He observed that 
when they reached the PNS/CNS border, the axons formed large retraction bulbs and 
growth stalled. Later, silver staining methods were refined to preferentially stain 
degenerating axons and this allowed the reaction of damaged axons to be studied 
specifically (Glees, 1946; Nauta and Gygax, 1951, 1954; Blackstad, 1965; Fink and 
Heimer, 1967). For example, Liu and Chambers applied this approach to study ‘spared 
roots’. That is, they cut a number of dorsal roots above and below a target root (the 
spared root). Some time later the spared root itself was cut and the degenerating fibres 
stained to ask if they had expanded their central terminals after the initial lesion of their 
neighbouring roots (Liu and Chambers, 1958). The authors concluded that they had 
indeed expanded their central arbours. This conclusion was challenged on technical 
grounds – that the silver staining may have been confounded by staining of the tracts of 
the original lesioned axons or dense body impregnation of glia in the deafferented 
region (Rodin et al., 1983). Such concerns led to repeated efforts to improve selective 
anatomical marking of particular populations of neurons, and to the birth of the field of 
neuroanatomical tract tracing in the latter half of the 20
th
 century. The application of 
these principles led to an explosion in our knowledge of the structure and organisation 
of the CNS, as well as the rapid development of additional tracers and this has been 
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extensively reviewed elsewhere (Kobbert et al., 2000; Vercelli et al., 2000; Lanciego 
and Wouterlood, 2011). 
 
4.1.1 Tract tracing molecules 
Kristensson and Olssen were the first to describe the ability of intrinsic cellular 
machinery to transport the enzymatic protein, horseradish peroxidase (HRP), thereby 
allowing visualisation of the origin, course and termination of groups of neurons 
(Kristensson and Olsson, 1971a, b). The development of this technique was a 
breakthrough in neuroanatomy, as it allowed the tracing of neuronal connections in vivo. 
This is a retrograde technique as application of HRP is internalised and transported 
back to the cell body, allowing identification of the axonal projection and the location 
of the parent cell. Around the same time, radiolabelled amino acids began to be used for 
neuroanatomical labelling (Cowan et al., 1972). The labelled amino acids are taken up 
by the cell body, incorporated into proteins and undergo axoplasmic transport. As the 
machinery for the manufacture of proteins is located in the cell body, this technique is 
an example of anterograde tracing, which involves the centrifugal transport of 
macromolecules along axons and is used to identify the targets of populations of 
neurons. Autoradiography (to reveal the location of the radiolabel) was most famously 
used to demonstrate ocular dominance columns (Hubel et al., 1977).  
 
Subsequently, the arrival of fluorescent tracers led to the ability to label multiple 
pathways in different colours. The relative ease, sensitivity and reliability compared to 
autoradiography or degeneration techniques led to their widespread use and the rapid 
development of a plethora of additional dyes. Early dyes applied to retrogradely label 
neurons include Fast Blue (Kuypers et al., 1980) and Lucifer Yellow (Stewart, 1981), 
but these have been supplemented by Fluorogold (Schmued and Fallon, 1986), Mini 
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Ruby (Novikova et al., 1997) and fluorescently tagged microspheres (Cornwall and 
Phillipson, 1988). Anterograde tracers include DiI (Thanos and Bonhoeffer, 1983, 
1987), the plant lectin Phaseolus vulgaris leucoagglutinin (Gerfen and Sawchenko, 
1984; Schofield, 1990; Wouterlood et al., 1990b) and dextran amines (Gimlich and 
Braun, 1985; Glover et al., 1986; Nance and Burns, 1990; Schmued et al., 1990). 
Transganglionic tracers such as CTB and wheat germ agglutinin (Schwab et al., 1978) 
can also be used to visualise primary sensory neurons and their central projections 
when injected into a peripheral nerve. This Chapter focuses on two neuronal 
populations: the corticospinal tract (CST) and primary sensory neurons. As we propose 
a new tool for studying these tracts, the tracers that have been most commonly applied 
to investigate their projections, biotinylated dextran amine (BDA) and CTB, 
respectively, will be described in more detail.  
 
BDA is part of the dextran amine family of molecules, which are hydrophilic 
polysaccharides that are resistant to cleavage by endogenous cellular glycosidases 
(Vercelli et al., 2000). The biotinylated form was found to be a superior anterograde 
marker and is the most commonly used dextran amine (Veenman et al., 1992). BDA is 
transported in axons at a rate of 15-20mm a week, is stable in rat neurons for at least 
four weeks and tolerates a range of fixing and processing techniques (Reiner et al., 
2000). Upon immunolabelling, the BDA appears homogeneously distributed within the 
neuron, resembling Golgi silver impregnation. The feature that makes this tracer 
especially useful for labelling the CST is that it appears equally homogeneous even 
very long distances from the cell body (Lanciego and Wouterlood, 2011), which can be 




The beta unit of the cholera toxin is non-toxic and is taken up after binding to the GM1 
ganglioside (Trojanowski, 1983). CTB was found to lead to more sensitive retrograde 
labelling of neurons than HRP (Trojanowski et al., 1981), which is due to its superior 
uptake via adsorptive endocytosis, rather than the fluid-phase endocytosis relied upon 
by HRP and the slower rate of elimination (Lanciego and Wouterlood, 2011). Although 
it was first introduced as a retrograde tracer, it became apparent that CTB could also be 
transported efficiently in an anterograde direction (Angelucci et al., 1996). Combined 
with the high level of anatomical detail produced, this led to the widespread use of CTB 
as a transganglionic tracer. Despite these advantages, any tracer that relies on receptor-
mediated uptake must be used with caution as receptors may be unevenly expressed 
across neuronal subtypes or act differently in the presence of damaged axons. This 
problem is illustrated by studies of large myelinated Aβ fibres, which are preferentially 
labelled by CTB (Robertson and Grant, 1985; LaMotte et al., 1991). After peripheral 
nerve injury, it was claimed that these fibres had sprouted into the superficial dorsal 
horn, which is normally exclusively innervated by nociceptive fibres, and that this 
sprouting was responsible for pain hypersensitivity (Woolf et al., 1992; Shortland et al., 
1997). It was subsequently shown that CTB also labels unmyelinated fibres when 
applied to a transected nerve (Tong et al., 1999; Bao et al., 2002) and single cell tracing 
studies have found little evidence that Aβ fibres sprout into superficial laminae after 
injury (Hughes et al., 2003).  
 
Thus, despite the clear benefits of injectable tracing molecules, important limitations do 
exist. Injury-induced changes in the axonal transport system can lead to apparent 
changes in tracer density, which can be misleading, and most commonly employed 
tracing molecules require immunohistochemistry or enzyme histochemistry, which 
precludes their use for in vivo imaging (Kobbert et al., 2000; Lanciego and Wouterlood, 
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2011). Another important limitation of injectable tracing molecules is the considerable 
variability in the number of neurons and/or axons labelled between animals. 
 
4.1.2 Intracellular dye injection 
Intracellular injection of dyes such as Lucifer Yellow (Buhl et al., 1989; Wouterlood et 
al., 1990a; Ochiai et al., 1993), HRP (Koerber et al., 1990; Pierce and Mendell, 1993), 
Neurobiotin (Kita and Armstrong, 1991) and biocytin (Coleman and Friedlander, 1992) 
are used to improve the quality of filling of neuronal processes and also to allow 
coupling of a neuron’s morphological and electrophysiological characteristics. By 
injecting dye into a neuron after an intracellular neurophysiology session, the 
morphological features of the cell can be documented in addition to the 
electrophysiological characteristics. Despite the impressive level of anatomical detail 
revealed using intracellular dye injection, the disadvantages of this procedure are the 
technical difficulty and time-consuming nature. 
 
4.1.3 Genetic tract tracing 
Transgenic expression of green fluorescent protein (GFP) and its spectral variants 
allows evaluation of axonal pathology and represented an important advance in 
neuroanatomical studies (Misgeld and Kerschensteiner, 2006). A group of mouse lines 
of considerable interest in neuroimaging are thy-1-XFP mice, which have been used to 
study the behaviour of specific neuronal tracts after spinal cord injury, including 
regenerative sprouting of dorsal column projections (Kerschensteiner et al., 2005), 
remodelling of CST components (Bareyre et al., 2005) and neuroprotection of 
corticospinal neurons after spinal injury (Carter et al., 2008). Analysis of labelled axons 
or cell bodies has been performed both using traditional post-mortem histochemical 
analysis (Bareyre et al., 2005; Carter et al., 2008) and in vivo time-lapse imaging 
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(Kerschensteiner et al., 2005). The use of these mice also avoids the methodological 
problems of tracer injection, such as invasive and technically demanding surgery, 
variability in labelling efficiency and local tissue damage at the site of injection 
(Kobbert et al., 2000). Important limitations of transgenic tract labelling include 
potential changes in expression pattern following injury and the bilateral nature of the 
labelling, preventing determination of the origin of newly grown fibres (e.g. Liu et al., 
2010). In one such mouse, the YFP-H mouse, it has been reported that long-term 
expression of YFP accelerates age-related pathology, such as axonal swelling in certain 
CNS regions (Bridge et al., 2009). Therefore, results related to axonal pathology in 
affected CNS regions from older XFP-expressing mice must be interpreted carefully. 
Viral vectors expressing fluorescent proteins represent a promising technique to label 
specific neuronal populations. They are versatile tools, as they can be injected 
unilaterally into an area of interest and label a specific neuronal population and, since 
they can encode fluorescent proteins, they also present the possibility of in vivo 
neuronal imaging.  Adeno-associated viral (AAV) vectors are strongly neurotropic and 
have been shown to efficiently transduce neurons, producing impressive anatomical 
resolution of neurons and their branches, including long distance projections such as 
primary sensory neurons and the corticospinal tract (Towne et al., 2009; Mason et al., 
2010; Blackmore et al., 2012; Hutson et al., 2012). Long-term gene expression may be 
achieved with AAV vectors, accompanied by only a minimal immune response 
(Chamberlin et al., 1998; McCown, 2005; Papale et al., 2009). Most AAVs use inverted 
terminal repeats (ITRs) from AAV2, but can be pseudotyped with the capsid from 
different serotypes of AAV, generating vectors with different cellular tropism and 
transduction properties (Burger et al., 2005; Vandenberghe et al., 2009). Recombinant 
AAV expressing the AAV1 or AAV5 capsid have been shown to have improved 
transduction profile and efficiency following injection into the mouse or rat brain 
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(Wang et al., 2003; Burger et al., 2004; Paterna et al., 2004). Drawbacks of viral vectors 
as tracers are similar to those of other injectable tracers, such as the possible damage 
caused by invasive injections and variability in the transduction efficiency between 
animals. This variability will not only be between individual animals according to 
injection technique, but will also be between batches of virus with different titres. The 
heterogeneity of serotype, promoter, envelope, transgene size and other factors also add 
to the complexity of this technique.  
 
4.1.4 Visualising plasticity 
The preceding sections have dealt with tracing techniques that visualise neurons in their 
entirety, either through cellular transport (e.g. HRP) or passive diffusion (e.g. GFP). 
These techniques are useful when examining the projection of a particular neuronal 
population, but do not provide evidence of synaptic connections. As discussed in 
previous chapters, several experimental therapeutic strategies lead to increased axonal 
growth, including regeneration of injured axons and sprouting of spared axons, as 
visualised using neuroanatomical tracers. Clearly, the formation of functional 
connections is required for these growing axons to mediate recovery but the anatomical 
evidence for this occurring is sparse.  Several studies have attempted to show evidence 
of connectivity by combining tract tracing with electron microscopy (Alto et al., 2009; 
Liu et al., 2010) or immunostaining for synaptic proteins, such as synaptophysin (Houle 
et al., 2006; Liu et al., 2010; Rosenzweig et al., 2010).  
 
The use of genetically encoded fluorescent probes to detect the morphological changes 
underlying synaptic plasticity has increased exponentially in recent years, vastly 
expanding scientific knowledge in the field of brain connectivity in health and disease 
(Tian and Looger, 2008). One group of these probes uses the pHluorin molecule 
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(Miesenbock et al., 1998), which is a pH-sensitive version of GFP. SynaptopHluorin 
(SpH) is the most commonly used pHluorin molecule and exploits the difference in pH 
between the lumen of a presynaptic vesicle and the extracellular fluid to report synaptic 
activity (Miesenbock et al., 1998; Burrone et al., 2006). Neurotransmitters are stored in 
presynaptic vesicles and released through exocytosis during synaptic transmission. The 
membrane containing vesicular proteins is subsequently re-internalised and reacidified 
during the process of endocytosis. By fusing the pHluorin molecule to the luminal end 
of the vesicular protein VAMP2, the pHluorin is exposed to a change in pH from ~5.6 
to ~7.4 during exocytosis. In the acidic conditions of the vesicle, SpH fluorescence is 
quenched but when the pH is raised the fluorescence intensity increases, as illustrated in 
Fig. 4.1 (Burrone et al., 2006). In this way SpH can act as a sensor of presynaptic 
activity. This probe has been largely used in vitro to study presynaptic vesicle cycling 
(Li et al., 2005b). 
 
4.1.5 Aims of the chapter 
In this Chapter we combine the principles of neuroanatomical tract tracing with the use 
of a genetically encoded fluorescent probe that accumulates at presynaptic sites. First, 
the generation of lentiviral vectors encoding synaptic probes, and their use in vitro, are 
described. Application of lentiviral vectors to the adult rat brain led to suboptimal 
transduction in vivo and the application of AAV vectors to central and peripheral nerves 
was found to be superior. Finally, this Chapter describes the visualisation and 
quantification of synapses in vivo after application of an AAV vector expressing SpH to 
two classic neuronal projections: the CST and primary sensory neurons. In this way we 










Figure 4.1: pH-dependent changes in synaptopHluorin fluorescence. 
Diagram illustrating the principle behind SpH as a marker of presynaptic activity. 
At rest, SpH resides inside synaptic vesicles where the intralumenal pH is acidic 
(pH ~5.5) and the fluorescence is quenched. Upon activation, exocytosis occurs 
(1), whereby vesicles fuse with the plasma membrane and the lumen is exposed 
to extracellular fluid, which is of neutral (pH ~7.3) and causes an increase in SpH 
fluorescence. Released vesicles are retrieved by endocytosis (2) and undergo 
reacidification an refilling with neurotransmitter (3). The return of the lumen to 





4.2 Materials and Methods 
 
4.2.1 Generation of lentiviral vectors 
Transfer plasmids. Two overexpression plasmids were generated, which expressed 
synaptopHluorin (SpH) or synaptophysin-GFP (Syn-GFP) under control of the 
cytomegalovirus (CMV) promoter. The original human immunodeficiency virus type 1 
(HIV1) lentiviral transfer plasmid was assembled by Dr Ping Yip (King’s College 
London, University of London) and contained a 5’ central polypurine tract (cPPT) 
element and a 3’ woodchuck post-tanscriptional regulatory element (WPRE) enhancer. 
The plasmid was altered by a commercial service (GeneScript) to include mCherry 
(Invitrogen) as reporter in place of GFP under the SFFV promoter (Fig. 4.2E). Dr Leon 
Lagnado (Cambridge University) kindly provided SpH and Syn-GFP cDNA plasmids. 
These two genes were subsequently cloned into the transfer plasmid backbone. The 
cDNA sequences were amplified by PCR with restriction sites at the end of the primers 
(XhoI/XbaI for SpH; XhoI/SpeI for Syn-GFP). The resulting products were then ligated 
into the lentiviral backbone. Successful insertion was ascertained by restriction enzyme 
digestion. Sequencing was also carried out for further confirmation (MWG Eurofins). 
Packaging. A third generation lentivirus packaging system was used to package the 
newly generated vectors into virus particles, as previously described (Naldini et al., 
1996; Dull et al., 1998; Yanez-Munoz et al., 2006). Briefly, the transfer plasmid was 
co-transfected with plasmids carrying essential viral genes (pMDLg/pRRE, 
pRSV.REV) and the viral envelope gene (VSV-G) into human embryonic kidney 
(HEK-293T) cells, using polyethylenimine (PEI) as a transfection reagent. All parent 
plasmids were the generous gift of Dr Rafael Yanez-Munoz (Royal Holloway, 
University of London) and are illustrated in Fig. 4.2. The transfection reaction was 

















Figure 4.2: Plasmids used for the manufacture of lentiviral vectors.  
Schematic drawing of the HIV provirus and the four constructs used to make a 
lentivirus vector of the third generation. A: the proviral HIV-1 genome contains 
genes encoding proteins and sequences essential for the regulation of the virus 
life cycle. B: the packaging construct, pMDLg/pRRE, expresses the gag and pol 
genes under the CMV promoter. The gag and pol genes are expressed only when 
Rev promotes their nuclear export by binding to Rev-responsive element (RRE). 
C: The rev cDNA is expressed by a separate construct, pRRE.REV. D: 
pMD.VSV-G, encodes an envelope to pseudotype the vector, in this case VSV-G. 
E: The transfer plasmid, pRRL.CMV.insert.SFFV.mCherry, is the only portion 
transferred to target cells and contains the expression cassette for the transgene, 
SpH or Syn-GFP. The long-terminal repeats (LTRs) have been modified such 










Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) daily while packaging 
occurred. The harvested HEK-293 cell medium was collected on days 2, 3 and 4 post-
transfection and centrifuged at 690g for 10 minutes at room temperature and then 
filtered through a 0.22µm filter (Nalgene) to remove cell debris. The filtered medium 
was then harvested and transferred to high speed polyallomer centrifuge tubes 
(Beckman) and centrifuged at 50 000g in a SW32Ti rotor (Beckman) for 2 hours at 4˚C. 
The vectors were then resuspended in DMEM, centrifuged at 1400g for 10 minutes and 
incubated with 5Uml
-1
 DNaseI (Promega) and 10mM MgCl2 (Sigma) for 20 minutes. 
The two vectors, LV-SpH and LV-Syn-GFP, were then aliquoted and stored at -80˚C.  
Vector titration. An infection assay was used for lentiviral vector titration. For this, 10
5
 
HEK-293T cells were seeded on 6-well plated (Nunc). The following day, the cells of a 
spare well were collected by incubation with 0.25% Trypsin (Sigma) and the total cell 
number/well was calculated using a haemocytometer (Invitrogen). For titration, serial 






 in 1ml) in DMEM media were 
supplemented with 16μg/ml Polybrene (Sigma) and added to the cells. After 72 hours, 
cells were fixed with 4% cold paraformaldehyde for 30 minutes and then washed 3 
times in phosphate buffered saline (PBS) with 0.1% TritonX. Cells were 
immunostained for GFP by incubation with a rabbit anti-GFP antibody (1:1000; 60 
minutes; Invitrogen), followed by three PBS washes and incubation with a donkey anti-
rabbit Alexa Fluor 488 secondary antibody (1:1000; 60 minutes; Invitrogen) for 1 hour. 
Hoechst (1:5000; Sigma) was added to the secondary antibody solution to allow 
visualisation of nuclei. An IN Cell Analyser Workstation (GE Healthcare) was used to 
randomly acquire images from each well. Sample wells that contained <10% GFP-
positive cells were used to determine the titre using the following formula:   
transducing units (TU)/ml = (% eGFP positive cells/100) x cell number on day of 
transfection x dilution factor. 
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, with the highest 
titre preparations typically from day 2 of the harvest. For brain injections, vector from 
the highest titre preparation (1.27 x 10
8
 TU/ml) was used. 
 
4.2.2 Application of lentiviral vectors in vitro 
Hippocampal culture. Primary hippocampal cultures were prepared from embryonic 
day 18 Wistar rat embryos of either sex. Hippocampi were excised from the brains of 
the embryos and dissociated using trypsin (5mg/ml  for 15 minutes at 37˚C; 
Worthington) and plated at 350 cells/mm
2
 on glass coverslips coated with poly-D-
lysine (50µg/ml) and laminin (20µg/ml). Neurons were incubated at 37˚C and 5% CO2 
in Neurobasal media (company) supplemented with B27 (2%) and glutamax (500µM). 
Twice weekly 50% of the media was removed and replaced with fresh supplemented 
Neurobasal.  
Lentiviral transduction. The number of biologically active virus particles per target cell 
is known as the multiplicity of infection (MOI). In these experiments lentiviral vectors 
were added at an MOI of 10, which typically produced close to 100% transduction of 
hippocampal neurons. Vectors were applied to the cultured cells 24 hours after plating 
and were left to express for 10-14 days: 10 days for immunocytochemistry and 14 days 
for SpH imaging.  
Immunocytochemistry. After 10 days in vitro, hippocampal cells were washed with PBS 
and fixed for 30 minutes with ice cold 4% paraformaldehyde, then washed three times 
in PBS with 0.1% Triton (5 minutes each). Neurons were immunostained with mouse 
anti-βIII tubulin (1:1000; Promega) and rabbit anti-GFP (1:1000; Invitrogen) primary 
antibodies for 1 hour. After 3 further washes, as above, goat anti-mouse Alexa Fluor 
546 antibody, donkey anti-rabbit Alex Fluor 488 antibody (both 1:1000; Invitrogen) 
and Hoechst (1:500; Invitrogen) were applied. Slides were coverslipped with Mowiol 
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mounting medium and images were captured on a confocal microscope (Carl Zeiss 
LSM 710).  
SynaptopHluorin imaging. After 14 days in vitro, SpH imaging was performed using 
one of the hippocampal cultures, in the manner previously described (Fredj and 
Burrone, 2009; Burrone et al., 2007). Briefly, a coverslip is placed in a custom-built 
Perspex stimulation chamber (World Precision Instruments) containing two parallel 
platinum wires ~5mm apart, which depolarise cells when current is passed between 
them. Neurons were depolarised sequentially with 40, 100 and 300 stimuli at 20Hz 
using an SD9 stimulator (1ms, 25mA; Grass Instruments), whose timing was controlled 
by a TTL signal from the imaging software (Slidebook). Images were obtained using an 
inverted microscope Olympus IX71 with a CCD camera (Coolsnap HQ; Photometrics) 
controlled by Slidebook software (Intelligent Imaging Innovations). Images were 
analysed offline using ImageJ, using a region of interest (ROI) containing a high 
density of synapses (Fig. 4.3G). The change in fluorescence (ΔF) within the ROI in 
response to a stimulus was calculated by subtracting the initial fluorescence intensity 
(F0) from the fluorescence of each time frame (ΔF = F – F0). A normalised value 
(ΔF/F) is then calculated to account for differences in the number of reporter molecules 
in each ROI. 
 
4.2.3 Application of lentiviral vectors in vivo 
All procedures were carried out in accordance with UK Animals (Scientific Procedures) 
Act 1986 and approved by the local veterinarian and ethical committee. For all recovery 
surgery, sterile precautions were used. Adult male Wistar rats weighing 200-220g were 
anaesthetised with 60mg/kg ketamine and 0.25mg/kg medetomidine, diluted in saline 
and administered i.p. Body temperature was monitored rectally and used to regulate a 
homeothermic blanket. Four animals received intracortical brain injections of viral 
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vector (n=2 each of LV-SpH and LV-Syn-GFP). Rats were prepared for surgery by 
shaving and disinfecting the skin overlying the skull. The rat was placed into a 
stereotaxic frame (David Kopf Instruments) and the incisor bar adjusted such that 
Bregma and Lambda were at equal heights and the surface of the skull was flat. 
Following a skin incision along the midline, the skin and periosteum were retracted to 
expose Bregma. Six holes were drilled through the skull overlying the right 
sensorimotor cortex, according to coordinates obtained from microstimulation mapping 
studies (Neafsey et al., 1986). Coordinates are relative to Bregma, the midline and the 
surface of the brain and are defined as anterior-posterior (AP), medial-lateral (ML) and 
dorsal-ventral (DV), respectively: 
1. 3.5mm ML; -0.5mm AP; 1mm DV 
2. 3.5mm ML; +0.5mm AP; 1mm DV 
3. 3.5mm ML; +2mm AP; 1mm DV 
4. 2.5mm ML; +1.5mm AP; 1mm DV 
5. 2.5mm ML; +0.5mm AP; 1mm DV 
6. 1.5mm ML; +1.0mm AP; 1mm DV 
6 injections of 0.5µl each were performed using a glass capillary pulled to a tip 
diameter of about 20µm, connected to a 10µl syringe and driven by a microdrive pump 
(Harvard Apparatus) at 0.25µl/min. The capillary was left in place for 2 minutes after 
the infusion to allow diffusion of the vector away from the injection site. Successful 
vector expulsion was confirmed visually. Overlying skin was sutured and 1mg/kg 
atipamezole hydrochloride was administered subcutaneously to reverse the anaesthetic. 
Animals recovered in an incubator and received 0.05mg/kg buprenorphine 
postoperatively. They were then left for 4 weeks to allow lentiviral transduction and 
expression of SpH and Syn-GFP. 
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4.2.4 Application of adeno-associated viral vectors in vivo 
AAVs. Two AAV vectors were used in these experiments, both containing genomes 
from AAV2 pseudotyped with capsid serotype AAV5. The first was a commercially 
available vector, AAV2/5.CMV.hGHintron.GFP-Cre.SV40 (Cat # V1705, University 
of Pennsylvania Vector Core Facility), expressing a fusion protein of GFP and the 
enzyme Cre recombinase. This vector will hereafter be referred to as AAV-GFP-Cre. 
The titre of this preparation was nominally 2.0 x 10
13
 genomic copies per ml, although 
the Vector Core facility guaranteed a titre of only 2 x 10
11
. The second vector, 
expressing SpH (AAV-SpH), was kindly provided by Professor R.M. Linden (King’s 
College London). The titre of this preparation was 3.5 x 10
12
 genome copies per ml. 
The vectors contained transgene expression cassettes that carried the human 
cytomegalovirus (CMV) promoter to drive transgene expression, the transgenic cDNA 
and a downstream SV40 polyadenylation sequence. The transgene expression cassette 
is flanked by the non-coding ITRs, which are essential for packing of the viral vector 
DNA and are the only wild-type viral sequences in the vector. The AAV-SpH vector 
also contained a WPRE sequence downstream of these elements, which enhances the 
expression of the transgene (Peel and Klein, 2000). 
Sciatic nerve injection. Animals were anaesthetised as above and the skin overlying the 
lateral aspect of the left hindlimb was shaved and disinfected. The sciatic nerve was 
exposed by blunt dissection between the musculus gluteus superficialis and musculus 
biceps femoris. A ~20µm tip diameter glass capillary connected to a microdrive pump 
(Harvard Apparatus) was used to deliver 5µl of AAV-GFP-Cre (n=6) or AAV-SpH 
(n=5) at 0.25µl/min. A subset of the AAV-GFP-Cre group of animals (n=3) received a 
distal sciatic nerve crush injury, via brief application of pressure with blunt forceps, 
immediately prior to nerve injection. 
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Intracortical injection. Rats were prepared for surgery, placed in a stereotaxic frame 
and 6 holes were drilled into the skull according to the coordinates listed in the previous 
section. In these experiments 6 0.5µl injections of AAV-GFP-Cre (n=3) or AAV-SpH 
(n=3) were performed using a 5µl syringe driven by a microdrive pump at 0.1µl/min. 
The needle was left in place for 10 minutes following each injection. 
After all types of injection overlying muscles and skin were sutured and 1mg/kg 
atipamezole was administered s.c. Animals recovered in an incubator and received 
0.05mg/kg buprenorphine postoperatively. All groups were left for 4 weeks to allow 
transduction and expression of GFP-Cre and SpH. 
 
4.2.5 Histology and immunohistochemistry  
Histology. Four weeks following AAV injection, animals were terminally anaesthetised 
with sodium pentobarbitone (80mg/kg, i.p.) and transcardially perfused with 200ml 
heparinised saline followed by 400ml paraformaldehyde (4% in 0.1M phosphate buffer). 
Brains, brainstems, spinal cords and dorsal root ganglia (DRGs) were dissected, as 
appropriate, from the animals in each group and post-fixed in 4% paraformaldehyde 
overnight at 4˚C. The following day the spinal cords and dorsal root ganglia were 
transferred into 20% sucrose for 48 hours at 4˚C and then blocked in OCT embedding 
compound (BDH) for cryostat sectioning. 20µm thick DRG sections and sagittal spinal 
cord sections were cryostat cut and thaw-mounted onto Superfrost Plus slides and 
stored at -20˚C. Brains and brainstems were embedded in 10% gelatin (Sigma) and 
placed in 4% paraflormaldehyde overnight to harden. They were cut rostro-caudally 
into 30µm coronal serial sections using a Vibratome (VT 10005; Leica) and collected 
into a 24-well plate (Nunc) containing PBS and 0.1% azide (Sigma). 
Immunohistochemistry. Brain and brainstem tissue was stained using the free-floating 
method; spinal cords and DRGs were stained on microscope slides. Tissue sections 
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were washed 3 times for 5 minutes each in PBS and immunostained with a rabbit anti-
GFP antibody (1:1000, Invitrogen), diluted in PBS with 0.2% Triton and 0.1% azide, 
overnight at room temperature. Primary antibody was then removed, sections were 
washed 3 times in PBS and incubated with a goat anti-rabbit Alexa Fluor 488 secondary 
antibody (1:1000, Invitrogen) for 2 hours at room temperature. Finally sections were 
washed 3 times in PBS, and mounted if necessary (brain and brainstem sections), and 
coverslipped using Vectashield with DAPI (Vector Labs). DRG sections were double 
stained with a mouse anti-β3 tubulin primary antibody and donkey anti-mouse Alexa 
Fluor 546 secondary antibody. 
 
4.2.6 Imaging and quantification 
For quantification of the number of transduced neurons in DRGs after sciatic nerve or 
spinal cord injection of AAV, low power mosaic images were taken on an Apotome 
microscope (Carl Zeiss) using the x 20 objective. Using Image J (NIH), we counted the 
total number of β3 tubulin labelled profiles and the number of GFP labelled profiles in 
4 sections per DRG for each animal and used these as an approximation of the 
percentage of transduced neurons ((no. GFP-positive profiles / no. β3 tubulin-positive 
profiles) x 100).  
For quantification of the number of transduced CST fibres at the C2 level of the spinal 
cord following brain injection of AAV, high resolution mosaic Z-stack images of 
transverse cord sections were captured on a confocal microscope (Carl Zeiss LSM 710) 
using a x 40 objective. The maximum intensity projection (MIP) from this stack was 
used to determine the number of fibres in the dCST by performing manual counts using 
Image J (NIH).  
The number of presynaptic boutons labelled by the virus was determined in transverse 
sections of the cervical cord of brain-injected animals and in sagittal sections of the 
177 
 
lumbar cord of sciatic nerve-injected animals. Three sections per animal were analysed. 
High resolution, mosaic images were captured, with Z-stacks including only the middle 
10µm of the section, such that the top and bottom of the section are discarded. Images 
were converted to MIPs and saved in an .LSM format before analysis using Image J 
(NIH) was performed. The area imaged included all GFP-positivity in the grey matter 
of the spinal cord (i.e. excluding the dCST). Initially, the ‘Despeckle’ function was 
used to remove noise from the image and a threshold was applied to achieve a binary 
image. An automated counting function (‘Analyse Particles’) then determined the 
number of synaptic boutons. Only objects that had a diameter greater than 0.4µm were 
included in the analysis, to eliminate small, non-specific GFP-positive objects. To 
establish the threshold chosen for each image, 5 sample areas per section were chosen 
and manual counts of boutons were performed. A range of thresholds was applied and 
the number of particles detected by the program was compared to the manual count. In 
















4.3.1 LV-SpH and LV-Syn-GFP allow visualisation of synaptic puncta in vitro 
To assess whether the lentiviral vectors generated (LV-SpH and LV-Syn-GFP) had 
been successfully packaged they were applied to dissociated hippocampal neurons from 
embryonic rats. This well characterised experimental system has been widely used for 
the study of synaptogenesis and synaptic plasticity in vitro (Verderio et al., 1999). 
Lentiviral vectors were added to culture medium after 24 hours in vitro and 10 days 
later neurons were fixed and stained for GFP and the neuronal marker β3 tubulin (Fig. 
4.3A-F). This time point was chosen as 7-9 days in vitro is a period of peak 
synaptogenesis in cultured hippocampal neurons (Fletcher et al., 1991). Indeed, 
punctate GFP staining was observed on the cell bodies and neurites of the cultured 
neurons transduced with either LV-Syn-GFP (n=5; Fig. 4.3A-C) or LV-SpH (n=5; Fig. 
4.3D-F). Using LV-SpH and LV-Syn-GFP at an MOI of 10 led to neuronal transduction 
of close to 100%. These findings indicate that LV-Syn-GFP and LV-SpH successfully 
transduce cultured hippocampal neurons and appropriately express synaptic proteins 
tagged with GFP. 
 
4.3.2 SynaptopHluorin delivered by lentiviral vector can be used to detect exocytosis 
We next tested whether the lentivirally expressed SpH could detect the pH change that 
occurs during exocytosis. To do this, live neurons were inspected under an inverted 
fluorescent microscope and a field of view with a dense concentration of synapses was 
chosen (Fig. 4.3G). The response of these puncta was evaluated in response to electrical 
stimulation with incremental numbers of stimuli (40, 100 and 300 stimuli at 20Hz). At 
rest, synapses emitted a low level of fluorescence, which increased rapidly during the 
electrical stimulation and subsided more gradually during the recovery phase (Fig. 
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4.3G). As expected, quantification of the change in fluorescence, normalised to the 
resting fluorescent intensity, showed that the increase in fluorescence correlates with 
the number of action potentials used to stimulate the culture (Fig. 4.3H). These findings 
indicate that LV-SpH can transduce hippocampal neurons in culture, the SpH construct 
can be targeted to presynaptic locations and respond appropriately to stimulation. Thus, 
LV-SpH can be used to monitor synaptic function in cultured neurons. Because the in 
vivo applications of this vector showed little sign of widespread neuronal labelling (see 


































Figure 4.3: In vitro application of lentiviral vectors expressing SpH or Syn-
GFP. A-F: dissociated embryonic rat hippocampal neurons immunostained for 
β-III tubulin (red) and GFP (green) after 10 days in vitro and incubation with 
LV-Syn-GFP (A-C) or LV-SpH (D-H). G-H: SpH responses to electrical 
stimulation of cultured hippocampal neurons transduced with LV-SpH. G: 
Typical response from axons expressing SpH to a train of high-frequency stimuli. 
Representative images are selected for display from the time series: (i) pre-
stimulation (rest), (ii) peak of response (stim) and (iii) post-stimulation 
(recovery). A region of interest (ROI) encompassing an area with a high density 
of SpH-expressing synapses was chosen. H: changes in SpH fluorescence (ΔF/F) 
of neurons when stimulated with 40, 100 or 300 action potentials at 20Hz. 
Synapses show increases in fluorescence during the stimulus (exocytosis) and a 










4.3.3 Brain injection of LV-SpH leads to limited neuronal transduction  
Having shown that LV-SpH can be used to visualise synapses and detect synaptic 
function in cultured neurons, we next tested this vector in vivo. LV-SpH was injected 
unilaterally into the sensorimotor cortex and 4 weeks later brains were examined for 
GFP expression. A small, localised area of GFP-positivity was observed in the cortex of 
injected rats (n=3; Fig. 4.4A). Higher magnification analysis of the transduced cells 
revealed the presence of GFP-positive cells of both neuronal and glial appearance (Fig. 
4.4B). Sensorimotor cortex injections of viral vectors have been used in a previous 
study and have achieved efficient CST transduction, with GFP-positive axonal 
projections observed in the brainstem and spinal cord (Blackmore et al., 2012). In our 
experiments we did not observe any transduced axons at or below the level of the 
brainstem (data not shown). Thus, LV-SpH, at least as used here, leads to suboptimal 
neuronal transduction after brain injection. 
 
4.3.4 Analysis of AAV2/5 vector ability to transduce neurons in vivo 
Since in vivo injection of a lentiviral vector led to suboptimal transduction, a pilot 
experiment was carried out using an AAV vector available in our laboratory, AAV-
GFP-Cre. This vector expresses the enzyme Cre recombinase, with a GFP tag. In this 
pilot experiment we did not use the enzymatic property of the Cre but were rather 
interested in the ability of an AAV2/5 vector to transduce neuronal populations, 
compared to a lentiviral vector. The viral vector was injected into different neural 
tissues of adult rats at the titre supplied (2 x 10
13
) to examine the transduction of 
neuronal populations, including (i) brain injections, targeting CST neurons (n=3), (ii) 
spinal cord injections, targeting spinal neurons (n=3), and (iii) sciatic nerve injections, 
targeting sensory neurons (n=6). Four weeks after injection into the sensorimotor cortex, 




Figure 4.4: In vivo application of lentiviral vectors. A: adult rat brain at one 
month after injection of LV-SpH into the somatosensory cortex, immunostained 
for GFP. A small area of GFP reactivity is present in a localised area within the 
cortex. B: high power image of transduced cells. Both neuronal and glial cells are 
transduced by the vector. 
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observed to have projected away from the injection site and into thalamic areas (Fig. 
4.5A). Higher magnification imaging revealed transduced cells to be neuronal in 
appearance (Fig. 4.5B). 
Spinal cord injection of AAV-GFP-Cre similarly led to transduction of spinal neurons 
in the grey matter of the spinal cord, iplsilateral to the injection (n=3; Fig. 4.5C). 
Interestingly, GFP-positive neurons were also observed in local DRGs following spinal 
cord injection (Fig.4.5D), indicating retrograde transport and transduction of sensory 
neurons after spinal injection. Quantification of the number of transduced sensory 
neurons in cervical DRGs following spinal cord injection (Fig. 4.6A) showed that the 
highest number of GFP-positive cells was found in the DRG immediately adjacent to 
the injected spinal segment, C5 (19.9±7.1%), followed by the rostral C4 DRG 
(15.2±2.5%). A smaller number of GFP-positive neurons were detected in the DRG 
immediately caudal to the injection site, C6 (5.5±0.03%).  
To investigate the ability of an AAV2/5 vector to transduce sensory neurons after 
distant injection into the sciatic nerve, we examined GFP expression in lumbar DRGs 4 
weeks after sciatic nerve injection of AAV-GFP-Cre. We also investigated whether 
simultaneous nerve crush could improve the transduction efficiency after AAV 
injection. When injected into the intact sciatic nerve, AAV-GFP-Cre transduced a small 
number of DRGs (Fig. 4.5E). Most positive cells had GFP immunolabelling only in the 
nucleus (Fig. 4.5F), presumably due to the nuclear targeting of the Cre part of the Cre-
GFP fusion protein. Occasional cells with diffuse GFP staining throughout the 
cytoplasm were observed, likely due to transduction of that particular neuron by a 
greater number of viral particles. Quantification of the number of GFP-positive profiles 
revealed that the highest numbers of transduced cells were in the L4 DRG (L4: 
2.8±2.2%, L5: 1.6±1.3%, L6: 1.43±0.6%, n=3; Fig. 4.6B). Subjecting the sciatic nerve 














Figure 4.5 In vivo application of AAV2/5. AAV-GFP-Cre was applied to 
three nervous system locations: brain (A, B), spinal cord (C, D) and sciatic nevre 
(E, F). Sections were immunostained for GFP (green) and DAPI (blue). Low 
power images of each tissue are shown in the left panels (A, C, E). A: coronal 
section of AAV-injected brain, showing a large area of transduction with GFP 
visible in the thalamus as well as in the cortex. B: high magnification image of 
the cortical GFP-positive area in A, showing that all visible cells have a neuronal 
morphology. C: transverse section of AAV-injected cervical spinal cord, 
showing numerous transduced GFP-positive cells in the grey matter of the spinal 
cord. D: C4 DRG from a spinal cord injected animal containing retrogradely 
transduced cells. GFP-positive axons are also visible running in the dorsal root. 
E: L4 DRG from a sciatic nerve injected animal that received a nerve crush at 
the time of injection, showing ~8% transduction of DRG neurons. F: High 


























Figure 4.6 Quantification of GFP-positive profiles in DRGs following 
AAV2/5 injection. A: Spinal cord injection of AAV-GFP-Cre led to retrograde 
transduction of sensory neurons in cervical DRGs adjacent to the injection site 
(n=3). The highest number of transduced cells was in the C5 DRG, immediately 
adjacent to the injection site in the C5 segment of spinal cord. Positive cells were 
also observed in the DRGs immediately rostral and caudal to the injection, C4 
and C6. B: Sciatic nerve injection of AAV-GFP-Cre led to retrograde 
transduction of DRG neurons. Injection into the intact nerve led to the 
transduction of a modest number of cells. Performing a nerve crush at the time of 
injection led to a significant increase in the efficiency of retrograde transduction. 











number of transduced neurons in lumbar DRGs (L4: 7.6±1.7%, L5: 7.8±0.9%, L6: 
2.4±1.9%; n=3, significant effect of nerve crush, p<0.05, unpaired t-test on L4-6 pooled 
for crushed and intact groups). This pilot experiment shows that AAV2/5 is capable of 
transducing large numbers of brain and spinal cord neurons when directly injected into 
the vicinity of their cell bodies, and can transduce a modest number of sensory neurons 
in a retrograde manner when injected into the sciatic nerve. Based on their promising 
transduction profiles we decided to use AAV2/5 vectors for further in vivo experiments. 
 
4.3.5 CST transduction using a synaptopHluorin-expressing AAV2/5 vector  
To investigate the synapses made by CST projections, we used an AAV vector 
expressing a GFP-tagged protein that accumulates at presynaptic sites, AAV-SpH, to 
transduce corticospinal neurons. This vector was made in the laboratory of Professor 
Michael Linden (King’s College London). We injected the vector unilaterally into the 
sensorimotor cortex of adult rats (n=3). Four weeks post-injection intense GFP 
expression was visible at the injection site (Fig. 4.7A) and many labelled neurons were 
also visible further away, extending throughout the ipsilateral cortex (Fig. 4.7B). 
Higher magnification imaging revealed that the majority of labelled cells had a 
neuronal morphology (Fig. 4.7C).  
To specifically assess CST transduction, the brainstems of brain-injected animals were 
immunostained for GFP in order to visualise SpH. Many transduced, SpH-positive 
axons were visible in the right medullary pyramid (Fig. 4.8A, B), where the tract from 
the right cortex is located as it projects towards the spinal cord. Below the level of the 
pyramids, at the spinomedullary junction, the CST decussates and projects dorsally, 
where it resides mainly in the dorsal columns of the spinal cord. GFP-positive axons 
transduced by AAV-SpH were visible in the left dorsal column (Fig. 4.8C, D). The 























Figure 4.7: Brain transduction following cortical injection of AAV-SpH. A: 
Representative images showing expression of SpH in the brain four weeks after 
AAV-SpH injection. Bright SpH labelling is observed at the injection site and in 
the ipsilateral thalamus. A small area of contralateral thalamic labelling is also 
present. B: Image from a different brain section in the same animal showing a 
widespread area of transduction extending throughout the cortex. C: High power 
image of an SpH-positive area in B, showing SpH present throughout the 































Figure 4.8: SpH is apparent throughout the CST projection to the brainstem 
and spinal cord. Sections were immunostained for GFP (green) and DAPI 
(blue). A: coronal brainstem section showing SpH-positive axons in the pyramid 
ipsilateral to AAV-SpH injection. B: horizontal brainstem section showing the 
same tract longitudinally. Again, the ipsilateral tract contains many SpH positive 
axons. C: transverse section of spinal cord at the C2 level. CST axons can be 
seen leaving the white matter tract and terminating in the grey matter of the 
spinal cord. The terminal branches are found in the intermediate laminae of the 
spinal grey matter, but a small number extend towards the ventral horn. D: higher 
magnification image showing the dorsal CST at the C2 level of the spinal cord. A 











4.3.6 AAV-SpH labels synapses made by CST neurons in cervical spinal cord 
Axons leave the CST throughout the spinal cord to make connections with neurons in 
the grey matter of the spinal cord. This phenomenon was observed at the cervical level 
of brain-injected animals, where dense SpH labelling is observed in the intermediate 
laminae of the spinal grey matter (Fig. 4.8C). Although the CST projections appear 
axonally labelled, when examined at higher power SpH was found to accumulate in 
large numbers of bright puncta resembling presynaptic boutons (Fig. 4.9A, B; 4.10A). 
These will henceforth be referred to as synapses, although what else they might also 
represent is discussed later. To quantify the number of synapses, we took high-
resolution images of the ipsilateral and contralateral spinal grey matter. During offline 
analysis, a threshold was chosen for each section and applied to create a binary image. 
Fig. 4.9 describes the method of thresholding, which involves performing manual 
counts on sample regions from the grey matter and choosing the optimum threshold to 
be applied to the whole image. The number of objects recognised after creation of the 
binary image was determined using an automated counting function in the imaging 
software. Any object with a diameter of less than 0.4µm was excluded from analysis to 
prevent the inclusion of small, non-specific areas of fluorescence. The spinal cords 
from 3 animals were imaged and SpH-positive synapses were counted in several 
sections. As expected, a greater number of synapses were detected in the grey matter of 
the animal with the largest number of SpH-positive dorsal CST axons and the smallest 
number in those animals with the fewest transduced CST neurons (Fig. 4.10C). There 
was very little variability between different sections from the same animal, as shown by 
the error bars in Fig. 4.10C. 
These findings indicate that AAV-SpH can be used to transduce corticospinal neurons 















Figure 4.9: Determination of threshold level for quantification of synapse 
number. A: Example of one tile of a large mosaic of maximum intensity images 
from a 10µm thick Z stack. The yellow box indicates the 360 x 360µm area used 
for threshold determination. B: Enlargement of the boxed area in A. One of five 
360 x 360µm areas chosen from throughout the grey matter of a given spinal 
cord section. A manual count of the maximum and minimum possible number of 
boutons in the image is performed. C-I: A series of thresholds are applied to the 
image and the number of objects is calculated using a counting function of 
ImageJ. J: The number of objects detected is plotted against the threshold 
applied to the image. A lower threshold allows a greater number of objects to be 
recognised. Using this range and the ranges from the four other sample areas 
throughout the section, an optimum threshold is chosen and applied to the entire 
image. An automated counting protocol is used to avoid bias in the counting 


























Figure 4.10: Quantification of the number of synapses in C2 spinal cord 
following brain injection of AAV-SpH. A: At high magnification the terminal 
branches of CST axons are faintly labelled with many bright SpH-positive puncta 
along their length, presumably presynaptic specialisations. B: Example image 
illustrating how quantification of the numbers of synapses is carried out. First 
non-specific noise is removed from the image using the ‘Despeckle’ function in 
ImageJ. A threshold is then applied, which creates a binary image. Any 
recognised object is then counted, excluding any object smaller than 0.4μm. This 
process is applied to the entire grey matter of each spinal cord section analysed. 
C: Data are shown separately for the three animals that received brain injections. 
Quantification of the number of transduced CST axons (blue bars) at the C2 level 
was performed by a manual count of the number of axons in the dorsal column 
projection in a section of spinal cord from this level. Quantification of the 
number of synapses (red bars) is shown for each animal. The animal with the 
greatest number of transduced axons also had the greatest number of synapses 
and vice versa. To determine the consistency of the number of synapses between 
sections, three sections from the cervical cord were analysed for each animal and 
the data are shown as the average number of synapses in these three sections. 








4.3.7 Sensory neuron synapses can be visualised using AAV-SpH 
We next investigated whether the synapses made by a second population of neurons, 
primary afferent sensory neurons, could be visualised using AAV-SpH. For this we 
injected AAV-SpH into the sciatic nerves of adult rats and examined SpH expression in 
the lumbar spinal cord (n=5). Four weeks following viral vector injection, SpH was 
expressed within the dorsal portion of sagittal sections of lumbar spinal cord within 
branching afferent fibres (Fig. 4.11A) of two rats. Unfortunately, as this work is still 
underway the remaining three rats have not yet been characterised, so the results 
reported here will refer to the two animals with complete datasets. Primary afferent 
terminals in the spinal dorsal horn of the analysed spinal cords were visible as bright 
SpH-positive puncta (Fig. 4.11C). Quantification of the number of labelled synapses in 
three sagittal spinal cord sections was performed as described above. Three sections 
were analysed for each animal using the method described above for CST terminals. 
High resolution images of all areas of SpH-positivity were taken and converted to 
binary images, prior to automated object counting. The total number of synapses 
counted in this way was 809 for animal #1, and 1504 for animal #2. To account for 
differences in the number of neurons transduced by AAV-SpH, it is necessary to 
normalise the number of SpH labelled synapses in the spinal cord to the number of 
transduced sensory neurons. Sciatic nerve injection of AAV-SpH into intact nerves led 
to transduction of a small number of DRG neurons (1.2% at L4, n=3; Fig. 4.11B), 
comparable to AAV-GFP-Cre injection into intact nerves described above. It will be 
possible to get a better idea of the usefulness of AAV-SpH as a tool for visualising 
primary afferent terminals when the spinal cords of all rats in this group have been fully 
analysed.  
These findings indicate that it is possible to visualise the synaptic connections of 
sensory neurons transduced with AAV-SpH. Despite the modest number of transduced 
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Figure 4.11 Spinal cord and DRG expression of SpH following sciatic 
nerve injection of AAV-SpH. A: Sagittal section of spinal cord showing 
branches of primary afferent neurons expressing SpH in the dorsal grey matter of 
the spinal cord. B: Small numbers of SpH-positive DRG neurons (green) in an 
L4 DRG also immunostained for β3 tubulin (red) and DAPI (blue). C: High 
magnification of SpH-positive primary afferent terminals showing presynaptic 








This Chapter has described the development of a novel tool that allows visualisation of 
synapses. Two neuronal populations, corticospinal neurons and primary afferent 
sensory neurons, were investigated in the adult rat. An AAV2/5 vector, AAV-SpH, was 
found to efficiently transduce corticospinal neurons and label synapses distant from the 
site of vector injection in the cortex via anterograde transport of SpH. Similarly, AAV-
SpH transduced a modest number of sensory neurons in a retrograde fashion after 
peripheral nerve injection and labelled their central terminals. Thus, AAV-SpH has 
been shown to label the synapses of both peripheral and central nervous system neurons 
and presents the potential for an anatomical measure of synaptogenesis. 
 
4.4.1 Using viral vectors to transduce the CST 
AAV vectors are commonly used for gene delivery to the CNS because they permit 
non-toxic transduction of neurons, resulting in long-term gene expression (Bartel et al., 
2012). These features make AAV vectors attractive candidates for translation into the 
clinic. Indeed, a number of trials involving gene delivery to the CNS by AAVs are 
currently underway and yielding promising results (Kaplitt et al., 2007; Muramatsu et 
al., 2010). The same properties that make AAVs promising for use in humans also 
make them useful for research into the structure and function of neural circuits (Betley 
and Sternson, 2011) and the neurotropic nature of AAVs has facilitated their use as 
anterograde fluorescent labels (Harvey et al., 2002; Leaver et al., 2006b; Leaver et al., 
2006a; Foust et al., 2008; Planchamp et al., 2008; Blits et al., 2010; Vulchanova et al., 
2010; Williams et al., 2012). This is consistent with the findings reported in this 
Chapter: the cells transduced by AAV-SpH appeared to be largely neuronal. In addition, 
the serotype used in this study, AAV2/5, has previously been reported to efficiently 
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transduce CNS tissue in a highly neuron-specific way (Burger et al., 2004; Paterna et al., 
2004; Foust et al., 2008; Hutson et al., 2012). The CST is of particular interest to the 
field of spinal cord injury research due to its central role in voluntary motor function. 
Achieving CST transduction with viral vectors has been attempted with varying degrees 
of success (Yip et al., 2006; Foust et al., 2008; Blackmore et al., 2012; Hutson et al., 
2012). In this Chapter, AAV-SpH injection into the cortex of the adult rat led to 
efficient CST transduction, as shown by a large area of transduction in the cortex and 
the presence of 2000-3000 transduced CST axons in the cervical spinal cord. In 
agreement with others (Harvey et al., 2002) we found that AAV was far superior to 
lentiviral brain injection, which led to a small area of transduction of SpH positive cells 
and no transduced axons were observed in the brainstem or spinal cord. It is likely that 
the relatively poor transduction observed after brain injection of LV-SpH can be 
attributed to the low titre achieved when vectors are made in-house. As we are not a 
specialist viral facility, our vectors are likely to be of lower titre and lower quality than 
those made by vector core facilities, for example, and significantly better cortical 
transduction may have been achieved using a commercially made lentiviral vector. 
Indeed, others have reported significantly better results using lentiviral vectors (e.g. 
Zhao et al., 2011), so it may not only be the type of vector used per se but also the 
quality of preparation that is most important. 
 
4.4.2 Potential uses of AAV-SpH to study the CST  
The delivery of fluorescent proteins by viral vectors for use as anterograde axonal 
labels is gaining in popularity and has recently begun to be employed as a tool for the 
study of axonal regeneration after injury (Andrews et al., 2009; Wu et al., 2009; Low et 
al., 2010; Wang et al., 2011). We have shown that following cortical injection of AAV-
SpH, SpH can be visualised throughout the length of the corticospinal axon by 
204 
 
immunostaining for GFP. Thus, AAV-SpH can be used for the study of regeneration in 
the same way as traditional tracers, such as BDA. However, plastic changes following 
CNS injury are also known to be important and have been shown using 
electrophysiology (e.g. Bareyre et al., 2004; Massey et al., 2006; Cafferty et al., 2008). 
This Chapter has described the development of an anatomical tool for the quantification 
of synapses made by a specific neuronal tract, the CST. By accumulating in bright 
puncta at presynaptic sites, SpH allows investigation of the number and distribution of 
synapses. For example, the small ventral component of the CST was also labelled by 
AAV-SpH, which is useful as this tract has been reported to undergo extensive 
remodelling after dorsal CST injury (Weidner et al., 2001) and the nature of these 
changes may now be further explored.  
 
A model that will lend itself to testing the usefulness of AAV-SpH is the pyramidotomy 
injury technique, which transects one half of the CST at the level of the pyramids in the 
brainstem, rostral to the spinal cord. The reactions of the uninjured tract can then be 
investigated as it projects in the spinal cord. This has been extensively used in the past 
to study the sprouting response in the spinal cord in response to treatments that promote 
growth or neutralise inhibitory factors in the spinal cord (e.g. Liu et al., 2010; Thallmair 
et al., 1998; Blochlinger et al., 2001). Using AAV-SpH the unilateral pyramidotomy 
model could be taken a step further, to investigate whether the regenerative sprouts are 
forming synapses.  
 
As the results reported here are only for 3 brain-injected animals, further 
characterisation clearly remains to be carried out. However, once the technique is fully 
optimised it has the potential to go further than previous techniques examining 
functional connectivity, such as combining tract tracing with electron microscopy, 
205 
 
because of the potential use of the pHluorin to additionally examine the function of 
newly formed synapses, as well as their location.  
 
4.4.3 Using viral vectors to transduce sensory neurons 
Gene transfer to primary sensory neurons has been of interest to researchers interested 
in dissecting the mechanisms underlying nociceptive processes. In the present study, 
injection of two different AAVs into the sciatic nerve led to transduction of a small 
number of sensory neurons. AAV vectors expressing either SpH or a Cre-GFP fusion 
protein, when injected into the intact sciatic nerve, were found to transduce 1-3% of 
DRG neurons. It has recently been reported that transient demyelination of sciatic nerve 
axons improves retrograde transduction, by improving axonal access (Hollis et al., 
2010). Similarly, we found that nerve crush could improve the number of GFP positive 
cells in the L5 DRG to 8%. This is lower than the 20% (Hollis et al., 2010) and 30% 
(Towne et al., 2009) transduction that have been achieved by others when injecting into 
the intact nerve. However, those studies used AAV2/1 and AAV2/6 vectors, which may 
be more effective at retrograde neuronal transduction than AAV2/5. Indeed, AAV2/5 
has been shown to exhibit very poor retrograde transduction of motoneurons following 
injection into nerve or muscle, compared to AAV2/1 (Hollis et al., 2008). Very efficient 
transduction of DRG neurons using AAV2/5 has been achieved using direct DRG 
injection (Mason et al., 2010), consistent with its remarkable efficiency when directly 
injected into brain or spinal cord, as shown in this Chapter and elsewhere (Burger et al., 
2004; Paterna et al., 2004; Blits et al., 2009). While 100% transduction of sensory 
neurons may be desirable for targeted gene delivery to act as a putative treatment, 





4.4.4 Potential uses of AAV-SpH to study sensory neuron projections 
A discussed above, AAV-SpH could be used to study plasticity of a major descending 
axonal tract after spinal cord injury. However, the versatile nature of viral vectors 
accommodates their application to a variety of neural tissues and experimental 
paradigms. One particular area where the application of the AAV-SpH virus may be 
useful is to elucidate the mechanisms underlying the development of neuropathic pain. 
One proposed mechanism is the sprouting of low threshold, large Aβ mechanoreceptors 
into superficial regions of the dorsal horn of the spinal cord, to synapse with 
nociceptive neurons (Woolf et al., 1992; Shortland and Woolf, 1993). However, this 
finding remains controversial as it has been claimed that the labelling, which was 
shown using CTB tracing, was artefactual (Hughes et al., 2003). Two recent studies 
have provided evidence for the role of synaptogenesis in the development of 
neuropathic pain by stereologically counting the number of synapses in the dorsal horn 
(Lin et al., 2011; Peng et al., 2010). This was achieved by immunostaining spinal cord 
sections for synaptophysin and counting the number of objects. This method did not 
identify the origin of the synapses. Using AAV-SpH, it would be possible to label 
primary afferents and map their terminations in the spinal cord. In addition, as the 
vector labels synapses, it becomes possible to measure synaptogenesis after neuronal 
injury.  
 
4.4.5 Technical considerations and future directions 
While viral vector delivery of SpH to neuronal populations is an exciting prospect for 
the study of synaptogenesis in a particular CNS tract or system, several considerations 
remain to be addressed. In this Chapter, the bright puncta that are observed on axons 
when SpH is expressed in neurons in vitro or in vivo have been referred to as synapses. 
However, whether these SpH-positive puncta are bona fide synapses remains unclear. 
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They may be vesicles transporting SpH along the axons and towards synapses, SpH 
aggregation in the axon as a side effect of overexpression or presynaptic specialisations 
with no corresponding postsynaptic site. To investigate the nature of the puncta, further 
work is required, including double immunostaining for pre- and postsynaptic markers 
as well as SpH. Colocalisation with a presynaptic marker (e.g. synapsin or 
synaptophysin) will rule out non-specific SpH accumulation. Close apposition with a 
postsynaptic marker (e.g. PSD-95) will confirm that the SpH-positive puncta are true 
synapses.  
 
A recent study has used inducible, genetically encoded markers of the CST to study 
remodelling of the tract after SCI and specifically counted the numbers of boutons 
along CST collaterals, which were identified by their morphology and co-expression of 
synaptic markers, such as synapsin I (Lang et al., 2012). The morphology of the 
terminal CST branches and their boutons are very similar in appearance to those seen in 
the present study. The authors used the Thy1 promoter to drive YFP expression, 
meaning that YFP expression was Golgi-like, filling the cytoplasm and complicating 
the discrimination of boutons. As used in this Chapter, AAV-SpH accumulates much 
more brightly in the puncta than along the collateral branches, potentially making it a 
more useful tool to study synapses. However, it remains likely that the tool can be 
further improved. The SpH construct expressed by AAV-SpH is the same as that 
originally described by Miesenbock et al. (1998), but improved constructs have 
subsequently been described and may be considered in the future. For example, fusing 
the pHluorin reporter to a synaptic protein that is more localised to the synapse, such as 
synaptophysin or vGlut1-glutamate transporter, results in a significantly improved 





This tool has been developed with a view to investigating the effect of nervous system 
injury on synapse location and function. However, it is possible injury could affect 
neuronal physiology and cause confounding issues. Axonal transport of SpH may be 
affected, such that if SpH is not visible in regenerating tips of axons, synaptogenesis 
may be underestimated. In addition, as with more traditional tracing techniques and in 
contrast with transgenic approaches, this approach is also subject to interanimal 
variability. Out of the 3 brain-injected animals the number of SpH-positive axons in the 
dorsal CST in the cervical spinal cord varied from ~1500 in the animal with the fewest 
positive axons to >5000 in the animal with the most. Viral vectors are additionally 
vulnerable to batch differences in titre, which may complicate their routine use. 
However, this variability can be controlled for by normalising to the number of 
transduced axons in the dorsal CST. Perhaps a more important issue is whether the 
number of presynaptic boutons corresponds to the number of axons in the tract. If there 
is great variability in this parameter, the ability to discriminate true injury or treatment 
effects from the natural interanimal variation in synapse number labelled will be 
compromised. Encouragingly, results gathered from brain-injected animals so far show 
that the number of synapses labelled is greater in those animals that have larger 
numbers of transduced CST axons and vice versa. In addition, the number of synapses 
labelled per spinal cord section is very consistent within an animal. However, the ratio 
of synapses to axons is not equivalent for the 3 animals. Further optimisation of the 
technique/quantification method will shed light on this issue.  
A further problem that was encountered in these experiments is the low transduction 
efficiency of DRG neurons following sciatic nerve injection of AAV-SpH. A simple 
way to address this would be to crush the sciatic nerve at the time of AAV injection, as 
this was found to improve AAV-GFP-Cre transduction fourfold. However, introducing 
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a crush injury may not be desirable for pain studies as this additional injury alone may 
affect syanptogenesis and pain behaviour. Instead, constructing a vector using a 
different serotype may be the optimal solution. AAV2/1 and AAV2/6 are likely to be 
good candidates for alternative serotyping, according to previous studies (Hollis et al., 
2008; Towne et al., 2009).  
 
In this Chapter we describe the visualisation of synapse function in vitro and 
anatomical synapse distribution in vivo. The ultimate aim of the project is to test 
whether newly formed synapses are viable and capable of releasing neurotransmitter. If 
not, the regenerative sprouting described by many may be exactly what Cajal suspected 
– an abortive attempt at regeneration, with little functional meaning. Certainly, 
significant challenges lie ahead in the development of a paradigm for using SpH as a 
marker of synaptic activity. It is likely that an ex vivo slice preparation will be the 
starting point for further studies, which will allow manipulation of the preparation and 
flexibility regarding imaging and electrical stimulating methods.  
 
4.4.6 Conclusions  
Despite these reservations and the considerable challenges that lie ahead, AAV-SpH is 
a promising tool for the study of anatomical plasticity in the nervous system. The use of 
viral vector technology is an attractive alternative to injection of classic tracers or 
transgenic animals. AAVs in particular are easy to produce, produce little or no toxicity 
and transduce CNS tissue in an efficient, stable and neurotropic manner. Here we have 
shown that an AAV expressing a fluorescent synaptic protein can selectively label the 
CST and allow the visualisation and quantification of the number of synaptic terminals 
of its axons. AAV-SpH has the potential to become a powerful tool for investigating 



























5.1 Challenges to clinical translation  
 
Traumatic SCI has catastrophic consequences, both for the individual living with 
lifelong disability and for society, in terms of the enormous healthcare and financial 
burden. Despite a wealth of research into regenerative medicine, no treatment that leads 
to any significant functional recovery has emerged. However, the scientific research 
effort continues to advance understanding of the neurobiological basis of SCI and has 
generated a plethora of prospective treatments, including pharmacological, biologic, 
surgical and rehabilitative interventions. A number of promising therapies have entered 
clinical trials, but most have been discontinued due to insufficient evidence of efficacy 
(Tator, 2006). An exception to this trend is the corticosteroid methylprednisolone, 
which is used routinely in some countries to minimise secondary damage and 
inflammation following SCI. However, the use of methylprednisolone has become 
increasingly controversial due to reports of limited clinical benefits and adverse side 
effect profile (Hurlbert and Hamilton, 2008). The complex and multifactorial nature of 
SCI makes it seem unlikely that targeting a single factor could lead to sufficient repair 
to generate functional recovery. However, significant plasticity occurs spontaneously 
after SCI, in parallel with spontaneous improvements in function (Raineteau and 
Schwab, 2001), so treatments that augment this endogenous process may represent a 
realistic therapeutic strategy. The extent of spontaneous improvement in humans with 
SCI is greater in those with a larger proportion of spared white matter, suggesting that it 
is reorganisation of this surviving tissue that mediates recovery (Blesch and Tuszynski, 
2009). The patients with the greatest spontaneous recovery are those termed ASIA B, C 
or D by the American Spinal Injury Association (ASIA www.asia-spinalinjury.org). 60-
80% of ASIA C patients undergo spontaneous improvement, compared with 20% of 
patients with clinically complete injuries (ASIA A patients). Evaluation of a putative 
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plasticity-promoting therapy remains challenging. The heterogeneity of human injury 
and the high rates of spontaneous improvement in function in patients with clinically 
incomplete injuries mean that it will be challenging to distinguish a treatment effect 
from endogenous changes, unless the drug effect is extremely striking (Fawcett et al., 
2006; Blesch and Tuszynski, 2009). Any effect could be easier to detect in ASIA A 
patients, but since there is less white matter for the drug to act on, achieving an effect 
will be difficult. Clearly, significant challenges in the translation of plasticity-promoting 
treatments remain. 
 
5.1.1 ChABC as a putative treatment for SCI 
ChABC has been reproducibly shown, by independent laboratories, to have beneficial 
neuroanatomical and functional effects across different experimental models (Bradbury 
and Carter, 2011). However, many questions remain to be addressed in small animal 
models before further progress toward the clinic can be made. The majority of studies 
have employed an injury consisting of the transection of specific tracts, or transection 
of one half of the spinal cord, but very few studies have investigated efficacy in animal 
models more closely mimicking human injuries, the majority of which involve a spinal 
contusion. Of the few studies which have employed contusion or compression injuries, 
beneficial effects on locomotion and bladder function have been reported following 
treatment with ChABC, either given as a single therapy (Caggiano et al., 2005), or 
when applied as a combination therapy (Karimi-Abdolrezaee et al., 2010). The results 
reported in Chapter 3 of this Thesis support these findings. Clearly, significant 
differences in the neuroanatomy, behaviour and physiology exist between rodents and 
humans, limiting the predictive value of small animal models for human trials. ChABC 
has been delivered intrathecally to cats with hemisection injury and has yielded 
encouraging results that support the efficacy described in rodent models, with cats 
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exhibiting accelerated recovery (Tester and Howland, 2008). Nonhuman primates bear 
a far closer resemblance to humans and represent an essential stepping stone on the path 
to translation (Courtine et al., 2007). Studies assessing ChABC in nonhuman primate 
models of SCI have not yet been performed, but will provide valuable insight into the 
safety, efficacy and potential future use of ChABC in the clinic.  
 
5.1.2 Potential side effects of ChABC 
Studies in rodent models of SCI have so far failed to highlight any adverse effects of 
ChABC treatment, but it is important to consider possible deleterious effects of 
chronically elevated plasticity. For example, it is conceivable that unchecked sprouting 
could lead to the development of aberrant connections and an increased sensitivity to 
painful stimuli (Christensen and Hulsebosch, 1997). This has been specifically 
investigated, in this Thesis (Chapters 2 and 3) and elsewhere (Barritt et al., 2006; 
Galtrey et al., 2007; Karimi-Abdolrezaee et al., 2010), without any evidence for 
increased pain sensation. However, pain remains a potential complication to be aware 
of as translation progresses to larger mammals. Another adverse outcome that appears 
to be the result of neuroplasticity is autonomic dysreflexia, an exaggerated sympathetic 
reaction in response to sensory input below the lesion (Weaver et al., 2006). This 
condition can be dangerous and investigators should remain cautious when using 
treatments that promote plasticity (Brown and Weaver, 2012). So-called maladaptive 
plasticity has also been implicated in spasticity, cardiac arrhythmias and bladder, bowel 
and sexual dysfunction (Collins et al., 2006; de Groat and Yoshimura, 2006; Johnson, 
2006; Nout et al., 2006). Thus, although neuroplasticity represents a promising avenue 
for the promotion of functional recovery after SCI, it is important to note that this 




5.1.3 Timing of intervention 
Anatomical data from Chapter 3 support a neuroprotective function for ChABC by 
showing reduction in the characteristic lesion pathology that develops following 
contusion injury and also showed evidence of anatomical plasticity below the injury. If 
neuroprotection is the main mechanism underlying improved function then this effect is 
likely to be reduced if there is a delay in ChABC expression. Although previous studies 
have reported efficacy with delayed ChABC delivery (Carter et al., 2011; Wang et al., 
2011), these studies employed injury models that have less traumatic pathology than the 
contusion injury. It is vital that experimental treatments in animal models of SCI are 
applied with an appropriate delay and that the therapeutic window for the effectiveness 
of treatments is established. So far, the majority of studies have investigated ChABC 
applied immediately after injury, but it would be helpful, and perhaps more realistic, to 
also investigate the effect of subacute application (72 hours to 14 days after injury, 
Tator, 2006). In addition, this will help elucidate the magnitude of the neuroprotective 
versus the plasticity-promoting effect of ChABC. 
 
5.1.4 Viral delivery of ChABC – advantages and limitations  
The prospect of long-term CSPG digestion using LV-ChABC makes this a promising 
tool for future studies, overcoming the considerable difficulties of delivering an active 
enzyme repeatedly to the spinal cord. However, translation of lentiviral vectors into the 
clinic is associated with significant biosafety concerns. Lentiviral vectors integrate 
randomly into the host cell genome, leading to the danger of insertional mutagenesis 
and the formation of cancers, which have been seen in animal models and in human 
clinical trials (Li et al., 2002; Hacein-Bey-Abina et al., 2003; Themis et al., 2005). 
These concerns may be circumvented by the use of integration-deficient vectors 
(Yanez-Munoz et al., 2006) or the use of regulatable viral vector, where gene 
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expression can be switched off (Gossen and Bujard, 1992; Gossen et al., 1995). An 
advantage of gene delivery via viral vector includes long-term expression of the 
transgene. In the case of lentiviral vectors, expression has been reported for periods of 
up to 16 months (Kordower et al., 2000; Bienemann et al., 2003; Balaggan et al., 2006). 
This is useful in the context of disease treatment as the therapeutic protein can act over 
an extended period of time, especially in the case of an enzyme, such as ChABC where 
digestive activity rapidly decreases within 1-2 days after a single injection (Lin et al., 
2008). Chapter 3 describes the use of three different lentiviral vectors expressing 
ChABC and demonstrates that there is considerable spatiotemporal variability in CSPG 
digestion between vectors. Furthermore, the extent of CSPG digestion appeared to 
correlate with the degree of improvement in axonal conduction after contusion injury. 
In Chapter 3 of this Thesis, LV-ChABC enabled CSPG digestion throughout the spinal 
cord, including in lumbar segments where the sciatic nerve spinal circuitry is located 
and which may have contributed to the development of A-fibre wind-up. The 
effectiveness of gene transfer in the nervous system could be compromised by an 
immune response to the vector particles (Wong et al., 2006). However, lentiviral vector 
injection has been associated with minimal, asymptomatic inflammation (Kordower et 
al., 2000; Mazarakis et al., 2001) and systemic immunity is not induced after their 
application to the CNS (Abordo-Adesida et al., 2005). Thus developments in enhancing 
the safety features of lentiviral vectors, together with a lack of immunogenicity, make 
lentiviral vectors potential attractive candidates for gene therapy applications and 
several clinical trials are underway (Snyder et al., 2010). 
 
5.1.5 Potential alternatives to ChABC 
Although it is well established that CS-GAG chains are responsible for CSPG-mediated 
inhibition, the mechanisms that govern the inhibition of axonal growth are not resolved. 
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It is becoming increasingly clear that CS-GAGs with different sulphation motifs are 
differentially up-regulated after injury, suggesting distinct roles for the various 
polysaccharides (Gilbert et al., 2005; Properzi et al., 2005; Lin et al., 2011). A recent 
study by Brown et al. (2012) identified a sugar epitope, CS-E, that is primarily 
responsible for the inhibitory effects of CSPGs and activates growth inhibitory 
signalling pathways via its interaction with a known CSPG receptor, PTPσ (Brown et 
al., 2012). Furthermore, the authors show that the use of a CS-E blocking antibody can 
enhance axonal regeneration in vivo, presenting the opportunity to block the inhibitory 
effects of CSPGs by targeting a specific CS epitope, rather than by removing all CS-
GAGs. These findings also present the opportunity to specifically target the enzyme 
that synthesises CS-E, sulfotransferase Chst15, by developing a small molecule 
antagonist. Another enzyme that has been suggested as a target to prevent the synthesis 
of CSPGs is xylosyltransferase, which is responsible for the glycosylation of CSPGs. 
Targeting this enzyme has been shown to lead to increased axonal growth in a model of 
SCI in vivo (Grimpe and Silver, 2004; Hurtado et al., 2008). Overall, using antibodies 
or small molecules to target specific CSPG components may offer an alternative 
approach to treatment which may be less invasive and immunogenic, as well as having 





The results of this Thesis are in support of other preclinical studies which suggest that 
ChABC is a promising treatment for SCI. Moreover, this work has demonstrated that, 
by using a gene delivery approach to optimise delivery and achieve stable degradation 
of CSPGs, we can promote significant functional repair in a clinically relevant 
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traumatic model of SCI, and can promote extensive plasticity of reflexes when applied 
to the spinal cord after injury to the peripheral nerve or the spinal cord. Although 
significant challenges remain before clinical translation of ChABC as a therapeutic 
strategy, nevertheless these data show promise that progress is being made towards 
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